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Abstract 
Today, more than 40 million people worldwide are affected by dementia and neurodegenerative 
disorders. Onset of these and more than other fifty human diseases is associated at the molecular 
level with insoluble fibrillar protein aggregates, termed amyloids. The molecular origin and 
mechanistic link between amyloid formation and disease aetiology remain unclear and no 
disease modifying therapies are available for these disorders. Strong evidence links propensity 
of proteins to misfolding and aggregation to the pathological biology implicated in the onset of 
these diseases. Despite its importance, unraveling amyloids properties and formation still 
represents a formidable experimental challenge, mainly because of their nanoscale dimensions 
and their dynamic, heterogeneous and transient nature. Therefore, the investigation of the 
misfolding of monomers and oligomers into fibrils and their mechanical and structural 
properties is central to understand their stability, toxicity and mechanism of clearance in the 
body and to design new therapeutic strategies to the amyloid diseases problem.  
 The main objective of this PhD thesis is the biophysical investigation of amyloids 
structure and formation at the single scale aggregate. This objective was pursed mainly by the 
use of both conventional and innovative Atomic Force Microscopy (AFM) methodologies. 
AFM imaging emerged in the last decades as one of the most powerful and versatile single 
molecule techniques, because of the possibility to acquire with sub-nanometer resolution 3-D 
morphology maps of specimens on a surface. In the frame of this work, conventional AFM 
imaging and innovative AFM-based methods were assessed to resolve the complex and 
heterogeneous energy landscape of proteins aggregation providing direct information on the 
aggregation pathway and on the morphology, structure and mechanical properties of species 
forming during the process. 
  Initially, we used AFM imaging to compare quantitatively the kinetics of aggregation 
and the oligomeric and fibrillar morphological differences between wild type and mutated 
forms of huntingtin and -synuclein proteins. In the first case, we focused on the effects of N-
terminal post-translation modifications in the fibrillization of huntingtin. We demonstrated that 
a phosphorylated mutated form (pT3) of the protein fibrillates significantly slower than the wild 
type protein and that both forms aggregate below the polyglutamine length threshold for 
Huntington’s onset. In the latter case, aggregation of wild type and H50Q mutated form of -
synuclein were investigated. This mutation was described in the case of patients with a familiar 
form of Parkinson’s disease and dementia. Our study demonstrated the strict link between the 
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disease and the mutated form of the protein, which effectively enhanced -synuclein 
aggregation. Successively, we investigated the early stages of -synuclein fibrillization. We 
showed that the early stages of amyloid assembly proceed directly through the formation of 
single monomeric strands, which hierarchically assembly into intermediate prefibrillar 
structures and into the final mature fibrils. To investigate further the properties of these new 
prefibrillar species, we performed AFM force spectroscopy experiments, which confirmed the 
non-mature cross--sheet structure of this species and enabled studying their force of 
interaction with surfaces.  
 Successively, new AFM-based methodologies, such as peak force quantitative 
nanomechanical mapping (PF-QNM) and infrared nanospectroscopy (nanoIR), were 
successfully implemented to unravel amyloids mechanical and structural properties at the 
nanoscale. The PF-QNM method enabled investigating the evolution of mechanical properties 
of aggregates forming during fibrillization of A42 and -synuclein. We demonstrated that β-
sheet content is a major factor determining amyloid intrinsic stiffness. NanoIR, simultaneously 
exploiting AFM and infrared spectroscopy, was applied to investigate at the nanoscale the 
misfolding process and the structure of the amyloid species present during the aggregation 
process. A first proof of concept enabled distinguishing and structurally characterizing 
monomeric and aggregated forms of lysozyme -droplets. Successively, it proved to be ideal 
to characterize, individually and at the nanoscale, the oligomeric and fibrillar species formed 
during amyloid aggregation of the Josephin domain of ataxin-3. We described their secondary 
structure, monitoring at the nanoscale an -to- transition, and coupled these studies with an 
independent measurement of the evolution of their intrinsic stiffness. Consequently, for the first 
time at the nanoscale, we were able to link nanomechanical and structural properties of 
individual amyloidogenic species throughout their fibrillization. 
 Innovative AFM-based techniques correlated morphological, mechanical and structural 
properties of amyloid aggregates at the nanoscale. For this reason, they represent a future 
fruitful avenue to unravel the process of protein misfolding and to elucidate the molecular 
mechanisms of amyloid formation. The comprehension of these fundamental processes could 
allow the design of pharmacological approaches to contrast the onset of amyloid diseases. 
Keywords: Neurodegenerative disorders; Amyloid; aggregation; fibrillization; Atomic Force 
microscopy; Single molecule Techniques; Nanoscale Infrared Spectroscopy; Secondary 
structure measurements; Nanomechanical Properties. 
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Abstract 
Oggigiorno, più di 40 milioni di persone in tutto il mondo sono affette da demenza e da malattie 
neurodegenerative. L’insorgere di queste malattie e di oltre altre 50 patologie umane è 
strettamente connesso a livello biomolecolare con insolubili aggregati di proteine, denominati 
amiloidi. L’origine molecolare e la connessione meccanicistica tra la formazione degli amiloidi 
e l’insorgere della malattia non è stata ancora elucidata, inoltre non esistono ancora delle terapie 
capaci di modificare o interrompere lo sviluppo della malattia. Notevole evidenza correla la 
propensione delle proteine a misfoldarsi e aggregarsi con i processi biologici che causano 
l’insorgenza di queste malattie. Malgrado l’importanza, la possibilità di svelare le proprietà e 
la formazione degli amiloidi rappresenta ancora una formidabile sfida sperimentale, 
principalmente a causa delle loro dimensioni nanometriche e della loro natura dinamica, 
eterogenea e transiente. Lo studio del misfolding dei monomeri ed oligomeri per formare le 
fibre e le loro proprietà meccaniche e strutturali è fondamentale per comprendere la stabilità, la 
tossicità e il meccanismo di degradazione di queste strutture nel corpo umano e per 
conseguentemente ideare strategie per curare le malattie amiloidogeniche. 
 Il principale obiettivo di questa tesi è l’investigazione biofisica della struttura e 
formazione degli amiloidi su scala del singolo aggregato. Questo obiettivo è stato perseguito 
principalmente attraverso l’uso sia di convenzionali sia di innovative tecniche basate sulla 
Microscopia a Forza Atomica (AFM). L’AFM è emersa negli ultimi decenni come una delle 
più potenti tecniche capaci di investigare singole molecole, grazie alla possibilità di acquisire 
immagini morfologiche tridimensionali di un campione su una superficie, con risoluzione sub-
nanometrica. Nell’ambito di questo lavoro, la realizzazione di immagini AFM e l’applicazione 
di nuove metodologie basate su questa tecnica sono state utilizzate per comprendere il 
complesso ed eterogeneo processo di aggregazione delle proteine e per fornire informazioni sul 
percorso di aggregazione e sulla morfologia, struttura e proprietà meccaniche delle specie 
formate durante il processo di aggregazione. 
 Inizialmente, la realizzazione di mappe morfologiche convenzionali è stata utilizzata 
per comparare quantitativamente la cinetica di aggregazione di forme standard e mutate 
dell’huntingtina e dell’-synucleina. Nel primo caso, abbiamo focalizzato l’attenzione 
sull’effetto di mutazioni post-traslazionali nell’ N-terminus della proteina nel modificare la sua 
dinamica di aggregazione. Questo, ci ha permesso di dimostrare che una forma fosforilata della 
proteina aggrega molto più lentamente che la forma non mutata. In particolare, entrambe le due 
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forme studiate hanno mostrato di essere capaci di fibrillare anche sotto la soglia genetica 
necessaria per l’insorgere della malattia. Nel secondo caso, abbiamo studiato la forma naturale 
e una forma mutata dell’-synucleina, quest’ultima è legata all’insorgere genetico del morbo 
di Parkinson. Il nostro studio ha permesso di dimostrare che questa mutazione è strettamente 
legata alla malattia ed che capace di aumentare la sua propensione ad aggregarsi. 
Successivamente, abbiamo anche studiato nel dettaglio i momenti iniziali dell’aggregazione di 
questa proteina. Questo studio ci ha permesso di mostrare che l’aggregazione procede 
direttamente attraverso la formazione dei catene di monomeri misfoldati. Per dimostrare che 
queste strutture non possiedono ancora una completa struttura amiloide, ne abbiamo anche 
investigato le loro proprietà meccaniche grazie alla spettroscopia a forza atomica. 
 Nella seconda parte di questo lavoro ill mapping quantitativo delle proprietà 
nanomeccaniche (PF-QNM) e la spettroscopia ad infrarosso su scala nanometrica (nanoIR) 
sono state usate per svelare le proprietà meccaniche e strutturali degli amiloidi su scala del 
singolo aggregato. Il PF-QNM è stato utilizzato per monitorare l’evoluzione delle proprietà 
meccaniche e per dimostrare che il contenuto di struttura secondaria  è uno dei fattori principali 
nel determinare la loro elasticità. Il NanoIR è stato applicato per investigare su scala 
nanometrica le specie amiloidi presenti durante il processo di aggregazione. Un primo 
esperimento ha permesso di mostrare che lo strumento è in grado di discernere proteine nello 
stato monomerico e proteine aggregate sotto forma di micro-gocce. Un secondo studio, ha 
dimostrato che la tecnica è capace di caratterizzare singole specie amiloidi, durante il processo 
di aggregazione della proteina Josephina. Lo strumento ha permesso di studiare la struttura 
secondaria degli aggregati e, grazie a misure parallele di elasticità, di collegare direttamente per 
la prima volta su scala del singolo aggregato le proprietà meccaniche e strutturali delle specie 
amiloidi. 
 Le innovative tecniche usate in questo studio hanno permesso di collegare direttamente 
su scala nanometrica le proprietà morfologiche e ultrastrutturali degli amiloidi. Per tale ragione, 
rappresentano una interessante e fruttuosa strada per elucidare in dettaglio le proprietà e il 
meccanismo di formazione degli amiloidi. Queste informazioni sono fondamentali per trovare 
un rimedio all’insorgere delle malattie correlate alle malattie neurodegenerative. 
Parole Chiave: Disordini Neurodegenerativi; Amiloidi; Aggregazione; Fibrillizzazione; 
Microscopio a Forza Atomica; Tecniche a singola molecola; Spettroscopia ad infrarosso; 
Misure di struttura secondaria; Proprietà nanomeccaniche. 
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Chapter 1. Introduction 
This first introductive chapter consists of two main parts. The first one defines the amyloid state 
of proteins and it describes the state of the art of amyloid properties and formation, as it is 
known today. Besides, it relates the problem of protein aggregation to misfolding diseases and 
nanotechnological applications. The second part describes the experimental path followed in 
this thesis to bring new insights into the amyloid formation and ultrastructural properties. The 
used methodologies are strictly related to the biophysical investigation conducted in this thesis 
are presented. They are divided in two categories: spectroscopic bulk techniques and the single 
molecule atomic force microscopy (AFM) based methods. In particular, last part of the chapter 
presents the application of recently established innovative AFM-based techniques enabling to 
study at the nanoscale amyloid formation and properties. 
1.1 Amyloids, Neurodegeneration and Nanotechnological Applications 
Aging of the world population has increased the visibility of several human neurodegenerative 
disorders and diseases such as Parkinson’s, Huntington’s, Alzheimer’s diseases, diabetes of 
type II and several forms of Ataxia.1-3 The onset of these and of more than fifty further related 
pathologies is associated at the molecular level with the proliferation of insoluble fibrillar 
protein aggregates, termed amyloids4, formed from normally soluble cellular proteins. Despite 
their key role in human health disorders, amyloid fibrils are not only associated with pathology, 
and such structures have recently been discovered in many physiologically beneficial roles. 
These include bacterial coatings, catalytic scaffolds, adhesives and structures for the storage of 
peptide hormones,5-7 for which the term of functional amyloids has been cast. Amyloid fibrillar 
aggregates possess a universal cross -sheet quaternary structure and are highly resistant to 
proteolytic degradation.8 Interestingly, despite the obvious differences in amino acid sequences 
and native structure, these amyloidogenic peptides all appear to share a common β‑sheet 
conformation of their polypeptide backbone and it is likely that this characteristic confers the 
fibrillar, proteolytic resistant and insoluble features to all forms of amyloids. From a structural 
point of view, they are unbranched, several micrometer long fibrils, with a diameter of the order 
of 10 nm.8,9 Moreover, amyloidogenic structures exhibit remarkable mechanical properties with 
Young’s moduli in the range of several GPa.10-12 
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1.1.1 Brief Early History 
The term amyloid, meaning starch-like (amylum in latin) was coined initially by Virchow in the 
19th century to describe structural bodies in human tissues, such as the iodine stained deposits 
seen in liver during post-mortem autopsy.13 He discovered that the macroscopic tissue 
abnormality stained pale blue on treatment with iodine, and violet upon the subsequent addition 
of sulfuric acid.14 For this reason, he concluded that the substance underlying the evident 
macroscopic abnormality was cellulose. At that time, the distinction between starch and 
cellulose was unclear and Virchow considered the amyloid substance to be starch. This 
hypothesis did not stand for long; indeed, few year later, Friedrich & Kekule demonstrated that 
proteins are the major component of amyloid deposits. Despite the demonstration of the 
proteinaceous nature, the name amyloid has endured.15 The initial method used to identify 
amyloid was that of iodine staining, introduced by Virchow. This method was soon replaced by 
one of the most important histological staining marker for amyloid, Congo red, which was 
introduced by Bennhold.16 In particular, the aggregates have a specific binding to the dye Congo 
Red which produced an apple green birefringence when examined between cross polarizers in 
a light microscope. Other staining methods have been successively developed and several of 
them are still used; the most important of these is probably Thioflavin T.17,18 The birefringence 
of polarized light suggested that amyloid was fibrillar in structure. We could affirm that the 
modern history of amyloidosis investigation have started with the discovery by Cohen and 
Calkins19 that amyloid are not amorphous, as contrarily suggested by light microscopy. Indeed, 
the two scientists showed by electron microscopy that amyloids have a characteristic fine 
fibrillar ultrastructure. This finding was confirmed in several other studies and pointed to a 
specific structural organization of the constituent proteins – an idea that at that time was a 
complete breakthrough. Finally, progress in biochemical and biophysical techniques enabled 
the isolation of amyloid fibrils from tissues and their X-ray fiber diffraction patterns allowed 
the interpretation of the nowadays universally accepted characteristic cross-β structure.20  For 
a long time it was believed that all amyloids possess the same amino acid composition. 
Sequence analysis of the proteins comprising a range of ex vivo amyloid fibrils revealed that 
each amyloid disorder was associated with a particular protein or peptide. One of the first 
amyloidogenic protein to be isolated and analyzed was the A peptide, which was discovered 
to be the main component forming the bulk of amyloid plaques in Alzheimer’s diseased brain 
specimens.21 Together with the postulation of the “prion hypothesis” describing the possibility 
of infectious amyloid protein species and the discovery of its link with the Creutzfeldt‑Jacob 
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disorders (spongiform encephalopathies),22,23 these findings enormously raised the interest of 
the scientific community in amyloids formation and properties. A new class of protein-related 
human diseases, due to not classical infectious agents as viruses and bacteria, was identified 
fuelling a new area of intense research. 
1.1.2 Amyloid Structure 
Amyloid fibrils appear at the atomic force microscopy or at the electron microscopy as 
unbranched elongated structures just few nanometers in diameter, but with several micrometers 
of length. As demonstrated by X-ray diffraction, amyloid characteristic fingerprint is the 
universal cross-sheet quaternary structure.8,20 The repeating subunit of such structure consists 
of β-strands, forming continuous hydrogen-bonded β-sheets, which are oriented 
perpendicularly to the fibril axis.24 The β‑sheet ribbons are associated via side chain interactions 
that serve to stabilize the structure, which is closely packed and highly ordered.25 The repeating 
cross- motif gives rise to two characteristic X-ray diffraction patterns: 1) a meridional 
reflection at ~5 Å, corresponding to the inter -strand spacing, 2) an equatorial reflection at ~10 
Å corresponding to the distance between stacked -sheets (Fig. 1.1).24 
 
Figure 1.1 Amyloid fibrils, cross- structure and related X-ray diffraction pattern. Adapted from 
Ref. 24. 
 Notably, there is not a clear similarity in the sequence, structure and functions of the 
group of amyloidogenic proteins. Indeed, the cross- structure is largely independent of the 
sequence of the polypeptide chain of the precursor protein and a number of unrelated 
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polypeptide sequences have been observed to form fibrils with a very similar structure at atomic 
level.8,26 Moreover, notwithstanding that the amyloid state was identified in the context of 
human diseases, several studies have shown that a wide class of peptides and proteins can 
aggregate into amyloid fibrils with same characteristics as the ones related to diseases. These 
findings suggest that the amyloid structure could be adopted by any polypeptide chain.27 To 
support this hypothesis, several experiments have been performed to show that homopolymers 
made up of only one type of amino acid can form the cross- sheet structure.28 Besides, several 
of the possible amyloid structures proposed, suggested that the amyloid core region is generally 
composed by two or four -sheets interacting closely each other.4,29,30 Nevertheless, several 
observations have demonstrated that the details of the structure and its stability are highly 
dependent on the side chains of the aggregating sequence.11 These details include the length of 
-strand, the parallel or antiparallel arrangement of the -sheets, the inter-sheet distance and 
the arrangement of all the other regions that are not part of the fibril core (Fig. 1.2).28 All these 
results confirm the universality of the amyloid state, which is accessible to extremely different 
polypeptide chains independently of their sequence.31,32 
 
Figure 1.2 Influence of side chains on the amyloid structure.  
(A) Schematic universal cross -sheet structure. (B) -strands spacing (orange) and -sheets distance 
(green) as a function of the amino acid side chain van der Waals volume (filled green circles indicate 
homopolymers, open symbols heterogeneous sequences). Adapted from Ref. 27,28. 
 These investigations also confirmed the observation that mature amyloid fibrils are 
formed by the hierarchical self-assembly33 of cross- protofilaments, composed by a pair of -
sheets, twisting together through specific side chains interactions.26 Although the basic 
structural arrangement of the cross-β structure is conserved for different fibrils, there are 
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different ways how protofilaments can pack into the three-dimensional fibril structure and 
causing a range of structurally different amyloid fibrils (Fig. 1.3).34 Morphological different 
fibrils can diverge in the nature and number of component protofilaments, in their arrangement 
inside the fibrils and in several structural properties, such as the cross-sectional thickness, 
helical periodicity and chirality.35-39 This heterogeneity is termed polymorphism and it implies 
that, for the same peptide, fibril formation can lead to many different patterns of inter- or intra-
residue interactions.34,36,40  
 
Figure 1.3 Fibrils self-assembly polymorphism. 
Several examples of fibrils polymorphism are shown. In particular, polymorphism can be due to 
different number, arrangement and structure of protofilaments composing the fibril. From Ref. 34.  
1.1.3 Misfolding and Amyloid Aggregation 
The native state of a protein was initially associated with a compact globular conformation 
possessing a rigid and highly ordered structure. It was discovered that the structure of globular 
proteins is encoded in their amino acids sequences and that these proteins spontaneously fold 
following a diffusional research of a conformational free energy minimum, which corresponds 
to the native state.41,42 Later on, it has been discovered that certain proteins do not form a rigid 
globular structure and that in their native structure they are intrinsically disordered, even under 
physiological conditions. These proteins are still able to fulﬁll their speciﬁc functions and they 
are termed intrinsically disordered or naturally unfolded proteins.43-45 The existence of the 
disordered regions allows these proteins to interact with their numerous binding partners, which 
eventually led the protein to acquire a partially folded state.46,47 Such interactions are often 
accompanied by the formation of complexes that possess a more ordered structure than the 
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original components and lower free energy minima than the native state.43,47,48 This implies that 
proteins can acquire other biologically relevant conformational states different from their native 
one. Globular proteins can also adopt intermediate conformations simply as consequence of 
thermodynamical fluctuations, which correspond to local minima in their energy landscape.49,50 
Some globular proteins are shown to have unstructured, highly dynamic fragments (termini, 
loops, etc.).51,52 Furthermore, partially unfolded states could retain a biological function as 
cellular trafficking and translocations through mitochondrial and nuclear membranes.53-55 
 The partially folded/unfolded states of a protein, independently of its globular or 
naturally unfolded conformation, are vulnerable to misfolding and to aggregation into amyloid 
structures.4,27,42,56-58 This condition is promoted by conditions that destabilize the native fold of 
the protein, such as high temperature, high pressure, low pH, organic solvents, natural or post-
translational mutations.57,59,60 During their aggregation, proteins initially in their native 
monomeric forms undergo internal structural rearrangement, and misfold into conformations 
that are susceptible to form fibrils.8 Besides, several coexisting aggregate species are formed, 
giving rise to a highly heterogeneous reaction mixture. The fibrillation process typically takes 
the form of a nucleation-dependent polymerization reaction.27,61,62 This model supposes that the 
formation of oligomeric structures is necessary to nucleate the first protofibrillar structures, 
ultimately leading to the formation of the mature amyloid fibrils. This process is typically 
described by a sigmoidal reaction time course, commonly measured by ThT fluorescence and 
light scattering assays (Fig. 1.4).18,63 
 
Figure 1.4 Schematic depiction of the nucleation dependent process of amyloid fibrils formation. 
From Ref. 64. 
7 
 
 According to the classical nucleation process, a primary nucleation step is necessary for 
the formation of aggregates, but in the case of amyloid fibrils several secondary steps exist that 
can be involved.65 In these secondary processes, the formation of the nuclei is catalyzed by 
fibrils fragmentation or surface catalyzed secondary nucleation (Fig. 1.5).27 The availability of 
integrated laws describing protein aggregation allows to extrapolate the microscopic parameters 
determining amyloid fibrillization and to individuate is primary or secondary nucleation 
processes dominate.65-69  
 
Figure 1.5 Possible processes of amyloids nucleation. 
A) Primary nucleation, monomers interact to form an oligomeric nucleus. B) Fragmentation, a nucleus 
breaks forming two nuclei. C) Nuclei surface catalyze the aggregation. Adapted from Ref. 27. 
 The conventional “first-misfolding-then-aggregation” paradigm is the generally 
accepted process of amyloid formation, but several observations have shown that the misfolding 
process could take place after a first step in which native monomers aggregate (“first-
aggregation-then-misfolding”).70-72 These native oligomers undergo a structural misfolding to 
form the early cross- sheets aggregate and the final amyloid fibrillar structures only in a second 
step. Despite the initial difference, both pathways are conceptually similar: a misfolded state, 
monomeric or oligomeric, is necessary to nucleate the formation of the universal amyloidogenic 
cross- sheet structure. 
 Notwithstanding the great success of the kinetics descriptions of amyloid 
formation66,68,73-76, the full elucidation of the process requires the identification of all the 
conformational and oligomeric states adopted by the protein and of its possible aggregates. 
Indeed, structural polymorphism can be encountered at all aggregation levels, and it originates 
as a consequence of the glassy, frustrated energy landscape that underlies misfolding and 
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aggregation.40 Furthermore, oligomeric and protofibrillar structures can form both in-pathway 
and off-pathway of mature fibrils formation.77-79 In Fig. 1.6, we can observe a schematic 
depiction of the different conformational states populated by a protein leading to the formation 
of oligomeric and fibrillar structures, which can be either biologically functional or disease-
related. All these conformational states are regulated in the cell’s biological environment by 
molecular chaperones, degradatory systems and quality control systems.4,56,57,80-82 
 
Figure 1.6 Schematic representation of proteins conformational states bringing to amyloid 
formation. From Ref. 4. 
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1.1.4 Misfolding diseases 
A broad range of human diseases and neurodegenerative disorders is due to the failure of a 
specific peptide or protein to keep its native functional conformational state. This group of 
debilitating pathologies has received increasing visibility because of their link to the ageing of 
the world population in the last century. There are up to now approximately 50 illnesses 
associated with protein aggregation and formation of amyloid structures and they are generally 
indicated as protein-misfolding diseases. In Table 1.1,4 a selected list of amyloid-caused human 
diseases is shown. They can be divided in three classes: neurodegenerative diseases, including 
Parkinson’s, Alzheimer’s, the several forms of ataxias and the spongiform encephalopathies;83 
non-neuropathic systemic amyloidosis, such as lysozyme amyloidosis;84 non-neuropathic 
localized amyloidosis, such as diabetes of type II, which is an endemic disease affecting 
approximately the 6% of human beings.85-87 The major part of these diseases are predominantly 
sporadic (85%), such as Parkinson’s and Alzheimer’s diseases, while others as lysozyme 
amyloidosis and Huntington’s disease arise from genetic mutations and are hereditary (10%). 
In addition, spongiform encephalopathies (5%) are transmissible from animals to humans and 
are highly infectious.23  
Table 1.1 List of Misfolding Diseases. From Ref. 4. 
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 Despite the widespread association of amyloid formation with disease states, the 
mechanistic role of amyloids in cell death and disease onset has remained challenging to 
identify. In particular, the nature of the specific state of proteins that is most prone to cause 
cytotoxicity is not well established. It is clear, however, that aggregated rather than monomeric 
proteins are primarily implicated in the toxicity characteristic of protein misfolding diseases. 
Evidences for this hypothesis derive from: pathology, aggregates localize in the region of 
neuronal loss; biophysics, mutated proteins associated to the disease aggregate more rapidly.88 
Initially, the prevalence of fibrillar protein aggregates in the brains of patients suffering from 
neurodegenerative disorders led many authors to hypothesize that these structures themselves 
cause cell death. Indeed, in the case of systemic amyloidosis, it seems that the major cause of 
the disease onset is simply the presence of large quantities, in some cases even kilograms, of 
amyloid deposits in vital organs, including liver, spleen and kidney.27 Instead, in the case of 
neurodegenerative disorders, several studies revealed only a weak correlation between the 
quantities of accumulated amyloid fibrils and the disease symptoms. In these cases, recent 
evidence has increasingly suggested that prefibrillar aggregates, such as oligomers and 
protofibrils, might be the toxic components, rather than the final mature fibrillar products.88-91 
The oligomeric toxicity could arise from their misfolded nature and at least by partial 
acquisition of the cross- sheet structure. In fact, the structural rearrangements during the 
misfolding and/or aggregation could expose hydrophobic chemical groups, otherwise buried by 
the protein folding in the case of globular proteins or dispersed in the case of intrinsically 
disordered proteins, which normally are not accessible to the cellular environment. The non-
native structure of misfolded oligomers could, finally, interferes with several cellular 
components and processes. Such events could bring to a malfunctioning of the cellular 
machinery and of its crucial aspects as membranes integrity and trafficking, oxidative stress, 
sequestration of essential proteins, ions balance causing finally the cell’s death.4,27,58  
 In the following sections, we briefly describe the details of the neurodegenerative 
diseases, together with the related proteins, mainly investigated in the frame of this thesis:  
Alzheimer’s disease: – Approximately 20 millions of people worldwide have dementia.92 The 
majority of these cases are due to Alzheimer's disease (AD). The most common early symptom 
of the illness is the short-term memory loss, followed then by other behavioral and cognitive 
problems. For this reason, the pathology represents a major public health concern and it has 
been identified as a research priority. The two main pathological hallmarks of Alzheimer's 
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disease are amyloid plaques and intracellular neurofibrillary tangles, formed by the aggregation 
of the of amyloid β proteins (Aβ).21,93 This peptide has a molecular weight of 4 kDa and it has 
an intrinsically disordered structure in solution.94,95. The biological role of the A peptides it is 
not yet clear, though it has been suggested that they could be part of the mechanism controlling 
the synaptic excitatory activity.96,97 A proteins are produced in the brain by a sequential 
proteolytic cleavage of the type I transmembrane amyloid precursor protein (APP) by β- and γ-
secretases. As a function of the site of APP cleavage by the secretase, proteins of different chain 
lengths are generated. The amyloid cascade hypothesis suggests that aggregation and deposition 
of Aβ triggers neuronal dysfunction and death in the brain.98 In the original hypothesis, the 
neuronal dysfunction and death was thought to be a toxic effect of the total fibrillar load. 
However, several studies showed that the number and size of plaques in post mortem AD brains 
do not correlate with the severity of the pathology and that amyloid plaques were found in the 
cortex of cognitively normal elder people.99,100 As the knowledge of pathological effects of 
Alzheimer's disease has increased, research has been focused on the specific alterations in Aβ 
processing, such as the cleavage of amyloid precursor protein (APP) into Aβ peptides, the most 
abundant of which are the Aβ1–40 (90%) and Aβ1–42 (10%) in humans. Despite its minor 
abundance in human plasma and cerebrospinal fluid, the Aβ1–42 peptide has higher aggregation 
propensity and toxicity than Aβ1-40.101 The ratio of these two isoforms is influenced by the 
pattern of cleavage from APP by β and γ secretases and it is more critical than the total amount 
of A produced.102,103 In vitro and in vivo studies have shown that A oligomers reduce 
glutamatergic synaptic transmission strength and plasticity, posing them as the putative toxic 
species.104-106 Indeed, since the protein is normally expressed in the organism and many 
different events could cause fibrils formation and disease, similarly as Parkinson’s disease, it is 
now generally accepted that the prefibrillar intermediates could be the triggering factor of the 
disease.107,108 However, the molecular mechanisms of the toxicity of different A 
amyloidogenic species is still under debate, the discussed evidences permit to conclude that 
fibrillar structures are not the only species causing the disease. Fibrillar aggregate formation 
could be even a protective mechanism by the organism to sequester intermediate aggregates, 
which could be toxic because of their misfolded nature. 
Parkinson’s disease – This illness is part of a group of neurodegenerative disorders termed 
Lewy Body diseases and it affects the central nervous system. Parkinson’s (PD) causes 
numerous devastating motor and non-motor manifestations, such as thinking and behavioral 
problems.2 The pathology affects millions of people worldwide and substantial evidence links 
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its onset to -synuclein.109 The pathogenic role of this protein is confirmed by genetic data, rare 
familial cases of PD are associated with four missense point mutations in -synuclein (A30P, 
E46K, A53T and H50Q) or with the hyper-expression of the wild type protein due to its gene 
duplication/triplication.110,111 Furthermore, -synuclein was identified as the major component 
of amyloid fibrils found in Lewy bodies and Lewy neurites, the characteristic proteinaceous 
deposits that are the diagnostic hallmarks of sporadic PD. The protein is normally present in 
high concentration at presynaptic terminals and it is found in both soluble and membrane-
associated fractions of the brain. It is a naturally unfolded protein and composed of 140 
residues. Structurally it can be divided into three regions with distinct characteristics.89 The N-
terminal domain, which encodes for a series of imperfect 11 amino acid repeats with a 
consensus motif of KTKEGV reminiscent of the lipid-binding domain of apolipoproteins. The 
central hydrophobic region having propensity to form fibrils with -sheet structure. The acidic 
C-terminal tail contains mostly negatively charged residues and is largely unfolded. When 
isolated in solution, the protein is intrinsically disordered. Numerous studies have established 
that recombinant -synuclein easily assembles into amyloid-like fibrils both in vitro and in 
vivo.79,112-114 In the presence of lipid surfaces, -synuclein adopts a highly helical structure that 
is believed to mediate its normal function(s), which are still debated.115-117 
 
Figure 1.7 -synuclein structure. From Ref. 118. 
 The role of -Synuclein in cell death is unclear, as it is not known the form of the protein 
when it causes cell death. The bulk of the available evidence points to the aggregation of -
synuclein being essential for the pathological effects associated with PD. Moreover, the 
prevalence of fibrillar protein aggregates in PD brains has led many authors to hypothesize that 
they cause cell death. However, the survival of neurons with intracellular Lewy bodies shows 
that the presence of intracytoplasmic aggregates is not toxic to all cells and considerable 
evidence suggests that oligomers, formed as prefibrillar intermediates, may be the toxic 
13 
 
component.79,89 In vitro studies showed that annular oligomeric forms are able to destroy or 
permeabilize cellular and synthetic membranes, causing an increased flux of calcium in the 
cell.119,120 Oligomers could also cause toxicity by damaging mitochondria121, triggering 
lysosomal leakage122 or disrupting microtubules.123,124 Moreover, several studies suggest that 
the process of conversion of oligomers into fibrils is strictly connected to the disease onset. 
Indeed, mutations enhancing fibrillization also increase cytotoxicity, while mutations blocking 
oligomerization and fibrillization have a beneficial role.111,125 In addition, it was also showed 
that even if -synuclein mutations enhance oligomerization, the loss of dopaminergic neurons 
is highly dependent on the ability of the protein to fibrillate.126 Similarly as in the case of AD, 
this suggests that toxicity could be related to the progress of misfolding and aggregation or to 
the contemporary presence of oligomeric and fibrillar structures rather than only to the amyloid 
fibrils formation.  
Polyglutamine diseases: Huntington’s disease and Ataxia-3 – A growing number of 
neurodegenerative disorders, termed polyglutamine diseases, have been found to result from 
the expansion of an unstable CAG trinucleotide repeat coding for a polyglutamine (polyQ) tract 
in the respective protein.127 Examples of such disorders are several forms of Ataxias and 
Huntington’s disease.128 Despite the lack of homology within the proteins involved in their 
onset, the pathologies all share fundamental common features: a severe neuronal dysfunction, 
an inverse correlation between age onset and length of the polyglutamine tract, a pathogenic 
threshold of the polyQ tract length, the presence of inclusion bodies constituted by the polyQ 
expanded protein.3,129 
 Huntington’s disease is an autosomal, dominant and strongly age-dependent 
neurodegenerative disorder. There are not sporadic forms of the pathology, which renders the 
disorder the most common inherited one.130 The main symptoms are psychiatric disturbances, 
motor impairment and cognitive deficit. The disease is caused by a CAG expansion in the exon 
1 of the IT-15 gene, which causes a consequent polyQ expansion of the encoded Huntingtin 
protein. The pathogenic threshold length for the disease onset is approximately 36-38 amino 
acids.131,132 Notably, CAG repeats in the exon 1 of the protein undergo expansion during 
transmission from one generation to the next. The severity of the pathology and the age of onset 
are is directly linked to the length of the expanded polyQ tract.131 Huntingtin is a soluble and 
large protein of ~350 kDa. It has a folded structure with high a -helical content and the polyQ 
repeat domain starts at the residue 18. It has been difficult to establish the protein physiological 
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function, mainly because of its homology with other proteins and its ubiquitous expression. One 
of the main hypothesis suggested an anti-apoptotic role.133,134 The protein is subjected to several 
post-translational modifications, which are mainly clustered within the first 17 amino acids, and 
that are known to affect protein structure, aggregation and toxicity. Moreover, the protein 
undergoes several proteolytic cleavages, which lead to the formation of different N-terminal 
truncated fragments of the protein. In these shorter fragments, a polyQ expansion is more likely 
exposed.135 Finally, the presence of diverse N-terminal huntingtin fragments in post-mortem 
brains affected by Huntington disease arouse the interest on their link to the disease. Strong 
evidences suggest that the N-terminal fragment 1-90, corresponding to huntingtin exon 1, is 
fundamental for the onset of the disorder. Indeed, if containing an expanded polyQ repeat, this 
fragment fibrillates into amyloid like fibrils and it is able to reproduce the neurological 
phenotype of the disease in animal models.136,137 Huntingtin exon 1 can be divided in five major 
subdomains: the 17 N-terminal amino acids (Nt17), the polyQ domain, two polyproline 
domains (polyP), a polyQ/P domain and the C-terminus. 
 
Figure 1.8 Human Huntingtin exon 1 sequence and major subdomains. 
 The polyQ and the Nt17 domains play a fundamental role in the aggregation of 
huntingtin exon 1. Initially, the aggregation of the protein was associated uniquely to the 
propensity of its polyQ domain to form a -sheet core into the fibrillar structures when its length 
is larger than the pathogenic threshold.138-140 Several successive studies have shown that also 
the Nt17 terminus plays a critical role in promoting huntingtin aggregation.139,141 Indeed, 
huntingtin peptides lacking the Nt17 terminus have slower aggregation kinetics that the full-
length counterpart. Additionally, it has been proposed that Nt17-mediated aggregation evolves 
through the formation of -helical oligomeric intermediates, which could be the fundamental 
factor for the formation of the final cross- sheet fibrillar structure.142,143 As previously 
described, it has been supposed that oligomers are the toxic species triggering the disease, 
however several contrasting evidences support both the hypothesis of a protective and toxic 
role of the protein inclusions in the brain.130,132,144-146 This discrepancy on the toxicity 
mechanism may be reconciled by taking into account the diversity of oligomeric and fibrillar 
forms of the expanded proteins. Indeed, morphology, composition and structure of polyQ 
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aggregates vary according to experimental conditions, subcellular localization, tissue 
environment, length of the polyQ and post translational modifications.146 Regardless of the 
nature of the involved species, toxicity is likely associated with: the failure of the degradation 
system in the cells, as suggested by the presence in the inclusions of proteasome and chaperones 
subunits; the sequestration by the aggregates of heterologous proteins, making them unable to 
solve their function; with the cellular membrane permeabilization by pore-like intermediate 
species, as in the case of AD and PD.144 
 Dominantly inherited spinocerebellar ataxias (SCA) are a group of neurodegenerative 
disorders characterized by a degeneration of the cerebellum, spinal tracts and the brain stem.127 
Spinocerebellar ataxia type 3 (SCA3) is the most frequent form among them and it is known as 
Machado-Joseph disease (MJD).147 The bulk of the evidence links the onset of the disorder to 
CAG repeats expansion in the MJD1 gene, which results in an abnormal polyQ expanded region 
in the encoded ataxin-3 protein.3,128 The pathogenic threshold length for the disease onset is 
when the polyQ tract is longer than 48-52 glutamines. There is not a clear correlation between 
the onset and the CAG repeat length, which just accounts for the 50% of the total variability in 
the age of onset.148 In particular, the aggregation of human ataxin-3 into amyloid fibrils and its 
neuronal inclusions, is responsible for the disease.149 Ataxin-3 is a ubiquitously expressed 
deubiquitinating enzyme, with important functions in the proteasomal protein degradation 
pathway.150 The protein has a variable molecular weight between 42–52 kDa and it is composed 
by a folded N-terminal domain (Josephin; residues 1–182), three ubiquitin interacting motifs 
(UIMs), a polyQ stretch of variable length and a C-terminal region.52,149 The polyQ region has 
been object of intense investigation, since it is insoluble in water and it has strong tendency to 
aggregate depending on the number of consecutive residues within polyQ stretches. However, 
it has been demonstrated that the Josephin domain of ataxin-3 strongly modulates the 
aggregation kinetics and aggregates into amyloid-like structures when isolated, suggesting that 
the full-length ataxin-3 aggregates with a two-stages mechanism.129 The first stage involves 
interacting Josephin domains resulting in the formation of prefibrillar aggregates. The second 
stage consists of a polyQ aggregation step causing a subsequent misfolding event, and resulting 
in formation of insoluble fibrils.151 Thus, the two domains in ataxin-3, with an intrinsic ability 
to misfold, aggregate sequentially.152 Moreover, Josephine fibrillar structures have high 
similarity with the full-length ataxin-3 ones153 implying that the Josephin domain has a strong 
influence on the aggregation pathway and on the shape and structure of ataxin-3 fibrils. It has 
been also shown that Josephin aggregation can be promoted by the exposition of hydrophobic 
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surfaces, otherwise buried in the native protein structure. This observation suggests that a 
structural rearrangement may not be necessary to induce aggregation and, as described above, 
that misfolding could be successive to the early aggregation process of the proteins. 4,154 
 
Figure 1.9 Structure of ataxin-3 e and its subdomains. Adapted from Ref. 52. 
 The expanded polyQ stretch in the C-terminus of ataxin-3 is thought to be the cause of 
the conformational changes of the protein aggregates, which may result in altered binding 
properties, loss of protein function, altered subcellular localization and proteolytic cleavage.155 
As suggested in the previously described disorders, intracellular ataxin-3 aggregates are 
probably not the main toxic entities in SCA3. The soluble protein fragments containing 
expanded polyQ, arising from proteolytic cleavage of ataxin-3 by caspases and calpains, are 
now considered fundamental in the pathogenesis.156,157 Moreover, recent evidence suggests 
potential involvement of a RNA toxicity component in SCA3 and other PolyQ expansion 
disorders, increasing the pathogenic complexity.150 Notwithstanding the extensive research, as 
for the others polyQ diseases, the molecular mechanisms underlying the cellular toxicity 
deriving from expanded ataxin-3 is still unknown and there are not preventive treatments 
currently available.150  
1.1.5 Functional amyloids and Nanotechnology Applications 
  Since their discovery, amyloid fibrils were associated with a pathological state of living 
organisms. However, several amyloid structures having a functional physiological role in living 
organisms, such as bacteria, insects, invertebrates and humans were found. This biologically 
active state of proteins has been termed functional amyloid (Table 1.2).158 The functional 
amyloid hypothesis states that living system have evolved to take advantage from the possibility 
that protein can form highly resistant to degradation and ordered fibrillar structures. Examples 
of such functional amyloids are bacterial coatings and adhesives, structures for the storage of 
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hormones and catalytic scaffolds.158 An example of a functional amyloid in humans is fibrils 
formed by Pmel17 serving as template for the biosynthesis of melanin.159 Moreover, it has been 
recently suggested that the a peptides play a fundamental physiological role in hippocampal 
memory formation in humans.160 Amyloid could be a powerful platform for the design of new 
biomaterials, since they are generally deriving from natural proteins and they could possess a 
low inflammatory and immunogenic response and high biocompatibility.161,162 
Table 1.2 Functional Amyloid exists in a wide variety of organisms. Adapted from Fowler et al.158 
 
 A wide class of peptides and proteins, if thermodynamically destabilized in vitro, form 
artificial amyloid-like fibrillar materials possessing the characteristic cross- structure. In 
particular, amyloid fibrillar structures are intriguing from a technological point of view because 
of their unique mechanical properties. They possess Young’s modulus in the order of Giga 
Pascal and they are within the stiffer proteinaceous materials in nature, comparable even to 
inorganic materials as steel.10,12,163 The rigidity of amyloid is predominately due to weak non-
covalent intermolecular chemical bonds (hydrogen bonds) involving polypeptide main chain. 
Their unique properties are sequence-independent and these structures form a generic class of 
stiff materials.11,163 Additional beneficial features for the use of fibrillar assembling as 
biomaterials are: the low cost of production, since they aggregate at room temperature and in 
aqueous solution without any external energy input; the bottom-up approach, in which few 
different molecular building blocks hierarchical assembly into several tunable polymorphic 
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structures with nanoscale dimensions;35,37 and the natural tendency of amyloids to form highly 
ordered structures can be used to template other materials otherwise disordered at the nanoscale.  
 Taking inspiration from functional amyloid and the properties described above, the self-
assembly of these peptides has allowed the development of biomaterials for a broad spectrum 
of applications in medicine and nanotechnology.161,162,164,165 The power of amyloid as 
biomaterials has been shown in the fabrication of conductive nanowires, in the realization of 
biofilms,164,166 new surfaces coatings for cells adhesion167 and in improving efficiency of 
organic solar cells.161 Several promising applications in medicine have been suggested. The 
conjugation of proteins with drugs could allow controlled long-lasting drug delivery. As proved 
in the case of the cancer therapy based on gonadotropin hormone, this could be achieved thanks 
to the administration of assembled amyloid structure with low dissociation rate compared to 
monomeric dissociation.168 Another similar case is the antibody-derived candidacidal 
decapeptide, which has been shown to form amyloid fibrils spontaneously and in a reversible 
manner. Since the aggregated state is more resistant to proteolysis than monomers, it could be 
used as long-lasting delivery system.169 Finally, the future integration of amyloid-based and 
carbon nanostructures could allow designing bio-inspired hybrids materials mimicking 
biological functions and including new properties such as conductivity, optical response and 
antiviral activity. This could lead to the development of tissues, biosensors and 
nanomedicine.165,170,171 Following this idea, for instance, -lactoglobulin fibrils were integrated 
with graphene. Fibrils from this milk protein are not necessarily toxic, while graphene has 
exceptional mechanical and electronic properties, but unfortunately its high hydrophobicity is 
not biocompatible. The low cost integration of the two materials permits the creation of a new 
class of biodegradable composite materials with tunable properties. These materials could be 
successfully used as biosensor and biomedical devices.165,172 
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1.2 Biophysical Investigation of Amyloid Properties and Formation 
 Biophysics is an extremely interdisciplinary science using methods and theories 
developed in the fields of physics, mathematics, and chemistry to study biological systems. One 
of the most significant achievement in biophysics remains the discovery in 1953 of the double-
helix structure of Deoxyribonucleic acid (DNA) by Watson and Crick. Nowadays, biophysics 
scans all biological scales from atoms and molecules to cells, organisms, and environments. 
Experimental biophysics is based on the use of several methodologies, which can be divided in 
two categories: bulk and single molecule techniques. The first category includes techniques, 
such as nuclear magnetic resonance, circular dichroism, Thioflavin T fluorescence, dynamic 
light scattering, X-ray scattering and infrared spectroscopy that determine only average 
properties of biomolecules and living systems. On the other hand, single molecule techniques 
enable measuring single molecule properties. In particular, atomic force microscopy (AFM) has 
become one of the most powerful techniques available to investigate the structure of 
biomolecules, but also for their manipulation, at the single molecule scale. In the following 
paragraphs, the biophysical techniques involved in the frame of this thesis will be presented. 
1.2.1 Spectroscopic Bulk techniques 
Bulk techniques, applied to aggregating samples, provide important information and 
fundamental feedbacks on the state of the solution. For this motivation, throughout all my PhD 
work, bulk techniques have been used as control for all the single molecule scale measurements. 
In the following paragraphs, we will briefly describe them in relation to the experimental work 
done in my thesis: 
Thioflavin T – The fluorescent benzathiole dye Thioflavin T (ThT) has become among the most 
widely used methods for selectively staining and identifying amyloid fibrils both in vivo and in 
vitro.17 Indeed, under the appropriate conditions, it selectively stains amyloid structures 
undergoing characteristic spectral alterations.173 ThT fluorescence originates from the dye 
binding to cross-sheet rich structures, which causes a dramatic enhancement of its 
fluorescence emission. When associated with amyloid fibrils, the dye displays a dramatic shift 
of its excitation maximum, from 385 nm to 450 nm, and of its emission maximum, from 445 nm 
to 480 nm.174 Despite its widespread use, the structural basis for binding specificity and for the 
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changes to the photophysical properties of the dye remain poorly understood.175 Unfortunately, 
ThT is not perfectly amyloid specific and it may not undergo a spectroscopic change upon 
binding to precursor monomers or small oligomers, even if with a high -sheet content.176 
Moreover, some amyloid fibers as Huntingtin’s ones do not affect Thioflavin T fluorescence, 
raising the prospect of false negative results and the necessity to couple studies based on this 
technique with other methodologies. However, as previously described in the paragraph 1.1.3 
and depicted in Fig. 1.4, the method notably enables to investigate the kinetics of amyloid fibrils 
formation and other many histological and bio-imaging studies rely on this technique.17,18,69 
Circular Dichroism – Circular dichroism (CD) is the differential absorption of left‑ and right-
handed circularly polarized light.177 In the case of chiral biomolecules, the CD absorption of 
light in the far-UV (wavelength between 180-240 nm) derives from the peptide bond (amide 
bond) electronic transitions:  * and n  * around 190 nm and 220 nm, respectively.178 
These transitions are highly sensitive to the molecule conformation and to its secondary 
structure. As we can observe in Fig. 1.9, when polarized light is absorbed by a protein, its 
electronic structure gives rise to characteristics bands in the far-UV.  
 
Figure 1.10 Circular dichroism signal for proteins with -helical (red), random coil (green) and 
-sheet (light blue) structure. Adapted from Ref. 177. 
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 The dichroic signature corresponding to: β-sheet has ππ* positive maximum near 195 
nm and nπ* negative maximum near 217 nm; random coil state a strong ππ* negative maximum 
near 200 nm; and the -helix structure has a strong maximum near 190 nm and a double 
negative maximum at approximately 208 nm and 222 nm.179 The capacity of CD to give a 
representative structural signature makes it a powerful tool in modern biochemistry, especially 
for showing changes in conformation during the fibrillization of amyloidogenic proteins as a 
function of time, temperature or different solvent.31,52,71,180  
IR spectroscopy – Infrared spectroscopy is a general established tool for the determination of 
secondary structure of proteins.181,182 Moreover, the technique has been extensively used to 
observe the conformational transition from monomers to cross -sheet amyloid structures 
during amyloid formation and to investigate the aggregates structural properties.63,64,183 IR 
spectroscopy is based on the molecular vibrations produced, under light exposition, by 
stretching, deformational motions, bending and rotations of chemical bonds. The amide I, amide 
II and amide III modes are the most commonly used to study the structural properties of 
polypeptides. The amide I mode arises mainly from backbone C=O stretching vibrations with 
frequencies at 1700-1600 cm-1. The exact band position is determined by the backbone 
conformation and thus by the secondary structure of the protein.181,184 The amide II band reflects 
a combination of backbone N-H bending and C-N stretching and has frequencies within 1580-
1510 cm-1. The amide III band at 1350-1200 cm-1 reflects a combination of different modes 
such as C-N stretching, N-H bending, C-C stretching and C=O bending. We could associate the 
position of these two bands to the secondary structure of the protein, but the analysis is far from 
trivial because of the various contributions. The amide I band is thus the most frequently used 
to infer the secondary structure of peptides. From several studies, a consensus has emerged for 
the assignment of the secondary structure IR peaks in this spectral region.185,186 As shown in 
Table 1.3, there are several components concurring to the shape and position of the Amide I 
band: intermolecular antiparallel -sheet are located within 1695-1680 cm-1; intramolecular -
turn within 1680-1665 cm-1; -helical between 1660-1650 cm-1; random coil between 1645-
1635 cm-1; intramolecular low density native -sheet within 1635-1620 cm-1; intermolecular 
high density amyloid -sheets within 1625-1610 cm-1. In particular, several studies showed that 
amyloidogenic -sheet are located at lower energy in the IR absorption spectrum than native -
sheet, reflecting likely the presence of stronger intermolecular hydrogen bonds in the cross- 
structure than the intramolecular ones in the native globular protein.64,180,186,187 Finally, respect 
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to CD or Raman spectroscopies, in IR spectroscopy the β-sheet contribution has the highest 
absorption coefficient. Therefore, IR spectroscopy is a particularly suitable technique to analyze 
β-sheet-rich amyloid aggregates.188 
Table 1.3 Amide I band secondary structure components. 
Amide I Structural assignment Wavenumber (cm-1) 
Antiparallel -sheets (Intermolecular) 1695-1680 
-turn (Intramolecular) 1680-1665 
-helix 1660-1650 
Random coil 1645-1635 
Low density Native -sheets (Intramolecular) 1640-1625 
High density Amyloid -sheets (Intermolecular) 1625-1610 
1.2.2 Single molecule investigation by Atomic Force Microscopy techniques 
In this section, the principle of working of scanning probe techniques is presented. In particular, 
Atomic Force Microscopy will be presented in detail, its operational modes and ultimate 
resolution will be discussed. Successively, the force spectroscopy related modes able to 
investigate the nanomechanical properties of biomolecules at the nanoscale are shown. At the 
end, the principle of functioning of the innovative AFM-based infrared nanospectroscopy will 
be described. 
Microscopy and Scanning Probe Techniques - A microscope is an instruments designed to 
produce magnified images of objects too small to be seen with naked eyes. The first idea that 
could come in mind in association with the word “microscope” is that the instrument 
manipulates light to obtain a magnified image of the object. Indeed, for a long time from its 
invention centuries ago, microscopy was normally based on a light source that emits photons 
that are used as probes directed onto or emitted from the specimen. Nowadays, there are 
different types of microscopes: optical, electron and scanning probe microscopy. 
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Optical and Electron microscopy are based on the scheme “source-specimen-detector-
analyzer”, where particles are probes sent to the sample, then registered by a detector and 
subsequently analyzed bringing information on its morphology. The first technique uses 
photons as probes and it can reach a resolution r as small as approximately the half of the 
wavelength of the light interacting with the sample (~200 nm), as stated by Abbe’s principle 
𝑟 = 𝜆/2𝑁𝐴 , where NA is the numerical aperture of the microscope.189 Electron microscopy, 
invented in the early 20th century, uses an accelerated electron beam to magnify and observe 
the specimen and, thanks to the much shorter wavelength of fast electrons, has a very 
significantly higher resolution than optical microscopy. A state-of-the-art electron microscope 
is capable of acquiring images with sub-angstrom resolution. The main limitation of this 
technique is that sample has to be conductive. Non-conductive samples, as biomolecules, must 
be coated with a conductive material, which could alter the sample or mask its properties. 
 In scanning probe microscopy (SPM), a sharp tip interacts with the sample and it scans 
its surface in a raster way. In other words, the probe interacts with the sample moving along 
sequential parallel lines. Every line is divided in pixels, which can record several types of signal 
as currents, voltages and forces. The first SPM technique invented was the scanning tunneling 
microscope (STM), which was awarded by the Nobel Prize.190 This system is based on the 
quantum tunnel effect, which causes a current between two conductive objects posed close each 
other. First, a metallic tip is brought close to a conductive surface, causing an electronic current 
flow depending exponentially on the distance between the two elements. Successively, the tip 
scans the surface. 
 
Figure 1.11 Schematic depiction of Scanning Tunneling Microscopy and Atomic Force 
Microscopy. From Ref. 191. 
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 As depicted in Fig. 1.10, by means of a feedback system controlling piezoelectric 
elements that can move the sample respect to the tip, the system can keep tip-sample distance 
or electronic current constant. The signal from the feedback mechanism allows retrieving the 
topography of the sample with a resolution along the Z direction of approximately 0.01 nm and 
along the XY directions with sub-nanometer resolution. This was a conceptual revolution in the 
field of microscopy, but unfortunately, the limitation of the investigation to only conductive or 
semiconductive samples remained. For this reason, STM it is not suitable for biological 
samples. 
Atomic Force Microscopy - In order to overcome the difficulties in investigating dielectric 
samples, in the 1986, Binnig et al. invented the atomic force microscope (AFM). They 
combined the principles at the base of the STM and of the so-called stylus profilometer. The 
probe of the AFM is a cantilever with a microfabricated sharp tip at its end, which is the sensing 
device. AFM probes are normally made of silicon or silicon nitride. The cantilevers have 
usually rectangular or triangular dimensions, typical length within 2-200 m and they can be 
considered as springs with elastic constant k in the range of 0.01-100 N/m. The tips and the end 
of the lever typically have an apical radius between 1-50 nm. Similarly to STM, by means of a 
piezo-actuators system, the probe is kept at a distance in the order of the nanometer from the 
surface and it scans the surface in a raster way. In the easiest configuration, during the scanning, 
interaction forces between the tip and the sample produce a bending of the cantilever, which 
can be directly measured. There are several methods to measure the cantilever deformation. 
However, the most commonly used is the optical lever method, where a laser beam is focused 
on the back of the lever and the reflected beam is detected by a four-quadrant photodiode (Fig. 
1.10). This configuration enables to measure vertical and lateral (torsion) deformations of the 
lever. Finally, the feedback electronics drives the piezoactuator in order to compensate the 
deviation of the lever deflection from the chosen setpoint and to keep a constant deformation 
of the cantilever. The bending x of the cantilever is proportional to the interaction force, as 
described by the Hook’s law: F = k·x, where k is the elastic constant of the lever.192 In a typical 
force microscope, cantilever deflection range from 0.1 nm to micrometers. This enable to 
routinely measure forces ranging from 10-13 to 10-4 N.193 
 The forces relevant to AFM are ultimately of electromagnetic origin, which are due to 
the interaction between tip and sample atoms. However, different intermolecular, surface and 
macroscopic effects give rise to interactions with distinctive distance dependencies. In the 
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absence of external fields, the dominant forces are van der Waals interactions, short-range 
repulsive interactions, capillary and adhesive forces (Fig. 1.11).192,193 If the tip is in strong 
contact with the sample, elastic forces can occur. All the described forces can be divided 
roughly in two categories: repulsive and attractive. The former dominate at a close tip-sample 
distance, while the latter are long-range interactions. The sum of these forces is generally 
approximated by means of a Lennard-Jones potential, which combines short-range repulsive 
and long-range attractive forces, as represented in Fig. 1.12. 
 
Figure 1.12 Summary of the possible relevant Forces in AFM. From Ref. 193. 
 Accordingly to the regime of interaction, there are two main operational modes of AFM: 
static, termed also contact mode, and dynamic mode. In contact mode, the tip is brought at close 
contact with the sample and scanned across the surface. In this modality, the tip-sample 
interaction is mainly due to strong repulsive forces (~1-10 nN). As described above, the imaging 
of the sample is generally obtained by maintaining a constant deflection (force) of the lever 
during the scanning. This is possible through the extension or retraction of the piezoactuator 
along the z direction by the feedback electronics loop, which adjusts the tip-sample distance in 
order to have a constant deflection of the lever. The z adjustment of the piezo is used to display 
the sample height for each pixel of the XY plane, so retrieving a 3D map of the morphology of 
the sample (Fig. 1.10). Static mode was historically the first operational mode of AFM, it allows 
straightforwardly to obtain morphology images with atomic resolution. However, huge tip-
sample lateral forces are present during scanning and they could introduce damage or artifacts 
into the specimen. For this reason, a dynamic mode was successively introduced. In this 
configuration, the tip is placed in oscillation, close or at resonance frequency of the cantilever, 
over the surface of the sample and typically at a distance from few to tens of nanometers. At 
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this distance, the tip-sample interaction is generally considered as mainly due to the much 
weaker attractive forces, such as Van der Waals and electrostatic interactions, which are 
typically below 1 nN. However, accordingly to the absolute value of amplitude oscillations and 
tip-sample separation, can have important contribution also the other of forces described above, 
such as repulsive, frictional and elastic deformation (Fig. 1.11). As shown in Fig. 1.12, two 
main dynamic regimes can be considered: the tapping mode, in which the equilibrium 
separation of the tip and sample is smaller than the amplitude of the cantilever oscillation, so 
the tip is periodically brought in contact with the sample; the non-contact mode, where there is 
not tip-sample mechanical contact, deformation and friction effects are eliminated, and the tip 
is mainly submitted to attractive forces.194  
 
Figure 1.13 AFM tip-sample potential energy representation and related AFM scanning modes.  
 In both dynamic modes, when approached towards the sample, the parameters of the 
oscillation are influenced by the tip-sample interaction. The amplitude, the resonance frequency 
and the phase shift link the dynamics of the vibrating cantilever to the tip-surface force of 
interaction and they can be used as a feedback parameter to record the topography of the 
specimen. Two major AFM dynamic modes have been developed: amplitude modulation (AM-
AFM) and frequency modulation atomic force microscopy (FM-AFM).193,194 In AM-AFM, the 
oscillation amplitude is used as a feedback parameter to measure the topography of the sample 
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surface. Indeed, when the tip approaches the surface the free oscillation amplitude is damped, 
the feedback loop will adjust the tip-sample distance in order to maintain amplitude constant 
and the measured difference is used to retrieve the topography. On the other hand, in frequency 
modulation the cantilever is kept oscillating with a fixed amplitude at its resonance frequency. 
This resonance frequency depends on the forces acting between tip and sample surface. The 
spatial dependence of the frequency shift f, the difference between the actual resonance 
frequency and that of the free lever, is the source of contrast. As in the case of amplitude 
modulation mode, a constant frequency shift can be chosen and an image is formed by profiling 
the surface topography maintaining f close to the reference value by means of the feedback 
system. FM-AFM has been implemented to reach atomic resolution in non-contact and in ultra-
high vacuum environment, however the more complex feedback mechanisms and the low 
thermal stability of resonant cantilever frequency in air have limited is spreading for common 
applications. While, AM-AFM is generally used to perform robust measurements in liquid and 
in air, for these reasons it is the most commonly used modality to study biological specimen 
and it has been widely applied to investigate structures from the single protein to the cellular 
scale. Together with topography, in this operational mode, material properties variations could 
be mapped by recording the phase shift between the driving force and the tip oscillation.193  
 
Figure 1.14 Schematic depiction of AFM phase shift measurements. Courtesy from Park System, 
South Korea. 
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 As shown in Fig. 1.13, it is possible to demonstrate that the interaction of the tip with 
materials having different mechanical properties causes a phase shift of the cantilever 
oscillation.194 Moreover, the phase change is strictly related with the phenomena of tip-sample 
energy dissipation during the scanning. In particular, it would negligible if tip-sample 
interaction would be absent. Therefore, it can be concluded that the minimization of the phase 
changes enables to perform less invasive measurements, where dissipation is minimal.194 
 Finally, the instrument resolution deserves a detailed discussion. AFM generates three-
dimensional images of the sample surface. Although not always independent, two different 
resolutions should be distinguished: lateral and vertical. Vertical resolution is limited by both 
noise from the detection system and thermal fluctuations of the cantilever. In general, the 
thermal noise of the cantilever is the largest source of noise in AFM.194,195 Damping systems 
have become so effective that mechanical vibrations represent a negligible perturbation of the 
cantilever oscillation. For a cantilever with a force constant of 40 N/m, the thermal fluctuations 
of the cantilever are below 0.01 nm. Therefore, vertical resolution of AFM along the z directions 
is easily below sub-nanometer scale. A notable effect, especially in air conditions, is that AFM 
measurements of biomolecules report heights that are always smaller than their nominal values. 
Smaller heights are a consequence of different processes such as dehydration, sample 
deformation due to repulsive tip-sample forces and differential tip-surface-sample interaction. 
In the case of the lateral resolution, three main factors should be considered: the instrumental 
resolution, defined by the ratio between size and number of pixels of the image, the precision 
of the piezo along the XY direction, and the radius of the scanning tip. The instrumental 
resolution is generally sufficient, since it is possible to use an elevate number of pixels to scan 
and the piezoelectric system possesses sub-nanometric precision, while the geometrical shape 
of the tip is mainly determining the lateral resolution. If the apical radius of the tip is of the 
same order or bigger of the dimensions of the object under investigation, an effect of lateral 
broadening will be visible always in the AFM image (convolution effect). In Fig. 1.14, we can 
observe a depiction of the convolution effect in the case of scanning by tips with broad or sharp 
radius of curvature. Only if the tip has comparable dimensions with the object under 
investigation, the broadening effect will be minimum.196 
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Figure 1.15 AFM Schematic illustration of the convolution of the shape of the AFM tip with the 
shape of the feature or particle being scanned. (a) Blunt tip, (b) sharp tip. From Ref. 196. 
Statistical analysis of AFM Images – AFM morphology 3-D maps furnish a nanometer-
resolution view of the structural and morphological characteristics of biomolecules aggregates, 
such as amyloid fibrils. From these maps is possible to retrieve several parameters regarding 
the structure of an amyloid fibril: height, width, contour length and periodicity.197 Furthermore, 
AFM enables investigating the bending rigidity and persistence length of amyloid fibrillar 
structures, as successfully applied in the case of -lactoglobulin fibrils.36 The persistence length 
lp is the length above which thermal fluctuations can bend a rod-like polymer and it is therefore 
a measure of its elastic properties.198,199 This quantity can be determined directly from AFM 
images, by means of the bond correlation function for semi-flexible polymers in a two-
dimensional conformation: 
cos Θ(𝑠) ≈ 𝑒
−
𝑠
2𝑙𝑝     (1) 
 
Figure 1.16 Schematic depiction of a semi-flexible polymer and the parameter used to calculate 
its persistence length. 
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As shown in Fig. 1.15, θ is the angle between the tangent vectors to the chain at two points 
separated by a contour distance s. The factor 2 is used to rescale the exponential decay in order 
to consider the two-dimensional nature of protein fibrils absorbed on a surface.197 These 
fluctuations depend on the fundamental physical properties of the polymer, such as its bending 
rigidity.199 The lp can be used to calculate the elastic modulus E of a semi-flexible polymer, 
indeed these two physical quantities are directly linked by the following relationship: 
𝑙𝑝 =
𝐸𝐼
𝑘𝑏𝑇
      (2) 
 Where I is the cross-sectional area moment of inertia of the polymer, T the temperature 
and kb the Boltzmann constant. Therefore, the study of the statistical mechanics of such 
fluctuations is a valuable route towards understanding the nanoscale mechanics of polymers 
and other linear structures. 
Force Spectroscopy Measurements and Peak Force Quantitative Nanomechanical Imaging – 
A cantilever is an extremely precise and sensitive force sensor with piconewton resolution.192 
Consequently, it can be used to measure mechanical properties of samples. The basic principle 
of this measurement relies on performing force-distance curves, in a trace-retrace manner, due 
to the vertical motion of the lever on the sample under investigation. A single force-distance 
curve is related to the plot of the tip-sample force versus the piezoelectric z displacement, as 
depicted in Fig. 1.16.192 The process can be illustrated by six fundamental regions.192 The 1-2 
line represents the zero-extension line, when tip is approaching out of contact. Line 2-3 
corresponds to the jump-in-contact, also called snap-in, which happens when gradient of 
attractive forces is higher than cantilever spring constant. The line 3-4 corresponds to the 
deflection of the cantilever in contact with the sample, in this region the lever passes from being 
bent downward, through the zero deflection, to being bent upward. This region is purely linear 
for perfectly elastic deformation, while is not linear in the case of plastic deformation. The line 
4-5, indicates the beginning of the retracting and it should be ideally superimposed and with 
same slope of the corresponding approaching line 3-4. However, an eventual distance 
displacement and a different slope of the two curves is relate to the plastic indentation of the 
sample. Line 5-6 represents the moment of the loose of tip-sample contact, it is termed snap-
out, and it is generally linked to adhesive forces. Finally, the line 6-7 represents the retracting 
out of contact. It is worth to underline that the instrument does not measure directly forces and 
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distances, but it measures directly the displacement of the piezo and the deflection of the laser 
by means of a photodiode. Therefore, in order to convert the read voltage by the photodiode 
into a distance, the photodiode sensitivity needs to be calibrated and this calibration is 
performed by relating the vertical movement of piezo relatively to the cantilever deflection on 
a stiff substrate. Successively, in order to convert the measured deflection into a force, the 
elastic constant of the lever is measured. A common method to perform this measurement is 
the thermal tuning.200 
 
Figure 1.17 Ideal force-displacement curve depiction.  
Ideal (A) force-distance and (B) force-time curves representation. From Ref. 201.  
 Once the force-distance curve is obtained, by means of its analysis, mechanical 
properties of the sample can be retrieved. Several methods have been implemented to study 
mechanical properties of biomolecules as amyloids. Nanoindentation, quantitative 
nanomechanical mapping and force spectroscopy pulling are part of this category (Fig. 
1.17).197,198 
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Figure 1.18 AFM-based methods to investigate biomolecules and amyloid aggregates 
nanomechanical properties. From Ref. 198. 
 Nanoindentation is one of the most common methodologies to retrieve the Young’s 
modulus and hardness of a sample. Indeed, if the sample is soft relatively to the tip stiffness, 
during the approach the tip will indent the sample (Fig. 1.18 A). The subtraction of the force-
distance curve obtained from an undeformable stiff substrate allows retrieving the indentation 
curve (Fig. 1.18 B-C). The fit of this curve, by means of a mechanical model192, enables to 
extract the intrinsic Young’s modulus of the object. Nanoindentation measurements have been 
able to extensively measure the Young’s modulus and stiffness of amyloid fibrils and to confirm 
its value in the range of GPa.198,202 
 
Figure 1.19 Nanoindentation measurements.  
(A) Schematic depiction of the indentation mechanism, (B) force-displacement curves on the sample on 
an undeformable sample, (C) force-indentation curve and fit. (Adapted from Ref. 203). 
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  In the frame of this thesis, we mainly concentrated on force spectroscopy 
nanomechanical manipulation and peak force quantitative nanomechanical mapping (PF-
QNM) and of amyloid structures. In force spectroscopy measurements, the tip is able to adsorb 
and manipulate the macromolecule on the surface. In this configuration, upon retraction of the 
tip once a binding is created, it has been shown that amyloid molecules can be stretched or 
unzipped.204-206 The resultant force curves and the stretching behaviour can be analyzed by 
theoretical models, as the worm like chain (WLC). This model, which will be described in the 
3rd chapter, enables to extract the persistence length of the stretched molecule. A further 
possible modality to perform nanoindentation studies is the Force-Volume mode, in which a 
map of force-distance curves is collected in a raster way over a selected area of the sample. 
However, a single force curve requires several tens of milliseconds to be completed, so a typical 
force volume image is characterized by long completion times (from several minutes to several 
hours) and low spatial resolution (32×32 or 64×64 pixel images are common). An 
improvement of the force-volume mapping is the Quantitative Imaging, implemented by JPK 
Instruments, which allows to acquire maps of mechanical properties of a sample with a 
resolution up to 512 x 512 pixel contemporarily with morphology maps.207,208 Finally, PF-
QNM, a similar and relatively new technique is able to map mechanical properties with higher 
speed and spatial resolution. The methodology is based on a new tapping mode in which every 
tapping of the probe on the surface produces a force-distance curve. This technique uses the 
peak force value of the force-distance curve as imaging feedback, diversely than AM-AFM that 
uses the amplitude as feedback parameter. This mode can be used with standard tips and 
cantilevers, the drive frequency is notably below the resonance one and the typical amplitude 
oscillation is approximately 100 nm. In Fig. 1.19 A, it is represented the tip trajectory as a 
function of time over a tapping cycle. Initially (1), the tip is far from the surface and it is brought 
in contact with the sample (2). Successively, the tip indents the sample until the maximum peak 
force in reached (3). Then, it is pulled off until the adhesion force is maximum (4) and it finally 
recovers its original position (5). Using the maximum peak force for the feedback calculation, 
a force-distance curve is generated at every pixel. Since the Z position of the modulation and 
the deflection of the cantilever are controlled as a function of time, it is possible to eliminate 
the time variable, from Fig. 1.19 A, and a force-distance plot can be generated, as in Fig. 1.19 
B. From those curves, the usually measured quantities by force spectroscopy can be measured: 
adhesion, dissipation and elastic modulus. This last parameter can be extrapolated by fitting the 
retraction curve by the Derjaguin-Mueller-Toporov (DMT) model.192 Since a force curve is 
obtained for each pixel, the resolution of channel is identical to the topography image. This 
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technique has been apply successfully, as it will described in the 4th chapter, to measure the 
intrinsic elastic modulus of several amyloid fibrils.163 
 
Figure 1.20 Principle of operation of PF-QNM.  
(A) Principles of peak force tapping. (B) Force-distance curve and indicative representation of the 
calculated mechanical properties. From Ref. 208. 
Infrared nanoscale spectroscopy – Invention of AFM was crucial to development of 
nanoscience. However, the study of macromolecules at nanoscale remains challenging, 
especially when truly quantitative information is required. The AFM-based local measuring 
methods that have developed until now have not brought wider field of applications. The main 
reason is that imaging, or in the best case mapping of a single property as stiffness and Young’s 
modulus, is not sufficient when studying inhomogeneous and complex materials, such as 
aggregating proteins.  
 A real breakthrough was reached with the development of nanoscale Infrared (IR) 
Spectroscopy (nanoIR). Fourier transform infrared spectroscopy (FTIR) is a key method for 
studying conformational properties of proteins and their structural conversion during amyloid 
fibrillation.64,209 However, a significant factor, limiting the general applicability of FTIR and 
other bulk techniques for the study of protein aggregation, is that they are mainly able to give 
average information only on the ensemble of the species present in the heterogeneous 
aggregating solution. A new technique (nanoIR), exploiting the simultaneous use of AFM and 
IR, can be efficiently used to characterize at the nanoscale the structural properties of amyloids 
during their aggregation pathway (Fig. 1.20).210  
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Figure 1.21 Schematic depiction of nanoscale infrared spectroscopy working principle. 
 The combination of AFM and IR spectroscopy is based on a photothermal induced 
resonance effect (PTIR).211 A pulsed, tunable laser beam passes through a ZnSe prism and 
undergoes total internal reflection from the upper face of the crystal (Fig. 1.20). An evanescent 
wave, with typical length of the order of the wavelength of incident light, interacts with the 
sample that is deposited on the ZnSe prism. If at a given wavelength, the IR pulse is absorbed 
by the sample, the local temperature rise leads to local thermal expansion. This deformation 
excites mechanical resonances in the AFM cantilever, which is in contact with the sample. The 
cantilever resonates with a ringdown shape containing several of its Eigen frequencies. If one 
mode is chosen, the peak-to-peak maximum and the Fourier transformed amplitude of its 
ringdown are directly proportional to IR absorption.212  Therefore, the AFM detection of the 
temporary expansion of the scanned region enables nanoscale resolution IR imaging and 
acquisition of local chemical spectra. The AFM–IR spectra generated from this technique 
contain the same information with respect to molecular structure as conventional IR 
spectroscopy measurements. Moreover, as illustrated in Fig 1.21 in the case of collagen fibrils, 
simultaneously with the acquisition of IR-absorption and topography images, the system is able 
to obtain qualitative stiffness maps. Resolution of the instrument in the case of the morphology 
maps is determined by the usual parameters in standard AFM. While, the resolution of the IR, 
stiffness maps and spectra is unrelated with the topographic channel. The critical thickness 
(AFM height along the z direction) of the sample to acquire IR information is in the order of 
50-100 nm and it is determined by the ultimate instrument sensitivity to the measurement of the 
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photo-thermal expansion.212 While, the lateral resolution for isolated objects is mainly 
determined by the geometrical shape of the tip. The instrument enables to acquire chemical 
information in a wide range of the infrared spectrum, more specifically between 3600-1000 cm-
1. However, it is worth to note that sensitivity of the instrument in the spectra region within 
1610-1550 cm-1 is limited by the very low laser power in this region, which causes low signal-
to-noise ratio. For this reason, in these region, the acquisition of chemical properties of objects 
with thickness close to the ultimate one (100 nm) is affected by high noise and signal 
fluctuations. 
 
Figure 1.22 NanoIR imaging and spectra acquisition of a bundle of collagen fibrils. 
In the figure are shown: the morphology, local stiffness and IR absorption maps; an IR spectrum in the 
proteins range (1800-1200 cm-1) is acquired at a specific location of the maps (indicated by a circle).  
 One of greatest benefits of the nanoIR technique is the fact that chemical analysis can 
be performed at the submicron scale, with extremely tiny quantity of biological specimens. 
Purification and high throughput production of proteins is extremely expensive and time 
consuming; for this reason, reduction of sample quantity to perform routinely FTIR and 
secondary structure analysis is a problem of extreme importance which nanoIR can solve being 
able to measure thin and small samples. This is one of the main advantages of nanoIR compared 
to conventional IR techniques, which have spatial resolution limited by the smallest achievable 
IR spot size (~20 m)213. NanoIR also requires very small quantities of biological specimens 
(less than picograms or sub-femtomoles is sufficient). This is a major advantage when working 
with biological materials whose production is expensive and time costly. Applications of this 
is instrument have been shown in the case of several biological system, first applications in the 
field of amyloids will be shown in the 5th and 6th chapter of this thesis.214 
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1.3 Objective of the Thesis 
The main objective of this PhD thesis has been the elucidation of amyloids structure and 
formation at the single scale aggregate, mainly by means of AFM-based techniques. The use of 
AFM is essential to unravel the characteristic of these structures at the nanometer single 
molecule length scale. In particular, to address the challenge of understanding amyloids 
aggregation, single molecule measurements possess increased robustness than bulk 
measurements measuring heterogeneous populations. For this reason, the use of single molecule 
techniques as AFM is fundamental to resolve the complex and heterogeneous energy landscape 
of proteins aggregation. Moreover, the application of new AFM-based methodologies, such as 
the recently established PF-QNM and infrared nanospectroscopy, represents a fruitful avenue 
to unravel the process of monomer misfolding and to elucidate the molecular mechanisms of 
amyloid polymorphism and formation. Furthermore, the biophysical characterization of the 
properties of the intermediate structures during the fibrillization process is of fundamental 
importance to unravel their stability and gain insights into the potential toxicity of the 
intermediate aggregation species, information of crucial value in order to design new 
therapeutic strategies to prevent or delay the onset of neurodegenerative disorders. In parallel 
with this extensive research related to the field of human diseases, it is important to measure 
and quantify the structural and mechanical properties of amyloid fibrils as well as understand 
how they emerge from the fibrillization process in order to appreciate them fully as novel 
biomaterials. 
 During my experimental work, I focused on the biophysical investigation of the kinetics 
of amyloid fibril formation, of the early stages of aggregation and on the study of the mechanical 
and structural properties of the intermediate and final products of aggregation. These studies 
were performed by means of spectroscopic bulk techniques and both conventional and 
innovative single molecule techniques based on Atomic Force Microscopy. Bulk techniques as 
Thioflavin T, Circular Dichroism and Infrared Spectroscopy are powerful methods to 
investigate the properties of amyloid aggregation in solution. In particular, Thioflavin T enables 
following the kinetic of growth of fibrils, while Circular Dichroism and infrared spectroscopy 
give information on the conformational change and secondary structure of the forming 
structures. However, a significant factor, limiting the general applicability of these bulk 
techniques for the study of protein aggregation, is that they are able to give only average 
information only on the ensemble of the species present in the heterogeneous aggregating 
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solution. AFM allowed investigating at the single aggregate scale the oligomerization and 
fibrillization of wild type and mutated forms of several amyloidogenic proteins, such as -
synuclein and huntingtin, as mainly shown in the second chapter. Moreover, different 
implementations of the methodology, such as force spectroscopy, force volume mapping and 
the peak force quantitative nanomechanical mapping (PF-QNM) enable investigating the 
mechanical properties of fibrils and other species forming during the aggregation process. In 
particular, in the third chapter, an application of force spectroscopy in order to manipulate at 
the nanoscale and investigate the mechanical properties of -synuclein prefibrillar structures is 
exposed. While, in the fourth chapter, the PF-QNM technique is implemented to study the 
evolution of the mechanical properties of amyloid aggregates. Notwithstanding the astonishing 
insight brought into the field of proteins aggregation by these techniques, until now the 
contemporary mechanical and structural characterization of amyloid aggregates has been 
limited by their nanoscale dimensions. A new AFM-based spectroscopic technique, termed 
infrared nanospectroscopy, has the potential to be used successfully to chemically and 
structurally investigate at the nanoscale the misfolding process and the structural properties of 
the oligomeric and fibrillar species present in the fibrillation pathway. This technique exploits 
the simultaneous use of AFM and IR. In the fifth chapter, it is exposed a first demonstration of 
the capability of this technique to distinguish and structurally characterize monomeric and 
aggregated forms of lysozyme micro-droplets. In the final chapter, for the first time at the 
nanoscale, the parallel application of AFM-based nanomechanical measurements and of the 
chemical investigation by infrared nanospectroscopy has allowed correlating amyloid elastic 
and structural properties during protein misfolding and aggregation of the Josephin domain of 
ataxin-3. 
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Chapter 2. AFM as a versatile tool to investigate pathway 
and kinetics of amyloids formation 
This chapter contain part of the data of two scientific publications. The first published in 
Journal of Biological Chemistry with the following authors: 
O. Khalaf1, B. Fauvet1, A. Oueslati1, I. Dikiy2, A. Mahul-Mellier1, F. S. Ruggeri3, M. Mbefo1, F. 
Vercruysse1, G. Dietler3, S. Jae Lee4, D. Eliezer2 and H. A. Lashuel1 
And the latter in Angewandte Chemie with the following authors: 
A. Ansaloni1, Z. M. Wang1, Jae Sun Jeong3, F. S. Ruggeri3, G. Dietler3, and H. A. Lashuel1 
Affiliations: 
1 Brain Mind Institute, EPFL, 1015 Lausanne, Switzerland. 
2Department of Biochemistry, Weill Cornell Medical College, New York, 10065, USA. 
3 Laboratory of Physics of Living Matter, EPFL, 1015 Lausanne, Switzerland. 
4
 Department of Biomedical Science and Technology, Konkuk University, Seoul, South Korea.  
Abstract 
Aging of the world population has increased the visibility of neurodegenerative disorders, such 
as Parkinson’s and Huntington’s diseases. These human illnesses are strictly linked with the 
aggregation towards amyloid fibrillar structures of -synuclein and huntingtin proteins, 
respectively. The use of Atomic Force Microscopy is essential to unravel the characteristics of 
amyloid structures at the nanometer scale. The technique is able to provide direct information 
on the size and the morphology of the species present during the pathway of amyloids 
formation. In the present work, we show that the realization of consistent AFM measurements 
enable to study the aggregation pathway of these two proteins and to quantitatively compare 
the kinetics of fibrillization of wild type mutated forms of the proteins. First, we studied the 
role in the protein aggregation process of a post-translational mutation (pT3), in the N-terminus 
of the protein. We showed that phosphorylation of the protein conspicuously slowed the 
oligomerization and fibrillization process. Notably, the protein is fibrillating below the 
pathogenic threshold. Successively, we were able to unravel -synuclein early aggregation 
pathway and to study the role of a new missense mutation (H50Q) in the process, in particular 
this mutation accelerated fibrillization in vitro. Elucidating the consequences of sequence 
mutations on the biochemical, structural and aggregation pathway of amyloidogenic proteins is 
essential for the unraveling of the molecular basis of their function in health and disease.  
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2.1 Introduction 
The onset of Parkinson’s (PD), Huntington’s diseases (HD) and of more than fifty further 
related pathologies is associated at the molecular level with the proliferation of amyloid fibrillar 
aggregates, formed from normally soluble cellular proteins.2,131 During their aggregation, 
proteins initially in their monomeric forms undergo internal structural rearrangement, and 
misfold into conformations that are susceptible to form fibrils. During the aggregation process, 
several coexisting aggregate species are formed, giving rise to a highly heterogeneous reaction 
mixture. The fibrillation process typically takes the form of a nucleation-dependent 
polymerization reaction.215 This model supposes that formation of oligomeric nuclei is 
necessary for the formation of the first protofibrillar structures, ultimately leading to the 
formation of the mature amyloid fibrils. Structural polymorphism can be encountered at all 
aggregation levels, and can be seen to originate as a consequence of the glassy, frustrated energy 
landscape that underlies misfolding and aggregation.40 
 Atomic Force Microscopy (AFM) has emerged in the last decades as one of the most 
powerful and versatile single molecule techniques because of the possibility to acquire 3-
dimensional morphology maps of specimens on a surface. This capability has been widely used 
in the field of protein aggregation and amyloid fibrils formation. Indeed, a simple AFM map 
provides extremely valuable information at the nanometer scale on the structure of amyloid 
fibrils, such as height, width, periodicity, flexibility and packing of single protofilaments inside 
mature fibrils.36,198 Furthermore, the possibility to analyze the morphology at several time 
points, during the process of amyloid aggregation, enables to shed light on the mechanisms of 
protein misfolding, on the pathway of aggregation and the hierarchical polymorphic process of 
assembly. In this chapter, AFM imaging is used to analyze in detail the early process of amyloid 
formation and to compare the kinetics of aggregation of different mutated forms of the same 
protein.  
 First, we investigated the effect of phosphorylation of the N-terminus of huntingtin 
protein. Despite constituting a small part of the total protein sequence (~3%), the 
overexpression of the N-terminal of the protein (residues 1-90, Httex1) is able to replicate the 
features of HD.145 Within these residues, the first N-terminal 17 amino acids play a fundamental 
role in Httex1 structure, aggregation and function.135 Increasing evidence suggests that specific 
N-terminal post-translation modifications of huntingtin play a role in the pathogenesis of the 
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illness.131 For this reason, here, we focused on the study of fibrillation differences between the 
wild type and a T3-phosphorylated forms of Httex1-23Q protein. For the first time, our AFM 
studies allowed to follow quantitatively the kinetic of amyloid fibrils formation and to show 
that the N-terminus phosphorylated (pT3) mutated form of the protein significantly slows the 
fibrillation process. Notably, the protein aggregate and fibrillate below the pathogenic polyQ 
stretch length for the onset of HD. This suggest that the crossing of the pathogenic threshold is 
not necessary for Httex1 formation of fibrillar structures. Afterwards, it was studied the 
aggregation process of wild type (WT) -synuclein and it was compared to a mutated form of 
the protein containing a new missense mutation encoding a histidine-to-glutamine substitution 
(H50Q), which was described in patients with a familial form of PD and dementia.111 During 
the last two decades, already three missense mutations were linked to familial forms of PD and 
they have been identified in the gene encoding α-synuclein: A30P, E46K and A53T.216,217 
Several studies, in vitro and in vivo, revealed that these mutations influence α-synuclein 
physiological properties and enhance its oligomerization, fibril formation and toxicity. Here, 
we investigated the effects of the novel H50Q mutation on the biophysical properties of α-
synuclein. Similarly to the previously discovered mutations, we demonstrated that it also 
enhances the oligomerization and fibrillization propensity. Moreover, in literature the 
aggregation process of -synuclein was almost completely studied under the condition of 
shaking (fast aggregation). The process in absence of shaking (slow aggregation) is extremely 
slow, takes months, and it is particularly difficult to obtain and it has been studied poorly.113 
Thus, we decided to investigate the pathway of slow aggregation process to understand if it is 
possible to resolve, with higher time resolution, the early moments in which monomers start 
aggregating. Through this approach, we were able to distinguish the moment when monomers 
started to assembly into the first prefibrillar structures.  
 The understanding of the mechanisms of amyloid fibrils formation and polymorphism 
can provide the basis for establishing approaches to the disease prevention, such as the 
inhibition of repression of the aggregation process in vivo or the stabilization of a specific non-
toxic species rather than another causing cell death. Moreover, understanding the biophysical 
effects of mutations on the kinetics and pathway of aggregation is fundamental to unravel the 
role of these proteins both in physiological and disease-related conditions. Finally, from the 
opposite point of view, in order to appreciate the full potential of amyloid fibrils as biomaterials, 
it is fundamental to understand how they emerge from the fibrillization process and how their 
structure could be modulated by changing the aggregation conditions. 
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2.2 Experimental Methods  
Expression and purification of -synuclein 
Recombinant wild type and mutated H50Q -synuclein were synthetized by E. Coli and then 
purified by standard previously accepted protocols.111,218  
Production of Huntingtin Exon 1 
A semisynthetic strategy was implemented for the site-specific introduction of post-
translational modifications (PTMs) within the Nt17 domain of huntingtin exon 1 (Httex1) using 
expressed protein ligation (EPL). This strategy was used to produce untagged wild-type (WT), 
single phosphorylated T3-phosphorylated (pT3) Httex1 containing 23Q.136 
Amyloid In vitro fibrillization assays  
Wild type and mutated H50Q monomeric filtrated through 100 kDa molecular weight cutoff 
filter (>95%) -synuclein, in a 50 mM TRIS-buffer solution with 150 mM, were incubated at 
37 °C and at a concentration of 45 M. Initial volume was 800 l and the solution was adjusted 
to both pH 5.5 and pH 7.5. Solutions were stored in a sealed Eppendorf tube, to avoid 
contamination and evaporation, under static and shaking conditions for a variable time up 365 
days. 
 Huntingtin exon 1 proteins were dissolved in 500 L of 10 mM Tris-HCl, 75 mM NaCl 
pH 7.4 at a final concentrations of 30 M. The samples were filtered through 100 kDa molecular 
weight cutoff filter to remove any preformed aggregates prior to sample incubation. Protein 
concentration was initially determined by weight and adjusted using a UPLC methods and a set 
of standards of known concentrations. Equal protein concentrations were also verified by CD 
and SDS-PAGE. Fibrillization was performed by incubation of the proteins at 37 °C without 
agitation for 8 weeks. 
Atomic Force Microscopy Imaging 
Analysis by AFM was performed on three differently charged substrates, Fig. 2.1: negatively 
charged bare mica, positively functionalized mica (mica-APTES) and hydrophobic highly 
oriented pyrolytic graphite (HOPG),. In the last case after the cleaving, the mica substrate, was 
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incubated with a 10-μl drop of 0.05%(v/v) APTES ((3-Aminopropyl)triethoxysilane, Fluka) in 
Milli-Q water for 1 minute at ambient temperature, rinsed with Milli-Q water and then dried by 
the passage of a gentle flow of gaseous nitrogen. 
 
Figure 2.1 Substrates used for AFM imaging. 
 In the case of -synuclein, samples were deposited on all surfaces at room temperature 
by deposition of a 10 l aliquot of solution, which was deposited at dilutions from full 
concentration (45 µM) to 100 times dilution, with a deposition time in the range of 1-10 
minutes. Successively, the sample was rinsed by water and dried by a gentle flow of Nitrogen. 
AFM images were made by means of two instruments in ambient condition: a Nanoscope IIIa 
by Bruker operating in tapping mode, equipped with a Silicon tip (Bruker, MPP-12120-10, 5 
Nm-1) with a nominal apex radius of 8 nm and a Park NX10 operating in true non-contact mode 
and equipped with a silicon tip (Nanosensor, PPP-NCHR, 40 Nm-1) with a nominal apex radius 
of 7 nm. The first microscope was utilized for monitoring all the fibrillation process and in 
particular the early stages, while the second was used to compared consistently the morphology 
of wild type and H50Q fibrils after 6 days. Huntingtin samples were prepared on mica-APTES 
at room temperature by the deposition of 10 l aliquot of full concentrated solution. AFM was 
performed on a Park NX10 AFM system, which as described above was operated in the non-
contact mode under ambient conditions, but using super sharp silicon tip with a nominal radius 
of 2 nm (Nanosensor, SSS-NCHR, 40 Nm-1). AFM-images were flattened using the PARK 
built-in software and SPIP (Image metrology, Horsholm, Denmark). The statistical analysis of 
the images was conducted using SPIP software and the home-made software in our laboratory 
DNA-trace.219 
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2.3 Kinetics of Aggregation of Wild Type and Phosphorylated Huntingtin  
The aggregation of Huntingtin protein and its mutated forms is linked to the onset of 
Huntington’s disease. Increasing evidence suggests that specific N-terminal post-translation 
modifications within the N-terminus of Huntingtin play a role in the pathogenesis of the illness. 
For this reason, we focused on the study of their fibrillation and on differences between wild 
type and a mutated form of this protein. Our AFM studies allowed following quantitatively the 
kinetic of amyloid fibrils formation and to show that the N-terminus phosphorylated (pT3) 
mutated form of the protein significantly slows the fibrillation process.  
 To assess the effect of phosphorylation at T3 on the aggregation properties of Httex1, 
we employed AFM, which allows the visualization and characterization of early aggregation 
events and the quantitative assessment of the size and morphological distribution of the 
aggregates. WT and pT3 Httex1, were incubated separately at 37 °C without agitation and 
aggregation was monitored using AFM for 14 days. The samples were filtered through 100 kDa 
molecular weight-cutoff filter to remove any preformed aggregates prior to sample incubation. 
In Fig. 2.2 A, we can follow the fibrillation process of wild type and pT3 Httex1. We imaged 
by Atomic force microscopy (AFM) our samples after 1 h, 7 days and 14 days of incubation 
time. Within the first few hours of incubation, Fig. 2.2 B, wild type proteins formed oligomers 
with a typical height of 1 nm and a broad distribution of diameter as big as 100 nm. While, pT3 
proteins were still present as oligomers with a typical height of about 1 nm and with small 
diameter (< 20 nm). After 7 days, Fig. 2.2 C, the wild type Httex1 oligomers with big diameter 
disappeared and the present small oligomers had slightly increased height. Furthermore, now 
the AFM revealed fibrils with a broad distribution of average height within 4 nm and 6 nm (Fig. 
2.2 D, blue bins in the histogram). Instead, after 7 days, pT3 Httex1 started to form oligomers 
with big diameter (ranging from 20 to 120 nm) and with slightly increasing height. At this point 
still no pT3 Httex1 fibrillar structures were formed. After 14 days, WT Httex1 formed extensive 
amounts of fibrils, whereas pT3 showed many elongated protofibrillar structures with an 
average height of approximately 2 nm, in addition to a small amount of mature fibrils with an 
average height of approximately 5 nm (Fig. 2.2 D, green bins in the histogram). The dimensions 
of pT3 fibrils were comparable with the dimensions of wild type Httex1 fibrils formed at 7 
days. These results demonstrated that wild type Httex1 aggregated and formed fibrils more 
rapidly than pT3 Httex1. Notably, the study revealed that wild type Httex1 containing polyQ 
repeats below the pathogenic threshold exhibit high oligomerization and fibrillization 
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propensity as evidenced by the rapid formation of oligomers and fibrils both for the wild type 
and phosphorylated form of Httex1 proteins. Thus, suggesting that crossing the pathogenic 
threshold is not necessary to start amyloid aggregation. 
 Elucidating the consequences of sequence mutations on the biochemical, structural and 
aggregation pathway of amyloidogenic proteins is essential for the unraveling of the molecular 
basis of their function in health and disease. 
 
Figure 2.2 Oligomerization and Fibrillization process of wild type and pT3 huntingtin. 
(A) Aggregation of wild type and mutated pT3 huntingtin followed by AFM. (B) Height and diameter 
distributions of mutated pT3 (green) a wild type oligomeric structures after 1 hour incubation. (C)  
Height and diameter distributions of mutated pT3 (green) a wild type oligomeric structures after 7 days 
incubation.  (D) Height distribution of mutated pT3 (green) at 14 days and wild type protein at 7 days. 
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2.4 Role of H50Q mutation in -synuclein kinetics of aggregation and early 
stages of fibrillization 
The exact molecular mechanism underlying -synuclein fibrillation it is not still fully 
understood and it is most likely determined by the experimental conditions used in the 
aggregation process. Fundamental parameters are: concentration, pH, salt content and shaking 
of the fibrillating solution. In particular, the shaking (agitation) is a strong accelerator of the 
fibril formation process: typically fibrillation of a 1 mg/mL concentrated solution of -
synuclein is completed within 3 days (fast aggregation), while without (slow aggregation) it 
needs a time of the order of months.  
 In the first part of this section, we will study and compare the fast aggregation of wild 
type and H50Q mutated -synuclein. Usually, in literature, the study of amyloid fibrillization 
is conducted by the use of one substrate in which proteins are deposited and analyzed, in order 
to study separately the oligomerization and fibrillization process, we performed our analysis by 
depositing on differently charged surfaces the aggregated protein. In the second part, similarly, 
we will investigate the process of fibrillization in absence of shaking. In particular, it will be 
shown that it is possible to profit of the slowness of the reaction to follow with higher time-
resolution the early moments of the aggregation process corresponding to the lag and growth 
phases. 
2.4.1 Comparison of the kinetics of aggregation of WT and H50Q mutated -
synuclein 
To determine the effect of H50Q mutation on -synuclein early stages of oligomerization and 
on fibrillation, we compared the fast aggregation at 37 °C, at pH 7.5 and at 45 M of WT and 
H50Q proteins by AFM imaging. Since -synuclein is negatively charged at physiological pH, 
it has high affinity towards positively charged surfaces, such APTES-mica. However, 
functionalization of mica causes a higher surface roughness (~0.1 nm) than the negative bare 
substrate, which possess low topographical roughness (~0.01 nm) allowing higher resolution 
imaging. Thus, both surfaces were used to image the aggregation of WT and mutated -
synuclein and to separately study the oligomerization and fibrillization process. At low 
concentration of deposition (0.5 M, i.e. low surface coverage) bare mica is suitable for the 
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visualization and statistical analysis of the single monomers and the early oligomerization 
process (Fig. 2.2). At the late aggregation stages, a high concentration of deposition (45 M) 
on APTES-mica is more suitable for a statistical characterization of protofibrils and fibrils (Fig. 
2.4, 2.5).  
 Freshly prepared WT and H50Q α-synuclein diluted to 0.5 μM and deposited on bare 
mica surfaces displayed a mixture of monomeric and dimeric species as well as some higher-
order oligomers (Fig. 2.3).  
 
Figure 2.3 AFM analysis of monomeric α-synuclein at a low concentration of deposition. 
Comparison of wild type (A) and mutated H50Q (B) -synuclein. For both parts: top left panel, high 
resolution height map; bottom left panel, zoomed section of the above picture showing typical monomer 
and dimer particles top right panel, height distribution histogram; bottom right panel, cross-sectional 
analysis of a monomer (magenta line) and dimer (green line) particles from the bottom left picture. 
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 Monomers and dimers from both α-synuclein variants displayed similar average 
diameters and heights, but H50Q α-synuclein showed more elongated oligomeric structures 
than WT α-synuclein. The height histograms show a first height population (monomers) with 
an average height of ~0.3 nm and a second population (dimers) composed with average height 
of ~0.9 nm. These dimers were always present for both WT and H50Q α-synuclein, with a 
higher proportion of dimers in H50Q compared to WT α-synuclein. Even though samples were 
filtered through 100 kDa membranes, these dimers quickly re-form after the filtration and might 
deposit more efficiently than the monomers on the mica surface. No larger species are 
detectable in significant proportions in Fig. 2.3, thus excluding the presence of large oligomers 
and/or protofibrils. Due to the limit of the AFM tip’s lateral resolution, it is not possible to 
obtain reliable lateral diameter estimation of the particles. Thus, the larger structures seen with 
H50Q α-synuclein (Fig. 4B, b) correspond to closely-associated monomers and dimers in the 
x-y plane. Together with circular dichroism data,111 these analysis suggested a faster rates of β-
sheet-rich oligomer formation for H50Q α-synuclein compared with its WT counterpart. 
 In order to determine whether fibrillization pathway and structural properties of -
synuclein fibrils were affected by the H50Q mutation, a first comparison of the aggregation is 
showed in Fig. 2.4. Both proteins were deposited at full concentration on an APTES-mica 
substrate. 
 
Figure 2.4 Aggregation process of wild type and mutated H50Q -synuclein. 
Deposition of proteins on APTES-mica at 0, 1, 3, 6 days. Top panel, aggregation of wild type protein. 
Down panel, aggregation of mutated H50Q protein. Arrows indicate small prefibrillar structures. 
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 At a first glance, in both cases, it is possible to conclude that initially only oligomeric 
structures are present (0 hours), successively first prefibrillar structures form (24 hours) and at 
later points (72 hours, 6 days) protofibrillar and fibrillar structures are formed. Notably, the WT 
fibrillar structures are longer than H50Q ones. This easy comparison could bring to the 
conclusion that WT protein fibrillate faster than mutated H50Q.  
 A single aggregate statistical analysis of the fibrillar cross-sectional dimensions scale 
enabled to quantitatively retrieve a comparison of the kinetics of aggregation of the two 
different proteins and to conclude that previous affirmation is erroneous. In order to prove it, 
we performed the statistical analysis after 6 days incubation (Fig. 2.5). The detailed analysis of 
WT fibrillar structures and the measurement of their cross-sectional dimensions enabled to 
observe two different populations of structures with height of ~4 nm and ~6-7 nm (Fig. 2.5 
A,B). While, the average height distribution showed an abundant population peaked at 4.8 ± 
0.5 nm and a tail with bigger fibrils (Fig. 2.5 C). This means that we had abundant formation 
of protofibrils (typical height between 3-4 nm) and formation of mature fibrils (typical height 
between 6-9 nm), which are much rare, is still at the initial stage. The statistical analysis of the 
length of WT fibrils showed an average value of 150 ± 70 nm (Fig. 2.5 D). The same analysis 
was performed in the case of the mutated protein. High resolution images of H50Q fibrillar 
structures and measurement of their cross sectional dimensions revealed again two distinct 
fibrillar populations (Fig. 2.5 E). Moreover, in this case, the statistical analysis of the height 
distribution of these structures showed that both populations were abundant. The first one had 
an average height of 4 ± 0.4 nm and the second one of 6.2 ± 0.5 nm (Fig. 2.5 F). This means 
that H50Q formation of amyloid mature structures is in a more advanced stage than the WT 
proteins, notwithstanding the fact they have shorter than WT fibrils average length, of 80 ± 30 
nm (Fig. 2.5 G). Considering that measurements of the two samples have been performed by 
the same AFM tip and in identical scanning conditions, we can affirm that: 1) H50Q protofibrils 
have smaller heights than WT ones. 2) H50Q fibrillar structures have smaller length than WT 
ones. 3) WT fibrillation is occurring more slowly than for H50Q. 
50 
 
 
Figure 2.5 Morphology of fibrillar structures of WT (top panel) and mutated H50Q (low panel) a-
synuclein after a 6 days incubation, high concentration deposition (45M) on APTES-mica.  
(A-B) Details of WT protofibrils and fibrils and cross-sectional dimensions. (C-D) Distribution of the 
average height and length of WT fibrillar structures. (E) Details of H50Q oligomers, protofibrils and 
fibrils and of their cross-sectional dimensions. (F-G) Distribution of the average height and length of 
H50Q fibrillar structures. 
2.4.2 Early aggregation pathway of wild type -synuclein. 
As it is indicated by the blue arrows in Fig. 2.4 and showed in detail in Fig. 2.6, in-pathway of 
the process of -synuclein fast aggregation at pH 7.5, prefibrillar structures are already present 
after 24 hour of incubation for both mutated and wild type protein. Accordingly, at this time 
point, CD measurements showed the initial acquisition of -sheet structure both for the mutated 
H50Q and the wild type protein. 
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Figure 2.6 -synuclein prefibrillar structures in-pathway of aggregation. 
(A) Top: detail of wild type joining prefibrillar structures and cross-sectional dimensions. Down: detail 
of H50Q prefibrillar structure and relative cross-sectional dimension. (B) CD measurements.111 
 As it is showed by the measurement of their height in Fig. 2.6, these prefibrillar 
structures have sub-nanometer apparent height at the AFM. Notably, their height and width are 
comparable to the monomeric and dimeric ones in Fig. 2.3. This strongly suggested for physical 
reasons that no more than a dimer could be packed inside such a small structure. Recently, it 
was again supposed that subfilaments with diameter of about 1 nm should be the constituents 
of final matures fibrils of -synuclein, but so small prefibrillar species were never been 
isolated.220 Thus, we started to modify the parameters of aggregation in order to understand if 
these prefibrillar structures are always in-pathway of aggregation. We found that 
presence/absence of salt content in the aggregating solution did not affect their formation, while 
a decrease in pH enhanced their formation in the early stages of fast aggregation, Fig. 2.7. 
 
Figure 2.7 Fast aggregation of -synuclein at 45 M and pH 5.5 on APTES-mica. 
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 The transient nature of the observed prefibrillar species, together with the short time of 
formation during the fast aggregation process, did not allow to study in detail the pathway of 
their aggregation. Thus, in order to unravel the process of prefibrillar structures formation, we 
decided to investigate the static and slow aggregation of the protein solution in identical 
conditions than the fast process (Fig. 2.8). Moreover, we followed the fibrillation by depositing 
wild type -synuclein on three different surfaces: negatively charged mica; positively 
functionalized mica (APTES-mica) and hydrophobic graphite (HOPG). 
 
Figure 2.8 Slow aggregation of -synuclein at pH 5.5 and 45 M on three different surfaces: mica, 
APTES-mica and HOPG. 
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 Our idea was that, during the aggregation process and before of formation of fibrils, 
different structures are present in the heterogeneous, in non-equilibrium, incubated solution and 
that they can be selected by differential interaction with each surface. Before of incubation, we 
observed just oligomers on our surfaces. We performed an accurate statistical analysis of their 
cross sectional dimensions on the atomically flat mica surface (Fig. 2.9 A). Similarly to Fig. 
2.3, at the initial stage of the aggregation two main height populations were found: first one 
were monomers and they have a height of ~0.4 nm, second one were dimers with height of ~0.8 
nm (Fig. 2.9 B). These oligomeric species were present with constant cross-sectional 
dimensions all over the aggregation process (Fig. 2.9 C). The high abundance of monomers 
and dimers confirmed that the aggregation reaction even after months is still in its initial stage. 
 
Figure 2.9 Statistical analysis of early oligomeric species during the slow aggregation process of 
-synuclein. 
(A) Oligomers at the initial stage of the aggregation (0 days). (B) Height distribution at 0 days of the 
more abundant populations: monomers (~0.4 nm) and dimers (~0.8 nm) and early oligomeric species 
(height >1 nm). (C) Height of monomers and dimers during the aggregation process. 
 As expected, with increasing incubation time, elongated structures started to be present 
on all surfaces (Fig. 2.10). We termed these structures protofilaments. Furthermore, we found 
that protofilaments formation was independent from presence of salt, shaking and pH of the 
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solution. Together with the previous findings on fast aggregation, this suggested that 
protofilaments are a general feature of the aggregation process. We performed a statistical 
analysis of the height of protofilaments on all the three surfaces.219 On charged substrates, we 
observed mainly two families of prefibrillar structures with height respectively of: ~0.4 nm and 
~0.8 nm; instead on HOPG, after 181 days, we could also observe abundant formation of 
protofibrils with average height up to ~2 nm (fig. 2.10 A-B). A direct comparison of the 
monomeric and dimeric dimensions with the prefibrillar ones showed a perfect correspondence 
between their heights, similarly as in the case of the fast aggregation process. Therefore, we 
suggested that the first family of protofilaments is composed by a single monomeric layer and 
we termed it single strand protofilament. While second population had height corresponding to 
the one of dimers, thus we termed it double strand protofilaments because they form by 
association of single strand ones (Fig. 2.10). 
 
Figure 2.10 Statistical analysis of prefibrillar species on mica, APTES-mica and HOPG. 
(A) Detail of the prefibrillar structures. (B) Height distribution at a time point. (C) Average value of 
height as a function of incubation time. 
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 A further analysis of the persistence length and the periodicity of the prefibrillar 
structures enabled to study their polymorphism. Single strand protofilaments did not show any 
internal structure and they appeared in the images as semi flexible rod-like structures. By means 
of the bond correlation function for semi-flexible polymers in a two-dimensional conformation 
(Equation (1), Chapter 1), we calculated a value of persistence length for single strand 
protofilaments of ~20 nm, which is the same for both the structures on mica and APTES mica. 
The analysis of this quantity for the protofilaments deposited on HOPG was not possible 
because of the notable surface effects, due to the ordering of the structures along the HOPG 
steps. 
 
Figure 2.11 Polymorphism of -synuclein protofilaments. 
(A) Single strand and double strand protofilaments on mica and cross sectional irregular profile of a 
double strand protofilament. (B) Double strand protofilaments on APTES-mica clearly showing 
periodicity and cross-sectional profile of a protofilament. The structure has a periodicity of ~8 nm.  
 It is worth noticing that double strand protofilaments showed a small periodicity of <10 
nm on APTES-mica, but not on mica (Fig. 2.11). Moreover, periodic (twisted structure) double 
strand structures had a persistence length of ~150 nm, while laterally associated (ribbon-like) 
ones had a persistence length of ~250 nm. All together, these results suggested that two 
polymorphic double strand protofilaments exist: (i) first type deriving from the intertwining of 
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two single strand ones; (ii) second type deriving from two laterally associating single strand 
protofilaments.  
 The measurement of the persistence length lp enabled extracting the Young’s modulus 
E of the protofilaments, through the application of the relationship 𝐸 = 𝑙𝑝𝑘𝑏𝑇/𝐼. An important 
issue that aroused to measure the Young’s modulus, it was calculating the protofilaments cross 
sectional moment of inertia I. If the fibril is formed by several filaments, it becomes necessary 
to propose a filament packing mechanism.11,36,221 Furthermore, the measurement of height by 
AFM, in air for a relaxed object on a surface less tall than 4 nm, is affected by a considerable 
underestimation. This is majorly due to dehydration effects, to the influence of the tip-substrate 
interaction in the measurement of the force between tip and sample and to the mechanical 
deformation and pushing of the sample by the tip.194,222 For this reason, the measured apparent 
heights at the AFM of the single strand population and of the oligomers (~0.4 nm) were much 
smaller than their “real” value.223 Thus, we deposited our prefibrillar structures together with 
circular DNA (Fig. 2.12) in order to use it as an internal ruler for the measurement of the “real” 
height of the prefibrillar structures, which is the fundamental parameter to calculate the cross 
sectional moment of inertia I. The structure of DNA has been extensively studied and it is 
universally accepted as a flexible double helix with ~2 nm diameter.224 Single strand structures 
possessed half of the height of DNA, while double strand ones had similar height as the DNA. 
Supposing that the structures have circular cross section, this means that the “real” diameter of 
first population is ~1 nm, while second one has a real diameter of ~2 nm.  
 
Figure 2.12 Comparison of the height of circular DNA and protofilaments. 
(A) AFM image of protofilaments and circular DNA deposited on APTES-mica. (B) Height distribution 
of DNA and protofilaments. 
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 Considering single strand protofilaments as a rod with circular cross section and 
moment of inertia of 𝐼 =
1
64
𝜋𝑑4, persistence length of 20 nm, diameter of ≈1-1.2 nm for a 
measurement at 295 K, we were able to extract a Young’ modulus of E ≈0.8-1.7 GPa. This 
notable value confirms that protofilaments possess a rigid structure, likely because of the 
formation of the universal amyloid cross- structure. Nevertheless, it is smaller than the typical 
value for a mature amyloid fibril (i.e. typical 2-4 GPa)163, confirming the prefibrillar nature of 
these protofilaments. We extracted the value of Young’s modulus also for the double strand 
protofilaments showing periodicity. We considered a twisted ribbon packing model38 with lp = 
150 nm and 𝐼 =
𝑛
64
𝜋𝑑4√
4
3
−
1
𝑛2
 , where n=2 is the number of component filaments. We obtained 
a value of Young’s modulus of E ≈1.2-2.5 GPa. Despite this is just a rough estimation, because 
of the indetermination in diameter, the value of stiffness is comparable to what obtained 
independently by PF-QNM for mature fibrils. This suggested that single strand structures had 
a non-mature amyloid structure, while double strand protofilaments possessed a more mature 
cross- sheet structure stabilized by the numerous intermolecular hydrogen bonds, which 
determine the high value of intrinsic stiffness. 
 Finally, we can affirm that this new approach, based on differential surface-molecule 
interaction, allowed a more detailed study of amyloids aggregation process and polymorphism. 
Surfaces with different state of charge/hydrophobicity selected different amyloids species. All 
the three used substrates were able to adsorb single strand protofilaments, APTES-mica was 
able to select mainly intertwining double strand protofilaments, bare mica just laterally 
associated ones and HOPG was able to absorb the forming protofibrillar structures. Rarely, also 
on charged substrates we could observe double strand protofilaments branching to higher order 
structures. Recently, it was supposed that subfilaments with diameter of about 1 nm should be 
the constituents of final matures fibrils of -synuclein.220 As it is extensively discussed in the 
third chapter of this thesis, the height of the single strand protofilaments is comparable to the 
height of proteins backbone, suggesting that they are formed from the direct assembly of 
monomers. According to the proposed model here, -synuclein is not aggregating through 
oligomerization, but it is assembling to prefibrillar structures directly from monomers. As 
depicted in Fig. 2.13, protofibrils structures derive from the hierarchical assembly of the 
protofilaments and oligomerization is off-pathway of fibrillization.  This picture is in fully 
agreement with the Hierarchical Assembling Process, proposed by Khurana as general trend for 
amyloids formation.33 This model hypothesizes that the nascent protofilaments are formed by 
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non-native partially folded monomers assembling in small protofilaments, which successively 
assemble to form mature fibrils.  
 
Figure 2.13 Early aggregation model of -synuclein. By means of the application differential 
substrate-protein absorption, the aggregation process of -synuclein is reconstructed. In particular, two 
separated process are shown: the first shows oligomerization process proceeding from monomers to 
dimers and larger oligomeric formation (down); the latter shows the hierarchical assembly of 
protofilaments towards protofibrillar structures. 
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2.4 Discussion 
AFM is a versatile tool to follow the kinetic of amyloid aggregation process of amyloid proteins. 
Here, we compared the kinetics of aggregation of mutated and wild type forms of the same 
protein. Initially we showed that a N-terminus phosphorylated form of the huntingtin protein 
aggregates slower than the wild type protein. Successively, we presented a comparison of the 
speed of fibrillization and difference in morphology of WT and mutated H50Q fibrils. In 
particular, H50Q fibrillar structures showed smaller dimensions than wild type ones and they 
aggregated faster. The study of the effects of mutation on the aggregation of amyloidogenic 
proteins is of fundamental importance to shed light on their role in both physiological and 
diseases-associated role. Furthermore, AFM analyses are routinely limited to the use of only 
one substrate and this procedure produces just a partial depiction of the extremely 
heterogeneous aggregating solution. The use of three different surfaces of deposition with 
different state of charge (positive, negative, hydrophobic) enabled to overcome the problem of 
surface selectivity and to inquire deeply amyloids polymorphism and to have a complete 
representation of the heterogeneity of the sample. We were able to highlight that first stages of 
their formation comes from direct assembling of unfolded monomers into prefibrillar species. 
Remarkably, this behavior was independent on the agitation of the sample during incubation. 
This new mechanism of fibril formation and the studied monomeric prefibrillar species could 
be fundamentally linked to the process of disease onset. Indeed, these never observed species 
could be responsible for cytotoxicity. Therefore, a rational approach to avoid their formation 
could be the base for the development of  pharmacological approaches to cure amyloid diseases. 
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Chapter 3. Nanomechanical Manipulation of Amyloid 
Protofilaments of -synuclein 
This chapter is based on an in revision paper in Journal of Biological Chemistry with the 
following authors: 
Francesco Simone Ruggeri1, Fabrizio Benedetti 2, Hilal Lashuel 3, Sergey Sekatsky 1, Giovanni Dietler 1 
Affiliations: 
1 Laboratory of Physics of Living Matter, EPFL, 1015 Lausanne, Switzerland. 
2 Center for Integrative Genomics, University of Lausanne, 1015 Lausanne, Switzerland.  
3 Brain Mind Institute, EPFL, 1015 Lausanne, Switzerland. 
Abstract 
Amyloids are insoluble protein aggregates with a common cross -sheet quaternary structure. 
Aggregation of -Synuclein plays a central role in the onset of Parkinson’s disease (PD). In our 
work, for the first time, prefibrillar structures of -synuclein with nanometer scale dimensions 
were observed and mechanically manipulated at single molecule scale by Atomic Force 
Spectroscopy. The filamentous structures could be detached from a surface. This unzipping 
process was represented in the atomic force spectroscopy curves by constant force pulling 
events (plateaus). We were able to measure a fundamental value of interaction force within a 
single molecule and surface of 56 ± 5 pN. Moreover, the study of stretching events inside a 
plateau by means of the statistical theory of biopolymers allowed to investigate the internal 
mechanical properties of our prefibrillar structures and to confirm their direct assembling from 
unfolded monomers. We modeled the process of contemporary detachment of n filaments from 
a surface by a Monte Carlo simulation as the contemporary breaking of n parallel bonds. The 
model successfully reproduced the experimental values of the rupture forces necessary to unzip 
n protofilaments from the surface. The presented results highlighted the potential of force 
microscopy to unravel the driving forces of the fibrillization process at surfaces. A quantitative 
understanding of the mechanical properties of new prefibrillar -synuclein aggregates is of 
fundamental importance for understanding their stability and mechanisms of clearance in the 
body. This would be central to design new therapeutic strategies for Parkinson’s disease.  
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3.1 Introduction 
The ability of proteins to assemble into functional complexes is one of the most fundamental 
processes in biology. One of these processes is the Amyloidosis, which is the aggregation of 
proteins in insoluble fibrous structures with a cross -sheet quaternary structure, termed 
amyloids. Aggregation of -synuclein towards amyloids quaternary -sheet structures plays a 
central role in the neuropathology of Parkinson’s disease (PD).2,89,110 Numerous studies have 
established that -synuclein easily assembles into amyloid-like fibrils both in vitro and in 
vivo.33,112,113 In addition, -synuclein can adopt a large variety of no-fibrillar oligomeric 
structures, the most commonly noted being the following: spheroidal, annular and chain-like 
aggregates with a broad range of variability of their dimensions. Moreover, α-synuclein 
fibrillation can take place in association with the cellular membrane surface 90. For these 
reasons, understanding of the mechanisms of formation of amyloid fibrils, of their intermediate 
products and of their deposition properties on surfaces is crucial for understanding the role of 
amyloid formation in the pathogenesis of PD. 
 Atomic Force Microscopy (AFM)-based single molecule force spectroscopy, similarly 
to AFM imaging, naturally poses itself as an important research tool in the field and can deliver 
information about mechanical and related structural properties of amyloid fibers at the single 
molecule scale. Force spectroscopy studies of different mature amyloid fibrils have been 
presented in the past by Kellermayer et al. .204,205 These studies tried to quantify the interaction 
forces within -sheet filaments inside a fibril of different fragments of A finding 
substantially smaller forces necessary to unzip subunit sheets of A1-42 mature fibrils in 
comparison with A1-40 ones. They well highlighted the importance of these works for 
understanding the details of amyloid formation and pointed out how single molecule 
manipulation methods allow to study mechanics and structural dynamics of amyloid formation. 
Such studies could be of special importance for initial and likely the most crucial stages of fibril 
formation. As an AFM study by Khurana showed, many amyloidogenic proteins follow a 
Hierarchical Assembling Model (HAM) in which a certain number of nanometer size 
protofilaments intertwine or laterally associate to form final amyloid polymorphic structures 
with typical diameter in the order of 10 nm; this was also the case of synuclein.33 Others 
studies by X-ray diffraction and electron microscopy (EM) demonstrated that the final amyloid 
structures should be composed of protofilaments with nanometer size diameter.8,225 Moreover, 
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this has recently been explicitly proposed for -synuclein by mean of an AFM mechanical 
study.220 Until this moment, nobody succeeded to isolate such small amyloidogenic precursors 
and researchers were constrained to explore their properties when already present inside a 
mature fibril. In the present work, we report first observations of protofilaments of synuclein 
having an apparent sub-nanometer diameter at the AFM height images. This observation 
enabled the possibility to nanomechanical manipulate the protofilaments by single molecule 
force spectroscopy studies. Thus, we could quantify the interaction force between of these 
amyloid protofilaments at the surface of deposition. Interaction forces at the surface could be 
of fundamental importance to unravel the driving forces of amyloid formation during the early 
assembling process and to understand their polymorphism. Finally, unraveling -synuclein 
amyloid structure, mechanical properties, stability and driving force of fibrils formation would 
be of fundamental importance to design therapeutic strategy for Parkinson’s disease. 
3.2 Experimental Methods  
Expression and purification of -synuclein 
Recombinant -synuclein was synthetized by E. Coli and then purified by previously accepted 
protocols.218  
Amyloid fibrils preparation 
A 45 M monomeric ( >95%) -synuclein filtrated solution in a 50 mM TRIS-buffer, NaCl 
150 mM, and pH 5.5 was incubated at 37 °C, in an sealed Eppendorf tube to avoid 
contamination and evaporation, for 180 days. 
Atomic Force Microscopy Imaging 
The protein solution was diluted to a concentration of 0.25 M by means of TRIS-buffer at pH 
5.5. AFM sample preparation was realized at room temperature on a positively functionalized 
mica surface. In order to functionalize the mica, after the cleavage, it was incubated with a 10-
μl drop of 0.05%(v/v) APTES ((3-Aminopropyl)triethoxysilane, Fluka) in Milli-Q water for 1 
minute at ambient temperature, rinsed with Milli-Q water and dried by a gentle flow of gaseous 
nitrogen. Then, a droplet of 10 l of our sample was deposited on the APTES-mica surface for 
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one minute, it was rinsed with Milli-Q water and dried by a flow of gaseous nitrogen. AFM 
images were realized in ambient condition using a Nanoscope IIIa (Bruker Corp.) operating in 
tapping mode, the microscope was equipped with an Antimony n-doped Si tip (Bruker, MPP-
12120-10, 5 Nm-1) with a nominal radius of 8 nm. 
Atomic force spectroscopy  
The imaged dried samples were rehydrated with the same Tris-buffer at pH 5.5 for the force 
spectroscopy measurements. Force-extension curves of pulled and stretched amyloids fibrils 
were obtained by means of a Picoforce AFM Nanoscope IIIa, equipped with a Mikromash 
CSC38 n-type silicon tip with a nominal radius of 8 nm and elastic constant k determined by 
thermal fluctuation method and with value equal to 0.103 Nm-1 (nominal 0.09 Nm-1). 
Force curves analysis 
We analyzed force curves by means of the built in Nanoscope (Bruker) program and by means 
of OriginPRO. In the case of non-linear mechanical response, we fitted the curves by the worm-
like chain equation, see eq. (2) below. The average plateau forces were measured by means of 
HOOKE software226, as the difference between the average force of the step and the average 
force of the retracting baseline. 
3.3 Results 
3.3.1 AFM morphology studies of amyloid aggregates as a function of the 
incubation time 
In this work, we considered the slow aggregation of -synuclein (i.e. without shaking during 
the aggregation). Aggregates of -synuclein showed different morphologies as a function of 
their incubation time. Immediately after the dissolution of the amyloidogenic proteins in buffer 
at 0 days, only monomers and oligomers were present on the surface and no fibrillar species 
were visible in our AFM scans (Fig. 3.1 A). After 180 days of incubation at 37 C°, we observed 
many flexible prefibrillar aggregates (Fig. 3.1 B). As shown in detail in the high-resolution 
AFM image in Fig. 3.1 C, they can be separated in two families accordingly to their height (Z 
direction in the AFM map). A statistical analysis of these prefibrillar species, Fig. 3.1 D, 
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showed that the type I had an average height of 0.3-0.4 nm, and type II had average height of 
0.7-0.8 nm. Moreover, the type II family was much less frequent. We could observe that the 
type II species is formed by entangling of two Type I structures, as can be seen in Fig. 3.1 C. 
Finally, this was the first observation of such small intermediate prefibrillar aggregates of -
synuclein. These aggregates did not have the typical dimensions of mature amyloid fibrils (i.e. 
measured height by AFM of 6-9 nm), since their heights were lower than 1 nm and smaller than 
the typical dimensions of protofibrillar species (i.e. measured height by AFM of about 3-4 nm). 
For this reasons, as extensively illustrated in the previous chapter, we termed them 
Protofilaments.33  
 
Figure 3.1 Morphology of oligomeric and prefibrillar a-synuclein species. 
(A) AFM image of monomers and oligomers covering the surface at time 0 h. (B) AFM image of 
protofilaments after several days of incubation. (C) High resolution detail of entangling protofilaments. 
(D) Distribution of heights of Type I and II protofilaments. 
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 A deeper analysis permitted to investigate the nature of these new intermediate 
amyloidogenic structures. The monomeric -synuclein protein is naturally unfolded (14 kDa, 
140 aa), it has a radius of gyration of about 3 nm and it could be represented at the scale of the 
AFM tip as a long flexible rod having the diameter of the carbon-nitrogen backbone.223 The 
average apparent height of type I protofilaments at AFM images was of 0.3 ± 0.1 nm, and we 
were able to measure a corresponding height of about 0.4 ± 0.1 nm for monomers.111 Therefore, 
the height of protofilaments corresponded to that of monomers suggesting that the 
protofilaments are made from the assembly of a single layer of monomeric -synuclein. 
Consistently with this model, previous STM studies of a slightly smaller protein (Cytochrome 
C, 12 kDa, 104 aa), showed a measured height of a protein on a surface ranging from 0.25 nm 
for the case of a totally unfolded structure to about 1 nm in the case of a partially folded state.227 
The same conclusion was supported by the use of ds DNA as an internal standard (ruler) for 
AFM measurements (Fig. 2.12). The actual diameter of ds DNA molecule is 2 nm. It is well 
established that its apparent height in air, as measured by AFM, is always smaller.228,229 We 
measured, in the same scanning conditions as those characteristic for the experiments with 
protofilaments, an apparent height of ds DNA molecule of 0.8 ± 0.2 nm (Fig. 2.12). These 
results suggested that the apparent height of our protofilaments is nearly one-half of that 
measured for the ds DNA molecule. Thus, protofilaments real diameter is of the order of 1 nm. 
As already discussed, this value is even smaller than the radius of gyration of single monomer, 
thus excluding the possibility that more than one protein is present in the cross sectional 
dimension of the protofilament. Consequently, we could affirm that our type I protofilaments 
were chain of monomers without any other internal structure. We termed them single-strand 
protofilaments. We also showed, Fig. 3.2 C, that the type II protofilaments were formed by the 
intertwining of two monomeric chains. For this reason, we termed them double strand 
protofilaments.  
3.3.2 Force response as a function of the amyloidogenic species  
The tip of our AFM cantilever was approached against the functionalized mica substrate, where 
our aggregates and fibrils were deposited. Then, it was retracted and force extension curves 
were recorded. The investigation of the spectroscopic force response for oligomeric and 
prefibrillar species showed a remarkable difference. Before of incubation at 0 days, in the force 
spectra there was no presence of any complex or repeatable force response, except for few 
unfolding peaks due to the monomers and oligomers. Some capture events were occasionally 
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present, but they did not show any characteristic pattern, and the lengths of the corresponding 
force curves were never longer than approximately 50 nm (Fig. 3.2 A). This behavior could be 
associated with the capture and pulling of oligomers of -synuclein. Diversely, after 181 days 
of incubation, multiple force plateaus (Fig. 3.2 B) forming a staircase-like picture were present 
in the corresponding force-distance curves.  
 
Figure 3.2  Mechanical response as a function of oligomeric or prefibrillar species.  
(A) An example of an event of unfolding of oligomers at time 0 h. (B) Plateau event associated with the 
pulling of several protofilaments, present after prolongated incubation of the proteins. 
 Based on these considerations, we affirmed that force plateaus are due to the presence 
of the two families of protofilaments on our mica-APTES surface. Similarly to the previous 
mentioned works of Kellermayer et al.204,205, we associated these constant force pulling events 
to an unzipping process and in particular to the unzipping of single and double-strand 
protofilaments from the surface. We could exclude any internal unzipping from the structure of 
protofibrillar or mature amyloid structures because single-strand protofilaments had cross-
sectional dimensions just of the order of the carbon-nitrogen backbone of a single -synuclein 
monomer. However, it was still possible the observation of some events corresponding to the 
unzipping of a double-strand protofilaments into the two intertwining single-strand 
protofilaments. However, the much lower abundance of these species and their much shorter 
length (Fig. 3.1 B,C) made such events rare. Thus, they could bring only rather insufficient 
broadening of the experimentally observed statistical distributions in this work. This evidences 
demonstrated that our force plateaus were mainly due to the pulling and detaching of the single-
strand protofilaments from the substrate. 
 
68 
 
3.3.3 Nanomechanical Manipulation of -synuclein protofilaments 
In order to investigate the properties of the amyloidogenic protofilaments of -synuclein, we 
analyzed the acquired force-distance curves in detail. Several kinds of mechanical responses 
were observed (Fig. 3.3).  
 
Figure 3.3 Force response of manipulated -synuclein protofilaments.  
(A) Single force plateau at 60 pN due to the pulling of one protofilament (B) Double plateau due to the 
pulling of 2 protofilaments with a force of 112 pN and 1 protofilament with a force of 57 pN. (C) Pulling 
of 4,3,2,1 protofilaments with force plateaus at 207, 160, 115, 56 pN. (D) Constant force plateau with a 
stretching event inside. Fitting by Worm Like Chain model (WLC, see below for details) gives a 
persistence length of 0.32 ± 0.05 nm. (E) Constant force plateau with two stretching events inside. Fitting 
by WLC gives a persistence length of 0.42 ± 0.06 nm and 0.44 ± 0.07  nm. (F) Force plateau preceeded 
by a stretching event with a persistence length of 0.47± 0.04  nm. (G) Non-specific event due to oligomer 
unfolding, WLC fit gives a persistence length of 0.31 ± 0.03   nm. (H) An oligomeric unfolding, preceded 
by a constant force plateau, is fitted by WLC with a persistence length of 0.28 ± 0.05  nm. (I) No 
interaction is observed. 
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 We could group the different force curves accordingly to their behaviour: (A) Single 
constant force plateau due to pulling and detaching of one protofilament from the surface. (B, 
C) Multiple constant force plateaus with a staircase shape due to detaching of several 
protofilaments from the surface. Constant force plateau with “stretching events” inside (D, E) 
or outside (F) the corresponding plateau regions. (G) Non-specific events linkable to pulling or 
unfolding of oligomers. (H) Plateaus mixed with non-specific events. (I) Flat curves due to 
approaching an empty area or picking up nothing. Similar combinations of plateau and 
stretching events were already observed previously.204,205 We collected in total 658 force 
curves, 64% of which showed pulling/unfolding events and the remaining 36% were just flat 
curves due to approaching and retracting on the bare surface or events with no interaction. From 
this 64%, 43% (282) of force curves recorded were plateaus, 8% (53) were plateaus mixed with 
stretching/defolding events inside or outside the corresponding plateau regions and unspecific 
behavior, 7.5% (50) were not specific events likely linked to oligomers pulling and unfolding. 
The remaining 3% (26) were curves with irregular retracting behavior. 
 A statistical analysis of the plateaus size showed that plateaus possessed average length 
of ~70 nm (Fig. 3.4 A). While, it was possible to observe that the fibrillar structures had a broad 
distribution of lengths with an average value of ~170 nm (Fig. 3.5 B). The statistical analysis 
confirmed that single-strand protofilaments were much longer than double-strand ones.  
 
Figure 3.4 Comparison of the lengths of -synuclein protofilaments and lengths of plateaus events 
in the corresponding force curves. 
(A) Distribution of the lengths of constant force pulling events (plateaus). (B) Distribution of the lengths 
of Type I protofilaments and Type II protofilaments. 
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 A comparison of the two distribution showed that the average length of protofilaments 
was double than the one of the observed plateau in the force-distance curves. This difference 
was likely due to the loosing of the tip-aggregate contact during the pulling of the 
protofilaments. A further statistical analysis showed that the length of force plateau decreased 
exponentially as a function of the position of the plateau in the staircase (Fig. 3.5 A), and 
similarly it decreased as a function of the force of pulling (Fig. 3.5 C). This suggested that 
probability to detach a high number of protofilaments, without any tip-protofilament contact 
break event, was smaller than the probability of pulling continuously just one of them. 
 
Figure 3.5 Comparison of the lengths of plateaus events in the force curves. 
(A) Distribution of the lengths of plateaus according to their position in the force curve. (B) Distribution 
of the lengths of plateaus belonging to different families of force peaks. 
 Successively, we measured the force difference F (Fig.3.3 A) between the average 
height of a plateau and the baseline in the force curve. The histogram of the force distribution 
is presented in Fig. 3.6 A. We observed a clear multimodal distribution with four peaks and 
some more rare higher force events, which we considered generically as the fifth peak. From 
the histogram, it was evident that the force peaks appeared at integer multiples of the “single 
detachment event” value of approximately 50 pN. This was in full agreement with the idea that 
our tip could pick up a different number of similar protofilaments. In order to justify the relative 
occurrence of the different force-peaks, it is worth to note that the size of our tip was of the 
order of 10-20 nm and thus comparable with the lateral cross-section of a single protofilament. 
Hence, the most probable case is the one in which the tip is able to catch just one protofilament. 
Then, it would be able to detach the protofilament from the surface with a characteristic force, 
which we measured to be about 50 pN. Furthermore, it could be also possible (but much less 
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probable) that the tip could land exactly on a crossing of two protofilaments, so that the first 
force plateau would be observed at 110 pN. Finally, it is quite probable, as it is possible to 
observe from the morphology of the sample in Fig. 3.2B-C, that certain single protofilament, 
which has been catch, actually crosses with another protofilament(s). Hence, it should be quite 
common to detach an increasing number of protofilaments one after another. 
 
Figure 3.6 Analysis of the constant force plateaus.  
(A) Histogram of the distribution of the average detachment forces. (B) Average force as a function of 
its position in the force curve (red), average value of the histogram maxima as a function of its position 
in the histogram by Gaussian fit (blue). 
 In order to quantify the process and obtain an experimental estimation of the detachment 
forces, we performed two types of analysis of our data: 1) we first numbered the force plateaus 
according to their position in the force curve, see the curve in Fig. 3.3 C as an example, and 
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then we averaged the values of the detachment force disregarding its number. 2) we fitted the 
peaks of the histogram of the distribution of the average detachment forces by a Gaussian curve, 
Fig. 3.6A. First method averaged all the values appearing as the first plateau in the force curve, 
independently of the fact that sometime the first force plateau could be a double force plateau 
because of the contemporary pulling of two protofilaments. This model gave back a good 
estimation of our “quantized” detachment forces, but it returned only a rough estimation of the 
statistical error. Instead, the second method, excluded the double pulling events and it gave 
back a better estimation of the experimental value of the interaction force of amyloid 
protofilaments with the surface as well as its error. However, it was not able to evaluate properly 
the last peak. As expected, both methods of analysis gave similar results and they allowed 
extracting a fundamental value of detachment force of 57 ± 10 pN and of 56 ± 5 pN, 
respectively. The results from these two methods of analysis are shown in Fig. 4 B, where the 
average force of the plateau is represented as a function of its position in the force curve. The 
force of pulling increases linearly with the position of the plateau in the force curve. This 
demonstrates that the force of pulling is proportional to the number of protofilaments that are 
detached from the surface. 
3.3.4 Elastic properties of -synuclein prefibrillar species 
The stretching events present inside or at the border of a plateau were linked to the stretching 
and unfolding of the carbon-nitrogen backbone of the protofilaments. For this reason, the study 
of these events by means of the statistical theory of biopolymers allowed to investigate the 
internal mechanical properties of these prefibrillar structures. In particular, by means of fitting 
the stretching event with a worm-like chain model (WLC, see eq. 2), it was possible to 
determine the persistence length of the structures. We were able to extrapolate an average 
persistence length of 0.29 ± 0.16 nm (calculated from totally 33 events). This value was fully 
consistent with the persistence length of an unfolded protein.230 Indeed demonstrating that our 
protofilaments were early species of amyloids aggregation composed by unfolded monomers 
and with a much less complex and stiff structure than a mature amyloid fibril. 
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3.3.5 Monte Carlo modeling of the process of protofilaments of -synuclein 
unzipping from the surface 
The aforementioned characteristic features of our experiments were modeled through a Monte 
Carlo method. The observed cases of double-, triple- and even larger detachment events, were 
modeled to reveal a connection between the different values of detachment forces (“plateau 
levels”), which were characteristic for events with different numbers of protofilaments 
interacting with the support surface. In doing so, we were inspired by our recent work231 where 
a connection between characteristic defolding forces observed for subsequent defolding events 
of individual modules constituting a (GB1)8 homopolymer molecules (multimodular protein 
constructs) with 8 modules, has been established. Certainly, in this work we had the case where 
a number of similar -synuclein protofilaments were connected in parallel rather than the case 
of a number of identical modules connected in series. Therefore, the previous approach231 was 
properly modified. 
 We first considered only one protofilament of -synuclein detaching from the surface. 
We considered this event as a single receptor–ligand bond breaking event occurring at the force 
loading rate of ?̇? = 53.3 𝑛𝑁/𝑠. Successively, we used the standard formula to describe the 
dependence of the probability of the bond rupture on the force f: (see e.g.232) 
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 By applying a bootstrap statistical modeling approach, we searched for such values of 
koff (so called bond break rate at no force conditions) and barrier thickness x which 
approximated more accurately possible the experimentally observed distribution of the 
detachment forces.  This enable to extrapolate the following values: koff  = 0.048 ±  0.030 s
-1 
and x= 0.91 ±  0.05 nm. 
 The next step of our modeling was the Monte Carlo simulation of the breaking of n 
equivalent parallel “molecules” stretched between an AFM cantilever and support surfaces. 
Each of these molecules possessed exactly the aforementioned interaction kinetic parameters, 
describing the breaking probability, and the following elastic parameters: contour length L=1 
nm and persistence length A=0.3 nm. These molecules were thought to behave as worm-like 
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chain (WLC) 230 polymers  upon stretching in the experimental conditions characterized by the 
pulling speed equal to 969 nm/s, temperature T=300 K and cantilever spring constant of 0.11 
N/m: 
              (2) 
Where z is end-to-end distance of the stretched polymer molecule.233 The procedure exploited 
for Monte Carlo simulation of the dynamic force spectroscopy experiment using above 
parameters was similar to the protocol reported in literature 234 and used earlier in the work of 
Rief et al.231. The time-step of the simulation procedure was set in such a way that for each 
increase of the complex end-to-end distance equal to 5 pm (at any loading rate) we controlled 
the probability to dissociate (to be detached) the protofilament from the surface.  
 The results of the Monte Carlo simulation are presented in Fig. 3.7. The above proposed 
approach captured and it explained the small but observable and statistically significant 
differences between the plateau heights characteristic for n protofilaments of -synuclein 
detached from the surface (n “parallel bonds” in above terminology) and the values of “n times 
the plateau height characteristic for single protofilament of -synuclein detached” (Fig. 
3.7A).231 The difference between experimental and modeled results for the fifth peak was 
simply due to the extremely poor statistics for this peak. Moreover, the values of standard 
deviations for each force plateau were also quite reliably predicted, Fig. 3.7B. 
 
Figure 3.7 Comparison between the experimental data and the Monte Carlo simulations.   
(A) Comparison of maxima of the peaks. (B) Comparison of standard deviations of the peaks. The 
simulated error bar is calculated using as maximum values of the kinetic parameters x =0.96 nm and 
koff = 0.078 s-1; and as minimum values of the kinetic parametersx = 0.86 nm and koff = 0.018 s-1. 
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3.4 Discussion 
In summary, the presented work illustrated the manipulation at nanometric scale of prefibrillar 
amyloid precursors of -synuclein. We could quantify their mechanical properties, as 
persistence length, when subjected to stretching and their force of interaction with a sylanized 
substrate. We modeled one of the possible unzipping events of a protofilament from the surface 
(Fig. 3.8): 1) AFM tip approaches towards a protofilament and it is brought in contact with it. 
2) The strong contact force (nN) breaks the polymer and it creates a tip-protein contact.  As 
already measured in the case of mature amyloid structures, ~500 pN are sufficient do break by 
indentation an amyloid fibrils.10 Then, the retracting of the tip detaches the protofilament from 
the substrate and allows measuring the related “quantized” unzipping force. 3) Tip-
protofilament contact is lost. 4) Tip returns to the initial position before approaching.  
 The measured quantum of interaction force within a single prefibrillar amyloid 
protofilament and the surface was 56 ± 5 pN. The quantized values of unzipping force obeyed 
to a linear law, implying that multiple plateaus were linked to the multiple unzipping of 
protofilaments from the surface. Monte Carlo simulation of the process, performed using rather 
simple model of breaking of n parallel bonds from the surface, quite well explained the nuances 
of this quantization. Moreover, the fundamental value of interaction force measured was 
substantially larger than the values of forces needed to unzip an individual Asubunit sheet 
from a mature fibril in a previous experiment (about 33 pN for Afibrils and about 23 pN 
for Aones204); though, the force curves recorded in the present work and those presented 
in the previous studies204,205 are rather similar in appearance.  Does this similarity suggest that 
the interpretation of results of the force spectroscopy experiments with mature amyloid fibrils 
given in the aforementioned studies204,205, explained as an observation of unzip of some subunit 
sheets from the fibrils, albeit plausible, is insufficient? In our opinion, also the possibility of an 
observation of detachment of mature fibrils from the support surface cannot be completely 
excluded. In fact, the authors based their previous works on the hypothesis of the impossibility 
to unzip fibrils from a silane-functionalized surface.204,205 In our work, we shed new light to 
these questions and we demonstrated clearly that this is possible to detach amyloid fibrillar 
structure from a surface with a similar chemistry of functionalization. We believe that a 
reversible observation of plateaus events, as that presented in Fig. 3f of Ref. 205, where exactly 
the same force curve is reproduced when AFM tip moves forward/backward, cannot always be 
explained as the re-assembling of an earlier unzipped -sheet to its maternal fibril. The latter 
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process would require a very precise reproducibility of all relevant positions during AFM tip 
movement. Instead, re-attachment/attachment of the earlier detached fibril (resting onto the tip 
surface after its detachment) onto the support surface (may be at some new position there), 
seems also quite probable and it would well explain the aforementioned experimental 
observations. 
 Furthermore, when subject to an elastic stretching, protofilaments showed an average 
persistence length of 0.29 ± 0.16 nm, which was in full agreement with the elastic properties of 
a polymer chain composed of unstructured monomers of -synuclein, as supposed by their 
cross sectional dimensions. Indeed, it was already measured by force spectroscopy that mature 
amyloid fibrils formed by the glucagon peptide have an average persistence length of 0.70 ± 
0.15 nm. This value is twice bigger than our protofilaments, suggesting that they possess 
prefibrillar structural nature. This was the first observation for -synuclein of direct assembling 
from monomers into simple prefibrillar structures. Even if it was already supposed that 
protofilaments structures form the mature amyloid fibrils, their mechanical properties were 
never singularly studied.33,220  
 Recent evidence has increasingly suggested that prefibrillar intermediates might be the 
toxic component causing the onset of misfolding diseases, rather than the fully fibrillar end-
products.124 This study poses the basis for new fundamental experiments to investigate and 
compare the interaction forces of different amyloid structure on different surfaces, such as 
hydrophobic ones. Unraveling these forces is central for the comprehension of the fibrillation 
process and its link to the disease onset. In fact, the obtained values of interaction force could 
be linked to the driving force within interacting protofilaments during the early hierarchical 
amyloid assembling process and could be central to unravel fibrillation process at surfaces, such 
as cell membranes. Moreover, the investigation of formation and of the mechanical properties 
of new prefibrillar species in-pathway of fibrillization in physiological-like conditions could be 
central to study their eventual toxicity, clearance mechanism in the body and to develop new 
therapeutic approaches to contrast amyloid diseases. 
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Figure 3.8 Model of single protofilaments pulling. 
1) After approaching, AFM tip is strongly pressed against a protofilament (force of about 2 nN). 2) The 
strong pressure by the tip causes polymer breaking and a constant force plateau due its unzipping from 
the surface.  3) Tip-filament contact is lost during the pulling. 4) Tip returns to the initial position 
preceding the approaching to the polymer. 
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Abstract 
Amyloid fibrils associated with neurodegenerative diseases such as Parkinson’s and 
Alzheimer’s consist of insoluble aggregates of -synuclein and A42 proteins with high -
sheet content. The aggregation of both proteins proceeds from monomers misfolding, through 
formation of oligomeric and protofibrillar species, to the final fibrillar cross -sheet structure. 
The morphological and mechanical properties of oligomers, protofibrils and fibrils formed 
during fibrillization process, investigated by Thioflavin T Fluorescence and Circular Dichroism 
techniques and combined with AFM peak force quantitative nanomechanical technique, reveal 
an increase of the Young’s moduli from oligomers to mature fibrils inferring that the difference 
in their mechanical properties is due to an internal structural change from random coil to an 
increase of -sheet content. 
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4.1 Introduction 
Amyloid fibrils as highly ordered insoluble protein aggregates are most often related to human 
diseases, including numerous neurodegenerative disorders such as Parkinson’s, Alzheimer’s 
Creutzfeldt-Jakob disease, type II diabetes and bovine spongiform encephalopathy.4,42,235 
However, amyloid fibrils are not only associated with diseases since they were also discovered 
in many physiologically beneficial roles including bacterial coatings, catalytic scaffolds, 
adhesives and structures for the storage of peptide hormones,5-7 from which the term of 
functional amyloids has been cast. A characteristic fingerprint of amyloid fibrils is the core 
cross-β-sheet structure in which β-strands contained within the β-sheets are oriented 
perpendicular to the fibril axis. From the morphological point of view, amyloid fibrils are 
unbranched, several micrometer long fibrils, consisting of 2-6 protofilaments associated 
laterally or twisted together.8,9,236,237 Moreover, amyloid fibrils exhibit remarkable mechanical 
properties with Young’s moduli in the range of several GPa.10-12 Taking inspiration from 
functional amyloid and the self-assembly of non-toxic proteins and peptides in vitro into highly 
ordered structures with unique mechanical properties, has allowed the development of 
biomaterials for a broad spectrum of applications in medicine, food and nanotechnology.164,197 
 Experimental techniques such as Atomic Force Microscopy (AFM) and computational 
simulations have been widely utilized in order to quantify the mechanical properties of amyloid 
fibrils. AFM represents one of the most suitable method for quantitative measurements of local 
elasticity of amyloid fibrils. AFM single molecule imaging features combined to a statistical 
analysis of AFM images,11,36 together with the possibility to impose and measure forces,10,197 
ideally makes AFM as an important research tool to deliver important information about the 
mechanical and related structural properties of amyloid fibrils at the single molecule scale. 
Atomistic simulations performed by Buehler and his co-workers have provided theoretical 
values of the Young’s moduli of amyloid fibrils in the order of several GPa.238-241 Moreover, 
the results obtained by both AFM and simulations, suggest that the intermolecular interactions 
(e.g. hydrogen bonds) between -sheet layers are responsible for the remarkable mechanical 
properties of amyloid fibrils. Recently, a relatively new AFM technique, called peak force 
quantitative nanomechanical (PF-QNM), has been used to estimate the values of the Young’s 
moduli of different classes of mature amyloid fibrils including β-lactoglobulin, α-synuclein, Aβ 
(1–42), bovine serum albumin, insulin, lysozyme, ovalbumin, and Tau protein in GPa 
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range,163,202,208,237 which are consistent with the values of the Young’s moduli obtained by 
statistical analysis of AFM images.11 
 In order to appreciate the full potential of amyloid fibrils as biomaterials, it is important 
to understand the mechanism of fibrillization process and to measure and quantify the 
mechanical properties of amyloid fibrils. Moreover, the understanding of the mechanical 
properties and of the intermediate structures during the fibrillization process is of fundamental 
importance to unravel their stability, toxicity and mechanism of clearance in order to design 
new therapeutic strategies to the onset of neurodegenerative disorders. For this reason, in this 
work, we set out to study the evolution of both the mechanical and structural properties of the 
amyloidogenic structures all over the fibrillization process of -synuclein and Aβ (1–42) 
(A42). 
4.2 Experimental Methods 
Fibrillization assay 
WT α-synuclein was incubated in an Eppendorf tube at concentration of 45 μM in an initial 
volume of 800 μL, under constant agitation at 400 rpm for 21 days at 37 °C. WT A-42 was 
incubated in an Eppendorf tube at concentration of 20 M, without agitation for one week at 
37 °C. 
Thioflavin T 
ThT fluorescence reading was measured for -synuclein at 45 M, diluted at 1.5 M with a 
ThT concentration of 10 μM, in a 70 μL solution with pH 8.5 buffer containing 50 mM glycine 
(Sigma-Aldrich). ThT fluorescence reading was measured for a 70-μl aliquot of Aβ-42 sample 
at 20 M  with 20 μL of 100 μM ThT and 10 μL of 500 mM glycine (pH 8.5) (Sigma-Aldrich). 
A Bucher Analyst AD plate reader was used to measure ThT fluorescence at an excitation 
wavelength of 450 nm and an emission wavelength of 485 nm. Aliquots taken at different time 
points were measured in triplicate. 
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Circular Dichroism 
Samples were analyzed at room temperature (RT) using a Jasco J-815 CD spectrometer. An 
average of 10 spectra was collected in the range of 190−250 nm using a 1.0-mm-optical-
pathlength quartz cuvette. Data points were acquired every 0.2 nm in the continuous scanning 
mode at a speed of 50 nm/min with a digital integration time of 2 s and a bandwidth of 1 nm. 
Processed spectra were obtained by subtracting the baseline signal due to the water and cell 
contribution from the protein spectra. 
Atomic force microscopy samples preparation 
Analysis by AFM was performed on three differently charged substrates: hydrophobic HOPG, 
negatively charged mica and positively functionalized mica. In the last case after the cleaving, 
the mica substrate, was incubated with a 10-μl drop of 0.05%(v/v) APTES ((3-
Aminopropyl)triethoxysilane, Fluka) in Milli-Q water for 1 minute at ambient temperature, 
rinsed with Milli-Q water and then dried by the passage of a gentle flow of gaseous nitrogen. 
AFM samples preparation was realized at room temperature by deposition of a 10 l aliquot of 
full concentrated 45µM solution for 10 minutes in the case of mica and 100 times diluted 
solution for 1 minute in the case of HOPG.  
Atomic force microscopy Imaging and PF-QNM measurements 
AFM images were realized by means of a Park NX10 operating in true non-contact mode and 
equipped with a silicon tip (Nanosensor, PPP-NCHR, 40 Nm-1) with a nominal radius of 7 nm. 
Images flattening and analysis was performed by SPIP (Image metrology) software. PF-QNM 
measurements were performed by using a MultiMode VIII Scanning Probe Microscope 
(Bruker, USA) operated in intermittent mode under ambient conditions at a scan rate of 1 Hz. 
The microscope was covered with an acoustic hood to minimize vibrational noise. The AFM 
cantilevers (Bruker, USA) were calibrated on the calibration samples (Bruker, USA), -typically 
low-density polyethylene and polystyrene- covering the following ranges of Young’s moduli: 
from 100 MPa to 2 GPa (for low-density polyethylene) and from 1 to 20 GPa (for polystyrene). 
The analysis of the Derjaguin–Mueller–Toporov (DMT) modulus was performed by the 
software Nanoscope Analysis. 
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4.3 Results 
4.3.1 Aggregation process studies by conventional bulk techniques 
Two of the most typical methods used to study the kinetics of amyloid fibrillization and to 
investigate the structural change that the proteins undergo during the fibrillization process are 
Thioflavin T (ThT) fluorescence113 and Circular Dichroism (CD),180 respectively. Figure 1 
displays the results of ThT and CD measurements of the fibrillization process of -synuclein 
(Figure 4.1A and C) and A42 (Figure 4.1B and D). 
 The amyloid fibril formation monitored by ThT is generally characterized by a 
sigmoidal curve representing three main steps of the fibrillization process: starting with an 
initial lag phase, where monomers misfold and oligomeric nuclei form; continuing with a fast 
exponential growth, due to a fast formation/elongation of protofibrillar and fibrillar structures; 
and finishing with a plateau indicating a dynamic equilibrium within the final mature amyloid 
fibrils. The fibrillization processes of both -synuclein and A42 amyloid fibrils followed the 
usually described sigmoid curve attributed to a nucleation-dependent polymerization process. 
(Figure 4.1A and B).65,242 The fibrillization process of -synuclein was slower compared to 
A42 because even after 24 days of incubation the ThT signal did not reach the plateau phase 
and was increasing as a function of time after the exponential phase (Figure 4.1A) suggesting 
that the fibrils were still forming/elongating. In the case of A42 fibrillization process, the 
ThT signal reached the plateau region already after 30 hours and fibrils formation was in the 
stationary dynamical equilibrium (Figure 4.1B). 
 CD spectra of synuclein fibrillization displayed in Figure 1c show that at 0 hours the 
peak minimum was detected at 203 nm corresponding to a random coil structure while after 48 
hours of incubation the peak minimum was shifted to 220 nm indicating the formation of -
sheet structure. The intensity of CD signal at 220 nm increased as a function of time and, 
according to the ThT signal, of fibrils formation. CD spectra of A42fibrillization are 
displayed in Figure 1d showing that the peak minimum at 0 hours was detected at 195 nm 
indicating a random coil structure while after 24 hours of incubation the peak minimum was 
shifted to 218 nm indicating the presence of the -sheet structure. In this case the intensity of 
CD signal at 218 nm was decreasing as a function of time. Since the kinetic of A42 fibrils 
formation was already in its stationary regime after 30 hours of incubation according to ThT 
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results (Figure 1b) and amyloid are insoluble aggregates, sedimentation that is occurring during 
the measurements, can explain the decrease of the intensity of the CD signal as evidenced by 
the turbidity of the solution. This trend, together with the slow aggregation kinetics leading to 
coexistence of unfolded oligomers with growing fibrils, complicates the evaluation of the exact 
composition of -sheet in the protofibrils during fibrillization, although it is evident from Figure 
1 that both systems evolve towards an overall increase of -sheet during aggregation. 
 
Figure 4.1 Kinetics of amyloid fibrils formation and secondary structure measurements. 
Thioflavin T fluorescence of A) -synuclein and B) A42. Circular dichroism measurements of C) -
synuclein and D) A42. Measurements were conducted at 45 M for -synuclein and 20 M for 
A42. (Please refer to section 4.3.1 for experimental details). 
4.3.2 Fibrillization investigation by conventional Atomic Force Microscopy 
Amyloid fibrillization is a complex process which proceeds through multiple pathways and 
several polymorphic amyloid species are contemporarily present in the heterogeneous 
aggregating solution.40 For this reason, bulk techniques such as ThT and CD just give average 
information of this ensemble. In other words, if for example fibrils and oligomers are 
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contemporary present in the solution, the -sheet signal for both bulk techniques is an average 
measurement of both structures.  
 A single molecule technique, such as AFM, allows gaining information on the 
fibrillization process and on individual protein structural transition.11,36 Figure 4.2 displays the 
fibrillization process of -synuclein and A42 by means of AFM imaging after deposition of 
the proteins on a positively functionalize APTES-mica substrate. 
 
Figure 4.2 AFM imaging of -synuclein and A42 fibrillization process.  
Incubation times of: A) 0 days, B) 7 days, C) 10 days for -synuclein; and D) 0 hours, E) 24 hours, F) 
72 hours for A42. 
 At 0 hours, -synuclein was mainly in the monomeric form, since the CD signal shows 
the typical random coil signal of intrinsically disordered proteins and just few early oligomers 
are present in AFM morphology images (Figure 4.1C, 4.2A and 4.3A-C). Already at 24 hours 
of incubation, the increase of number of bigger oligomers with height of 2-6 nm (Figure 4.3D-
F) was detected. After 7 days of incubation the fibrillar structures started to assemble (Figure 
4.2B) continuing to form mature amyloid fibrils (Figure 4.2C) with height of 6-7 nm (Figure 
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4.3G-I) at 10 days of incubation. Similarly to the case of -synuclein, at 0 hours, A42 was 
in monomeric and early oligomeric structures (Figure 4.1D and 4.2D) with height of 0.5-3 nm 
(Figure 4.4A-C). After 24 hours of incubation, abundant curly protofibrillar structures (Figure 
4.2E) with the height of 3-4 nm (Figure 4.5D-F) were observed.  Finally, at 72 hours of 
incubation, mature amyloid fibrils (Figure 4.5F) with the height of 4-6 nm (Figure 4.5G-I) 
were formed. Thus, in the case of both proteins the classical oligomerization process of 
aggregation was observed.242,243 This mens for both proteins that formation of oligomeric nuclei 
is necessary for the formation of the first protofibrillar structures, ultimately leading to the 
formation of the mature amyloid fibrils.  
 
Figure 4.3  Analysis of the morphology of -synuclein oligomers and fibrils. 
Oligomers at 0 days: A) AFM image. B) Cross sectional dimensions of an aggregate. C) Distribution of 
height. Oligomers at 24 h: D) AFM image. E) Cross sectional dimensions of an aggregate. F) 
Distribution of height. Fibrils at 7 days: G) AFM image detail of fibrils. H) Cross sectional dimension 
of a fibril. I) Distribution of height. 
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Figure 4.4 Analysis of the morphology of A-42 oligomers, protofibrils and fibrils. 
Oligomers at 0 days: A) AFM image. B) Cross sectional dimensions of an aggregate. C) Distribution of 
height. Protofibrils at 24 h: D) AFM image. E) Cross sectional dimensions of an aggregate. F) 
Distribution of height. Fibrils at 72 hours: G) AFM image detail of fibrils. H) Cross sectional dimension 
of a fibril. I) Distribution of height. 
4.3.4 Peak-force Quantitative nanomechanical measurements of amyloid aggregate 
stiffness 
In order to characterize the mechanical properties of the different species forming during the 
fibrillization process, PF-QNM measurements were performed. As starting point, the 
mechanical properties of early oligomeric structure of -synuclein formed after 24 hours and 
deposited on a positively functionalize APTES-mica substrate, (Figure 4.5) were investigated. 
In the case of the oligomeric structures, the measurements revealed that they possessed already 
a notable value of Young’s modulus in the order of the GPa and more specifically of 1.5 ± 0.5 
GPa (Figure 4.5B-C). 
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Figure 4.5 Young’s modulus of -synuclein oligomeric species.  
A) AFM morphology image and B) AFM Derjaguin–Mueller–Toporov (DMT) modulus image of 
oligomers on APTES-mica with incubation times of 24 h. B) Distribution of Young’s modulus of 
oligomers. 
 The same measurements were performed on the -synuclein mature fibrillar structures, 
as confirmed by CD (Figure 4.1C), formed at 10 days incubation at 37 °C and deposited on 
three different substrates: positively functionalized APTES-mica substrate, negative bare mica 
and hydrophobic HOPG (Figure 4.6A-C). The reported a value of the Young’s modulus was 
identical, inside the experimental error, on all the three substrates (Figure 4.6D-I). These result 
is in agreement to previously reported values of stiffness, available for mature fibrils only.163,202 
The measurement of stiffness of the fibrillar structuresof-synuclein was realized on the three 
different substrates, described above, in order to rule out the surface effect on the estimation of 
the Young’s modulus and to give more significance to the slight difference of the value of 
stiffness respect to the one of the oligomeric species. In all cases, the value of Young’s modulus 
of fibrils adsorbed on these two substrates was 2.2 ± 0.6 GPa (Figure 4.6G-I), thus 
demonstrating that PF-QNM measurements are independent from surface influences. 
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Figure 4.6 Young’s modulus of -synuclein fibrillar species.  
A-B-C) AFM morphology images and D-E-F) AFM Derjaguin–Mueller–Toporov (DMT) maps of 
fibrils on APTES-mica, mica and HOPG. G-H-I) Histogram distributions of the Young’s modulus of 
the fibrillar structures on each substrate. 
 Similarly, in order to eliminate the possibility of errors deriving from the nanoscale 
nature of the AFM tip and sample dimensions, the nanoindentation measurements were 
validated on thick aggregates of alpha-synuclein (AFM height ~50 nm, Figure 4.7A-C). In 
these conditions both substrate and cantilever tip radii corrections become irrelevant. These 
measurements yielded results identical to single fibril indentation, within experimental error, 
and to a value of stiffness of 2.3 ± 0.8 GPa (Figure 4.7 D-E). Finally, all together these results 
revealed that oligomers possess a lower elastic modulus than mature fibrils, but still in the order 
of GPa. 
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Figure 4.7 Stiffness of a -synuclein bundle of fibrils.  
A) AFM height image, B) AFM DMT modulus images, C) Cross section of the height of a bundle, D) 
Histogram of Young’s modulus of the bundle of fibrils. E) Cross sections of AFM DMT images. Single 
fibrils and bundles of fibrils show similar values of Young’s Modulus. 
 To generalize these results, PF-QNM measurements for A-42 fibrillization were also 
performed (Figure 4.8). The Young’s modulus of the oligomers at 0 hours (Figure 4A), of 
protofibrils at 24 hours (Figure 4B) and of mature fibrils at 72 hours (Figure 4C) was evaluated 
accordingly. In the same way as in the case of -synuclein, the value of the Young’s modulus 
increased from a value of 1.2 ± 0.5 GPa for oligomers (Figure 4D), through 2.1 ± 0.6 GPa for 
protofibrils (Figure 4E), to a final value of 3.3 ± 0.8 GPa for mature fibrils (Figure 4F). Once 
again, oligomers and protofibrils showed an increasing and high value of intrinsic stiffness in 
the order of GPa, but still lower than mature fibrils. Indeed, we can suggest the generality of 
this result since, as we previously measured, several mature amyloid fibrils range their stiffness 
value between 2-4 GPa (Table 1). 
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Figure 4.8 Young’s modulus evolution of A42 during fibrillization process.  
AFM morphology maps A) 0h, oligomers, B) 48 h, protofibrils, C) 72 h, fibrils. Derjaguin–Mueller–
Toporov (DMT) modulus images of D) 0h, oligomers, E) 48 h, protofibrils, F) 72 h, fibrils. Distribution 
of the measured Young’s modulus for G) oligomers, H) protofibrils and I) fibrils. 
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Table 4.1 Young’s Modulus of Amyloid fibrils.163 
 
 It was mentioned above that the hydrogen bonds between -sheets play a key role in the 
mechanical properties of amyloid fibrils and the presence of -sheets is a characteristic feature 
of amyloid fibrils. It has also been reported that during the aggregation process, oligomers or 
eventually present protofibrils contain partial -sheet conformations.79 This suggests that the 
content of -sheets in the assembled structures during fibrillization process is an important 
parameter affecting the mechanical properties of these structures. The presented results just 
confirm these predictions. Indeed, although mature fibrils were initially not observed by AFM, 
CD spectra indicated the presence of -sheet structures already at 48 hours for -synuclein 
(Figure 4.1C) and 24 hours for A42 (Figure 4.1D), and the measured values of the Young’s 
moduli of the corresponding assembled structures (oligomers and protofibrillar structures) were 
already in the order of the GPa (Figure 4.5 and Figure 4.8). 
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4.4 Discussion 
PF-QNM allowed us to investigate at the single molecule level the nanomechanical properties 
of different products of amyloids aggregation process. In particular, we were able to measure 
the evolution of Young’s modulus during fibrillation of -synuclein and A42. As resumed in 
Table 1, their elastic modulus evolved monotonically during the process of aggregation as a 
function of the maturity of the fibrillation process. In fact, oligomers and protofibrils showed 
an increasing value of the intrinsic stiffness in the order of GPa. These results, as proved by CD 
and ThT bulk measurements (Figure 4.1) and other previous studies,79  are explained by the 
fact that early oligomeric and protofibrillar structures have already a partial and increasing -
sheet content. Furthermore, we previously demonstrated that: PF-QNM technique measures 
Young’s modulus of amyloid fibrils independently of the polymorphic state and cross-sectional 
structural details; their high value (GPa) of the elastic modulus is mainly due to the tight -
sheet ordering in the forming amyloid structure. For this reasons, it is natural that intermediate 
products of aggregation with partial -sheet conformation possess a high value of the intrinsic 
Young’s modulus, but still consequently lower than the one of mature fibrils with complete 
cross -sheets structure.244 As demonstrated by previous studies245, even if DMT-QNM 
technique could overestimate by about a factor of two the value of Young’s modulus, the 
measured values would still be in the order of GPa and the measured monotonically increasing 
behavior would not be modified. Finally, increase in the Young’s modulus during amyloid 
fibrillization can be interpreted as the result of the internal structural rearrangement of 
monomers from their intrinsically disordered structure towards aggregated structures with an 
increasing content of -sheet conformation. This work allows, for the first time, a quantitative 
understanding of the structural and mechanical properties of -synuclein and A42 aggregate 
snapshots during the fibrillization process, which can be of significant importance for the 
understanding of the cytotoxicity mechanisms and the design of new therapeutic strategies for 
Parkinson’s and Alzheimer’s diseases. 
Table 4.2. Young’s Modulus of amyloidogenic structures. 
 Oligomers Protofibrils Fibrils 
-synuclein 1.5 ± 0.5 GPa - 2.2 ± 0.6 GPa 
A-42 1.2 ± 0.5 GPa 2.1 ± 0.6 GPa 3.3 ± 0.8 GPa 
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Chapter 5. Nanoscale spatially resolved infrared spectra 
from single microdroplets 
This chapter is based on a paper published in the journal Lab on a Chip with the following 
authors: 
+Thomas Müller1, +Francesco Simone Ruggeri2, Andrzej J. Kulik2, Ulyana Shimanovich1, Thomas O. 
Mason1, Tuomas P. J. Knowles1 and Giovanni Dietler2 (+ These authors contributed equally to the manuscript) 
Affiliations: 
 1 Department of Chemistry, University of Cambridge, Cambridge, UK. 
 2 Laboratory of Physics of Living Matter, EPFL, 1015 Lausanne, Switzerland. 
Abstract 
Atomic force microscopy (AFM) has enabled gaining notable insights into the formation and 
properties of amyloid structures. Despite capable of unraveling morphological and mechanical 
properties at the nanoscale, AFM is not able to investigate the structural and chemical properties 
of these structures. Inversely, infrared spectroscopy (IR) is a key method for studying 
conformational properties of proteins and their structural conversion during amyloid 
fibrillation. However, it is able to give average information only on the ensemble of the species 
present in the heterogeneous aggregating solution. In this chapter, it is shown that a new system, 
exploiting the simultaneous use of AFM and IR (nanoIR), can be efficaciously used to 
characterize at the nanoscale the structural properties of amyloids during their aggregation. In 
this first proof of concept, the system was used to analyze proteins deposited as patterned -
droplets by means of a microfluidic system. Droplet microfluidics has emerged as a powerful 
platform allowing reactions to be carried out in spatially distinct micro-compartments. The 
compartmentalisation of biomolecules into monodisperse, micrometer-sized droplets allows for 
quantitative and high-throughput biochemical studies on amyloid formation. Due to their small 
size, however, the spectroscopic characterization of species encapsulated in such systems 
remains challenging. Infrared nanospectroscopy is able to acquire infrared spectra from single 
-droplets containing aggregation-prone proteins. The technique is capable of investigate 
structural differences in the amide bands of the spectra of monomeric and aggregated lysozyme 
from single microdroplets with picolitre volume. In particular, the shift of the amide I band 
toward lower wavenumbers allowed identifying an -to- structure transition associated with 
amyloid formation.  
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5.1 Introduction 
Lab on a chip technologies offer a range of unique opportunities for preparation and 
manipulation of molecular species. In particular, the compartmentalisation of biomolecules into 
monodisperse, micrometer-sized droplets allows for quantitative, high-throughput biochemical 
studies such as directed evolution,246-248 screening for reagents, reaction conditions or cells,249-
251 as well as for the fabrication of designer emulsions and microgels.252,253 Microdroplets can 
also allow the study of rare events, such as nucleation, and have thus enabled studies of the 
nucleation step of Aβ aggregation254 as well as insulin amyloid growth.255 With the rapid 
development of microfluidic technologies, the need of ultra-sensitive detection methods 
becomes ever more pressing. A large fraction of present-day experiments rely on optical 
detection,256-258 with alternative strategies including, for instance, electrochemistry,259,260 mass 
spectrometry261-263 or Raman spectroscopy.264,265 Also, infrared (IR) spectroscopy techniques 
have been utilized to monitor the contents of microfluidic flows.266,267  
 Here, we demonstrate an approach for performing IR spectroscopy on the contents of 
single microdroplets with sub-micrometer spatial resolution. Infrared spectroscopy (IR) is a key 
method for studying conformational properties of proteins and in particular for inferring their 
secondary structure.182,209 Exposed to IR radiation, chemical bonds undergo vibrations such as 
stretching, bending and rotating. In the case of proteins, this leads to a spectrum characterized 
by a set of absorption features in the amide bands.185 Thereby, the modes most commonly used 
to study the structural properties of polypeptides are the amide I, amide II and amide III bands. 
Amide I arises mainly from CO stretching vibrations and is generally localized within 1690–
1600 cm−1; the exact band position is determined by the backbone conformation – in other 
words by the secondary structure of the protein. In contrast, amide II originates from a 
combination of N–H bending and C–N stretching and is localized around 1580–1510 cm−1. It 
is still possible to associate the position of the band to the protein's secondary structure, but the 
fact that this band stems from a combination of two different modes makes this analysis less 
straightforward. Finally, the amide III band is a combination of many modes such as C–N 
stretching, N–H in-plane bending, C–C stretching as well as CO bending and occurs in the 
range of 1300–1200 cm−1. In practice, α-helical structures have this band centered around 1654 
cm−1, random coil proteins show a maximum between 1635-45 cm−1, and β-sheet-rich 
amyloidic aggregates exhibit an amide I maximum within 1610–1630 cm−1.64 
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 To achieve sub-micron spatial resolution for protein IR spectroscopy experiments, we 
utilized a thermomechanical detection technique based on atomic force microscopy (AFM): if 
an IR pulse at a given wavelength is absorbed by a sample, the local temperature rise leads to 
local thermal expansion.211,268,269 This deformation excites a mechanical resonance in the AFM 
cantilever which is in contact with the analyte. AFM detection of this temporary expansion of 
the scanned region therefore allows nanoscale resolution IR imaging and acquisition of local 
chemical spectra. Simultaneously with the IR-absorption image, the system is able to scan 
topography (with conventional contact mode) and sample stiffness (related to the frequency of 
the cantilever oscillations). 
 The capability of studying the contents of single microdroplets individually with a high-
precision method paves the way for a wide range of experiments harnessing the advantages of 
microfluidics. For instance, combination with on-chip selection techniques270-274 that pre-screen 
for a predefined species within droplets could allow for specific in-depth investigation of 
analytes in the context of protein aggregation as well as directed evolution. In addition, it should 
be emphasized that the technique of aligning individual microfluidic droplets off-chip offers 
further possibilities for systematic ex situ assays beyond IR spectroscopy or AFM. In order to 
be able to reliably locate and distinguish the protein contents of individual microdroplets for 
performing nanoscale IR spectroscopy as well as to provide for an enormous amount of 
statistics, the droplets are aligned on a ZnSe prism using a pre-patterned polymer stamp and 
dried overnight, as shown schematically in Fig. 5.1A–C. Thereafter, spectra of single dried 
microdroplets containing monomeric, aggregating and aggregated lysozyme protein are 
acquired. The ability to easily differentiate between these different species demonstrates the 
efficacy of the presented approach to study amyloid properties. In particular, this experiment 
represents the first step towards the application of infrared nanospectroscopy in order to unravel 
the process of protein misfolding and aggregation at the nanoscale.  
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5.2 Experimental Methods 
In brief, micrometer-sized droplets of protein solutions in fluorinated oil are generated via a 
microfluidic droplet maker and deposited on a ZnSe prism (Fig. 5.1A). These droplets are then 
aligned on a grid using a patterned stamp of polydimethylsiloxane (PDMS) as shown in Fig. 
5.1B and dried overnight in a desiccator at room temperature or in an oven at 65 °C. To measure 
the IR spectrum, the dried protein is heated locally using a laser and the resulting thermal 
expansion is determined using an AFM tip, which is sketched in Fig. 5.1C. In the following, 
these steps are described in more detail. 
 
Figure 5.1 Droplets deposition on the prism for the Infrared Nanospectroscopy analysis. 
(A) Schematic representation of the droplets deposited on a ZnSe prism and the pre-patterned polymer 
stamp. The indents on the grid are 20 μm × 20 μm × 25 μm, separated by 200 μm in each direction. (B) 
Alignment of the droplets on a grid by pressing the polymer onto the solution. (C) Pictogram of a laser 
locally heating the dried protein contents of single droplets, with an atomic force microscope measuring 
the resulting thermal expansion.  
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Protein solutions 
For the monomeric solution, lysozyme from chicken egg white (Sigma-Aldrich, #62970) is 
dissolved in deionized water at a concentration of 6 mg ml−1. Aggregates are formed by mixing 
60 mg lysozyme with 1% Sodium Azide, 200 μl of 1M HCl, 600 μl of 10 mM HCl, 200 μl of 2 
M NaCl and 5 μl of a preformed seed-fibril solution, filtering through 0.45 μm pores, followed 
by incubation at 65 °C for 24 h. This approach yields approximately micrometer-sized fibrils 
that form a gel-like structure when encapsuled as an aqueous droplet. 
Droplet generation 
As depicted in Fig. 5.2, droplets are generated using a microfluidic junction with a cross-section 
of 25 μm × 25 μm, fabricated through a standard soft lithography approach.275 The protein 
solution is injected through the central arm at a flow rate of 50 μl h−1, whereas fluorinated oil 
(Fluorinert FC40, Sigma-Aldrich, #F9755) containing 2% w/v surfactant (N, Nbis(n-
propyl)polyethylene oxide-bis(2-trifluoromethyl polyper fluoroethylene oxide) amide) is 
pumped through the side channels at 100 μl h−1. These settings result in droplets with a diameter 
of approximately 25 μm which are collected in a microcentrifuge tube. 
 
Figure 5. 2 Micrograph of droplet formation in a microfluidic device. 
The aqueous solution containing the protein is pushed through the central channel and encapsulated in 
fluorinated oil streaming in from both sides. 
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Droplet alignment and drying 
One ml of solution with droplets from either monomeric or aggregated protein, respectively, 
are pipetted onto opposite ends of the surface of an attenuated total internal reflection element 
prism made out of ZnSe monocrystals. Thereafter, a pre-patterned PDMS stamp is pressed onto 
each drop of liquid in order to align the droplets to its imprinted grid. The grid consists of 20 
μm × 20 μm × 25 μm indents to capture individual droplets, with a spacing of 200 μm, and is 
imprinted into PDMS by soft lithography.275 This process is illustrated in Fig. 5.1A and B; for 
simplicity, only one instance of droplet solution is shown. The prism – including the alignment 
polymer – is then stored for 15 h in a desiccator. Alternatively, the devices can be dried at 
elevated temperatures – for instance, in an oven at 65 °C at ambient pressures for 15 h. This, 
however, will lead to further aggregation inside the droplets upon drying. Careful removal of 
the PDMS slab yields a regular pattern of the dried contents of single microdroplets – in the 
present case protein – as shown in Fig. 5.3A-B. 
Spatially resolved infrared spectroscopy 
Samples were scanned by a commercial nano-IR microscopy system (Anasys Instruments), 
with a line rate between 0.02–0.08 Hz in contact mode. We used a silicon cantilever (AppNano) 
with a nominal radius of 10 nm and a nominal spring constant of 0.5 N m−1. All images have a 
resolution of 512 × 256 pixels. Spectra were collected with a step width of 1 cm−1 within the 
range of 1200–1800 cm−1 at 40% of the instrument's maximal laser power. All measurements 
were performed at room temperature. 
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5.3 Results 
5.3.1 Patterned micro-droplets 
Our results demonstrate that using the approach presented here, it is feasible to align tens to 
hundreds – if desired even thousands – of microdroplets, as shown in Fig. 5.3A-B.  
 
Figure 5.3 View of the aligned droplets. 
(a) Photograph of the aligned and dried droplets after removing the polymer slab. Each bright spot is the 
protein content of a microdroplet. (b) Optical image during AFM imaging, each black dot is a 
microdroplet. The smears in the background stem from the fluorinated oil which has been found to not 
affect the IR measurements. 
 Such a regular deposition allows for reliable, systematic off-line assays including ultra-
high precision analytical tools as, for instance, the nanoscale IR spectroscopy utilized in this 
work. Our droplets were aligned at the corners of squares with a side of 200 m. 
 Several conditions for drying and analyzing the droplets were investigated. We have 
deposited microdroplets on pure ZnSe prisms and SiO2-coated ZnSe prisms. As mentioned 
above, drying was effected by either placing the prisms under vacuum at room temperature or 
in an oven at 65 °C at ambient pressure for a time span of 15 h. The resulting morphologies 
varied significantly, as summarized in Fig. 5.4. Most importantly, droplets that have been 
heated overnight (G-J) exhibit a smaller size, which may well be caused by the protein 
becoming more attached to the PDMS stamp and therefore being removed when detaching the 
stamp. 
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Figure 5.4 Atomic force microscopy images of droplets dried under different conditions.  
(A) Aggregated lysozyme, deposited on a ZnSe prism and dried for 15 h at room temperature under 
vacuum. Scale height is ±250 nm. (B) Same as (A), for a different droplet. Scale height is ±500 nm. (C) 
Aggregate lysozyme, deposited on a SiO2-coated ZnSe prism and dried for 15 h at room temperature 
under vacuum. Scale height is ±500 nm. (D) Same as (C) but for a different droplet. Scale height is ±500 
nm. (E) Monomeric lysozyme, deposited on a ZnSe prism and dried for 15 h at room temperature under 
vacuum. Scale height is ±150 nm. (F) Monomeric lysozyme, deposited on a SiO2-coated ZnSe prism 
and dried for 15 h at room temperature under vacuum. Scale height is ±250 nm. (G) Aggregated 
lysozyme, deposited on a ZnSe prism and dried for 15 h at 65 °C at ambient pressure. Scale height is 
±300 nm. (H) Monomeric lysozyme, deposited on a ZnSe prism and dried for 15 h at 65 °C at ambient 
pressure. Scale height is ±300 nm. (I) Same as (H), but for a different droplet. Scale height is ±300 nm. 
(J) Same as (H), but for a different droplet. Scale height is ±300 nm. 
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5.3.2 Infrared Nanospectroscopy Absorption Maps  
The nanoIR system, contemporarily to conventional IR maps Fig. 5A, allows to measure sub-
micron IR absorption maps of our droplets. Fig. 5.5B–D shows how the aggregated lysozyme 
from an individual microdroplet can be analyzed accurately.  
 
Figure 5.5 IR absorption maps of aggregated lysozyme. 
(A) AFM morphology and (B-D) IR maps from a microdroplet on a ZnSe prism at different excitation 
wavelengths corresponding to the amide I, II and III bands.  
 Presented is the spatially resolved absorption of infrared radiation, determined via 
thermal expansion as measured by an AFM tip. The wavenumbers are fixed at 1640 cm−1 (A), 
1620 cm−1 (B), 1530 cm−1 (C), 1250 cm−1 (D), corresponding to two instances from the amide 
I band, one from the amide II band, and one from the amide III band, respectively. While all 
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the four plots share their topographical features, it is readily apparent that absorption is higher 
in the amide I band than the amide II and III bands. Moreover, the absorption in the amide III 
band exhibits a stronger spatial dependence. This could be linked to the fact that this band is 
sensitive to different vibrational modes and therefore is influenced by local conformational 
changes accompanying the transition of protein from its monomeric form into aggregates.42 
Thus, it is possible to investigate the IR absorption behaviour of the contents of individual 
droplets locally. Furthermore, the correlation with the height measurement from the AFM scan 
in Fig. 5.5(A) emphasizes that the recorded absorption originates from the contents of a single 
microdroplet. 
5.3.3 Infrared Nanospectroscopy Spectra 
The complete spectrum of the lysozyme aggregates in this droplet – averaged over 12 spectra 
recorded at different locations and smoothed by a Savitzky–Golay filter – is given by the dashed 
blue line in Fig. 5.6. As expected from the spatially resolved data, the nearly constant absorption 
observed in the amide I band – lightly peaked at approximately 1640 cm−1 – is higher than in 
the amide II and III bands. Remarkably, when comparing with a spectrum taken from a droplet 
containing only monomeric protein (the solid red line is the smoothed average over 15 
individual spectra), striking differences are apparent. First and foremost, the monomeric protein 
exhibits a sharp peak at around 1655 cm−1, due to the high α-helical content of lysozyme, and 
a shoulder at 1640 cm−1 originating from random coils and β-sheets – all in good agreement 
with the structure of lysozyme.276 Secondly, the amide II band seems slightly shifted towards 
higher energies for the monomer, and thirdly, absorption in the amide III band is significantly 
higher in monomeric than in aggregated protein.  The shift of the amide I peak as well as the 
dramatic increase of absorption at 1620 cm−1 are the typical signatures of the formation of 
amyloid-like cross-β structure and have been studied extensively for the case of lysozyme.183 
Notably, our spectra from dried lysozyme correspond very well to measurements obtained in 
bulk solution.183 In fact, even if monomers already contain β-sheet domains their spectra differ 
from the amyloidic β-sheets and can be distinguished by the change in the location of the amide 
I peak.277 Similarly, the position of the amide II band is expected to shift towards lower 
wavenumbers if the secondary structure changes from predominantly α-helical to β-sheet.209 As 
the amide III band has a significantly more complex origin, the differences in the monomeric 
and aggregated spectra are less directly explainable, but strong deviations are reasonable 
bearing in mind the extensive structural modification proteins undergo during aggregation. 
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Figure 5.6 IR Spectra from micro-droplets.  
Spectra of monomeric (solid red line) and aggregated (dashed blue line) Lysozyme on the ZnSe prism. 
Insets for the structures of monomer and lysozyme amyloid are adapted from ref. 278 and 279, respectively. 
 To demonstrate the repeatability of our approach, we present spectra of droplets 
containing monomeric and aggregated lysozyme dried under the described different conditions 
in Fig. 5.7A-B, respectively. Specifically, we investigated two different types of infrared-
transparent prisms (ZnSe and SiO2-coated ZnSe) and dried the droplets either at room 
temperature under vacuum or at 65 °C at ambient pressure. For the monomeric protein, the 
vacuum-dried droplets on either substrate exhibit a distinct peak around 1655 cm−1 as well as a 
sharp feature in the amide III band which is pronounced more strongly for the plain ZnSe prism. 
Heating the droplets for 15 h to evaporate all solvents lead to a drastic increase of the absorption 
in the amide I band (see black ellipse in Fig. 5.7A) that corresponds very well to the spectra 
observed for aggregated protein. Furthermore, in the case of the heated, SiO2-coated prism the 
peak in the amide III band also vanishes. Considering the original approach for forming the 
aggregates, it is highly plausible that the conditions for drying the droplets at elevated 
temperatures are sufficient to cause at least partial aggregation of the initially monomeric 
protein in particular since the evaporation of water continuously increases the protein 
concentration. The spectra of the droplets containing aggregated protein presented in Fig. 5.7B 
are very similar for all conditions and demonstrate the reliability of our approach. The most 
notable difference is that with the additional layer of SiO2 on the surface of the prism the 
absorption at the high-energy side of the amide I band is increased relatively to the rest of the 
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spectrum. The peak positions, however, are unchanged. Also, the spectra from three droplets 
on the same substrate (solid, dashed and dotted blue lines) indicate the quantitative variability 
between individual droplets with nominally the same contents. 
 
Figure 5.7 Spectra of monomeric and aggregated proteins with different method of deposition. 
(A) Spectra of dried droplets containing initially monomeric protein. Shown are droplets dried in 
vacuum at room temperature during 15 h, deposited on a ZnSe prism (solid red line; same curve as in 
main text) or a SiO2 -coated ZnSe prism (dotted orange line), as well as dried at ambient pressure at a 
temperature of 65 ◦ C on a ZnSe prism (dash-dotted green line; same curve as in main text) or on a SiO2 
-coated ZnSe prism (dashed magenta line). The black ellipse marks the appearance of a shoulder in the 
amide I band for the heated droplets. (B) Same as in (A) but for aggregated protein. For the vacuum-
dried ZnSe prism spectra of three different droplets are presented (dashed, solid and dotted blue lines). 
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 In both cases - that is monomeric and aggregated protein - some of the differences 
between the spectra from ZnSe prisms and SiO2-coated ZnSe prisms may be explained by the 
different absorption behaviour on different substrates. Indeed, in all instances of the coated 
prisms we observe stronger absorption towards higher wavenumbers. Therefore, if protein 
aggregation from microdroplets is investigated, it is highly recommended to effect the drying 
under vacuum instead of at elevated temperature. Furthermore, we find that our spectra exhibit 
sharper features on the pure ZnSe prisms. Finally, comparison to a spectrum from a droplet 
containing initially monomeric protein that was dried at 65 °C and ambient pressure for 15 h – 
such that aggregation can occur within the droplet – reveals that the monomeric features of the 
amide I and III bands are lost upon fibrillation (dash-dotted green line; average over 21 spectra). 
Note that due to the normalization of the spectra to 1, the amide II band seems more pronounced. 
Nevertheless, the relative amplitudes of the amide II and III bands correspond very well to the 
spectra from the aggregates. For a ZnSe prism that was covered with SiO2 and heated with 
droplets containing monomeric lysozyme, we observed a similar increase of absorption in the 
amide I band but the peak in the amide III band did not vanish, which may be an indication of 
partial aggregation. 
5.3.3 Sensitivity and throughput of the method 
Given a droplet diameter of 25 µ m, the molar weight of lysozyme (14.3 kDa) and the 
concentration we have used for the monomers (6 mg/ml ∼ 400 µM), each droplet contains as 
little as 50 pg or 3 fmol of protein. We can estimate the sensitivity of this approach via the 
minimal sample thickness (recommended is 0.1 µ m, but we have obtained spectra from 
samples downto h≈ 60 nm height) of our Anasys nanoIR platform. Let evaluate the amount of 
analyte deposited on a square with length l to a height h using the inverse density of lysozyme 
(v = 0.7 ml/g). This yields to: 
𝐶𝑚𝑖𝑛 =  
𝑉𝑠𝑎𝑚𝑝𝑙𝑒/𝑣
𝑉𝑑𝑟𝑜𝑝𝑙𝑒𝑡
 ~ 
ℎ/𝑣
𝑙
     (1) 
and with l being maximally of the order of 300 µ m the minimal concentration is around 0.2 
mg/ml ∼ 20 µM.  While standard optical techniques may detect much smaller concentrations, 
nanoIR provides a quite different set of information: the nanometer spatially resolved IR spectra 
from picograms or sub-femtomoles of protein material. 
108 
 
 Finally, the time required to obtain a spectrum of a single droplet is typically of the order 
of a few minutes. Performing spatially resolved measurements may take much longer. 
Therefore, nanoIR can by no means be considered a high-throughput technique. NanoIR can 
provide information on the contents of the droplets that it is not accessible using traditional 
techniques. It should rather be regarded as a method complimentary to on-line high-throughput 
techniques where measurements can be taken at kHz rates at concentrations as low as tens of 
nM.280,281 
5.4 Discussions 
A technique for deposition and alignment of individual micrometer-sized droplets for their 
precise analysis using nanoscale spatially resolved IR spectroscopy was presented. Off-stream 
alignment on a grid was achieved by means of a stamp with a patterned indentation on its 
surface. Drying overnight fixes their content, which is accessible upon removal of the polymer 
grid. Subsequent high-precision measurement of local IR absorption demonstrates the power of 
this approach to probe structural transitions in ultra-small volumes. Spectra from droplets 
containing monomeric, aggregated and aggregating lysozyme were obtained and found to be 
readily distinguishable. In particular, the shift in the amide I band allowed us to identify an α-
to-β secondary structure transition which is associated with amyloid formation. Therefore, 
nanoscale IR spectroscopy represents a valuable analytic technique for the investigation of the 
amyloids. Once its robustness in differentiating diverse amyloidogenic species has been proved, 
the method could be successively applied to study the formation and properties of individual 
forming amyloidogenic aggregates at the nanoscale. 
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Chapter 6. INFRARED NANOSPECTROSCOPY 
CHARACTERIZATION OF OLIGOMERIC AND FIBRILLAR 
AGGREGATES DURING AMYLOID FORMATION 
This chapter is based on a paper in revision in the journal “Nature communications” with the 
following authors: 
Francesco Simone Ruggeri1, Giovanni Longo2, Serena Faggiano2, Ewelina Lipiec3, Annalisa Pastore2 
and Giovanni Dietler1  
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Abstract 
Amyloids are insoluble protein fibrillar aggregates. The importance of characterizing their 
aggregation has steadily increased because of their link to human diseases and material science 
applications. In particular, misfolding and aggregation of Josephin domain of ataxin-3 is 
implicated in spinocerebellar ataxia-3. Infrared nanospectroscopy, simultaneously exploiting 
Atomic Force Microscopy and Infrared Spectroscopy, can characterize at the nanoscale the 
conformational rearrangements of proteins during their aggregation. Here, we demonstrate that 
we can individually characterize the oligomeric and fibrillar species formed along the amyloid 
aggregation. We described their secondary structure, monitoring at the nanoscale an -to- 
transition, and coupled these studies with an independent measurement of the evolution of their 
intrinsic stiffness. These results allowed suggesting that the aggregation of Josephin proceeds 
from the monomer state to the formation of spheroidal intermediates with a native structure. 
Only successively, these intermediates evolve into misfolded aggregates and into the final 
fibrils.  
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6.1 Introduction 
Aging of the world population has increased the visibility of several neurodegenerative 
disorders such as Parkinson’s, Huntington’s, Alzheimer’s diseases and that of several forms of 
Ataxia.1 The onset of these and of more than other twenty pathologies is connected with fibrillar 
aggregates, termed amyloids.4 However, these structures are not only associated with diseases 
since they were also discovered in many physiologically beneficial roles (functional amyloids) 
including bacterial coatings, adhesives and structures for the storage of peptide hormones.5-7 
During their aggregation, these proteins, which are initially monomeric and soluble, undergo 
internal structural rearrangements leading to the formation of fibrils with a universal cross -
sheet quaternary structure.8 This is independent of the monomeric initial structure and is the 
fingerprint of amyloids. During the fibrillization process, several coexisting amyloidogenic 
species are formed.40 The aggregation pathway typically proceeds through the formation of 
oligomers and protofibrils, which eventually lead to the mature fibrils. Strong evidence 
indicates that the intermediate stages of fibrillization rather than the ending point are associated 
to cytotoxicity, posing the problem of investigating these early stages of fibrillization and the 
inter-conversion of monomers and oligomers into amyloid fibrils.24 However, the investigation 
of these processes and of the chemical, mechanical and structural properties of amyloid 
structures represents a formidable experimental challenge, in large part due to the dynamic and 
transient nature of the intermediate aggregation products. 
 To assist this challenging endeavor, development of new methodologies capable to 
capture shapes, size, chemical and structural properties of the aggregation species is of primary 
importance. In this work, we have employed an innovative technique able of monitoring the 
aggregation process of proteins at the nanoscale. This instrument (nanoIR, Anasys) exploits the 
combination of Atomic Force Microscopy (AFM) and infrared (IR) spectroscopy. AFM can 
provide direct information on the size, morphology and mechanical properties of amyloid 
species along the aggregation pathway.36,197,163 While, IR is widely used to describe the 
conformational changes in secondary structure of a protein through the process of 
aggregation.209,277,180,64 Separately, these conventional techniques do not tell us if and at which 
time point misfolding occurs, nor what is the secondary structure of the individual species. 
Indeed, AFM can only give morphological and nanomechanical description of the species 
formed during the aggregation pathway. While, as other bulk spectroscopic techniques, IR is 
just able to provide average structural information of the several amyloidogenic species, present 
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contemporarily in the heterogeneous aggregating solution, because it has limited  the smallest 
practical IR spot size to 20 m213  We, thus, used the new AFM-IR technique to structurally 
characterize the amyloid species at the nanoscale.212 This means that the system allows to 
overcome the diffraction limit and to map and characterize the chemical properties of biological 
specimens at the nanoscale.282 
This new technique is of primary significance when studying non homogeneous samples such 
as amyloids and it requires only tiny quantities of biological (smaller than pico-kilograms) 
specimens282, that is a major advantage when working with biological material whose 
production is expensive and time costly. 
In a preliminary work, we used nanoIR to analyze proteins deposited as patterned micro-
droplets by a microfluidic system. We acquired spectra from droplets containing monomeric 
and aggregated lysozyme, which were readily distinguishable. A shift in the amide I band 
allowed us to identify a -to- structure transition associated with amyloid formation.282 In the 
present work, we show how we are able to measure sub-micron maps and IR spectra along the 
whole aggregation pathway of the Josephin domain of ataxin-3. This human protein is of 
interest because responsible for spinocerebellar ataxia of type 3, an incurable neurodegenerative 
disease caused by misfolding and aggregation of this protein. The process is triggered by 
expansion of a polyglutamine tract present at the C-terminus but strongly modulated by the N-
terminal Josephin domain which is itself highly prone to aggregation.283,77,152,151 By means of a 
combination of size exclusion chromatography and circular dichroism spectroscopy, we 
previously suggested that Josephin retains its native-like structure at the initial states of 
aggregation, while eventually undergoing a -enriched structure.153 However, with the 
techniques available at the time, we could not determine when the conformational transition 
occurs or characterize structurally the aggregate intermediate species.  
We demonstrate here that nanoIR allows distinction in the same AFM map of structurally 
different objects by means of their different IR light absorption and chemical spectra. We could 
simultaneously detect the standard AFM morphology imaging and a description of the structural 
properties of Josephin protein and its aggregates. This allowed to structurally describe both 
oligomeric and fibrillar properties almost at the nanoscale providing new and powerful 
information on the aggregation pathway. We could also detect directly the conversion of 
monomers into amyloid -sheet aggregates and demonstrate that this occurs only after the first 
events of aggregation. Understanding the aggregation pathway of Josephin may provide 
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essential information on the role of this protein, which could ultimately be correlated to the 
mechanism that induces neurodegeneration. 
Our results provide convincing evidence that AFM-IR is a powerful methodology of general 
validity, which allows the study of the heterogeneous and polymorphic aggregation pathway of 
proteins. Its application to understand the structural bases of protein aggregation and misfolding 
holds a concrete promise towards a deeper comprehension of this field. 
6.2 Experimental Methods 
Sample preparation  
The N-terminal Josephin domain of ataxin-3 (residues 1-182) was produced as reported 
previously.154 Josephin was incubated at 37 °C to follow the aggregation pathway. Aliquots of 
10 l were taken before 2 and 7 days after incubation. 
Quantitative imaging AFM  
We performed all the Force Volume investigations using JPK Nanowizard III microscope (JPK 
Instruments AG, Berlin, Germany). The AFM head is working on a commercial inverted optical 
microscope (Axio Observer.A1, Carl Zeiss, Göttingen, Germany). Analyses were performed 
using Bruker DNP-10 cantilevers (Bruker probes, Berlin, Germany), choosing the ones with a 
nominal spring constant of 0.35 N/m. Before each experiment, we calibrated the mechanical 
properties of the tip using the JPK software. All images were obtained by working in the 
quantitative imaging (QI) modality, an evolution of the force-volume mode in which the AFM 
tip is placed in fast oscillation over the sample and the deformation of the cantilever is recorded 
to reconstruct an image formed by a large number of force distance (FD) curves. Typical images 
contain up to 256x256 pixels and, for every pixel, 2048 points per FD curves were collected. 
The length of the curves was 300 nm and the imaging speed ranged from 0.1 to 3 lines per 
second. The tip-sample interaction was limited to a maximum cantilever deflection of 3 nm (i.e. 
1 nN). The data files were recorded on at least 5 different areas per sample and on minimally 
20 different molecules per area. In total, the average values were calculated over more than 100 
individual molecules. Depending on the size and on the resolution of the image, the stiffness of 
each molecule was measured on a minimum of 5 points. Processing was done in a semi-
113 
 
automated way with the JPK data processing software assuming that the cantilever behaved 
accordingly to the Hook law (i.e., the deflection of the cantilever is directly proportional to the 
vertical component of the force applied on the tip). In this case, the FD curves collected on the 
sample can be subtracted from the FD curves obtained on the hard substrate, resulting in 
indentation curves. For calculations, we assumed a pyramidal tip model with a 35° opening 
angle. The shape of each indentation curve is then used to calculate the mechanical properties 
of the sample and specifically the stiffness. Measures of the average stiffness values for each 
condition (monomers, oligomers, fibrils) are expressed in MegaPascals (MPa) or GigaPascals 
(GPa) as the mean ± standard deviation (SD). 
NanoIR measurements  
For all the nanoscale IR measurements, we used a nanoIR platform (Anasys, CA- USA), which 
combines high resolution and low noise AFM with a tunable IR laser.  This instrument allows 
nanoscale measurements of IR absorption as a function of wavenumber to characterize 
specimens at spatial resolutions not previously achievable.  This approach has been made 
possible by the photothermal induced resonance effect (PTIR), also referred to as AFM-IR. 
More details regarding the AFM-IR experiment can be found elsewhere284-286.  
 The aliquot samples, diluted at 1 M, were deposited at the surface of the attenuated 
total internal reflection element prism made of ZnSe monocrystals and dried.  Then, they were 
scanned by the nanoIR microscopy system, with a rate line within 0.08-0.04 Hz and in contact 
mode. We used a silicon (AppNano, CA - USA) cantilever with a nominal radius of 10 nm and 
an elastic constant of about 0.5 N/m. All images have a resolution of at least 1024x512 pixels 
per line. The AFM images were treated using SPIP software. The height and IR amplitude 
images were first order flattened. The spectra were collected with a sampling of 1 cm-1 and 256 
co-averages, within the range 1200-1800 cm-1 and with a spectral resolution of 8 cm-1. Spectra 
were averaged from at least 10 measurements.  They were normalized using the microscope’s 
built-in Anasys software (Analysis Studio) and OriginPRO. Successively, they were smoothed 
with a Savitzky-Golay filter (2nd order, 9 points).  
 All measurements were performed at room temperature. The ultimate resolution of the 
instrument allows detecting objects with thickness of 50-100 nm and with a lateral resolution 
as small as the radius of the AFM tip. This minimal measurable thickness is defined by the 
minimal detectable photo-thermal expansion of the sample. On the other hand, the lateral 
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resolution of an isolated object is only limited by the sharpness of the AFM lever. In the case 
of non-isolated objects, thermal diffusion can limit lateral spatial resolution. 
Principal Component Analysis 
We performed the Principal Components Analysis (PCA) by means of the Non-linear Iterative 
Partial Least Squares (NIPALS) algorithm with cross validation and mean centered data, using 
Unscrambler 9.2 software (CAMO Norway). Analysis was performed on underivatised spectra 
and second derivatives. Second derivatives were calculated with Unscrambler 9.2 software 
using Savitzky–Golay algorithm for smoothing (2nd order, 9 smoothing points). The amide II 
region (1620 cm-1–1480 cm-1) was excluded from the analysis because of low signal to noise 
ratio in this spectral range, as mentioned earlier. 
6.3 Results 
6.3.1 Morphological properties of Josephin aggregates 
First, we followed the amyloid aggregation of the Josephin by AFM at 0 days, 2 and 7 days of 
incubation at 37°, Figure 6, to set the scenario for further observations.  At 0 days, spheroidal 
oligomeric species were present, with varying diameters from 3 to several hundreds of 
manometers (Figure 6.1A).  After 2 days, we could still observe a similar picture, but the 
oligomers lost their spheroidal shape (Figure 6.1B). At 7 days, there was massive formation of 
fibrillar aggregates (Figure 6.1C). The images showed fibrils entangling and forming supra-
molecular rod-like aggregates of progressively increasing height and width (Figure 6.1D-F). 
Moreover, a quantitative analysis indicated a linear relationship between the height and the 
convoluted width of the fibrillar structures. This suggested that the supra-molecular rod-shaped 
aggregates derive from the association of the single amyloid fibrils with height of 10-15 nm.287 
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Figure 6.1 Josephin’s aggregation and fibrillization process.  
AFM morphology at A) 0 days, B) 2 days, C) 7 days of incubation at 37 °C. D) Smaller observable 
fibrils with height in the order of 10-15 nm. E) Entangling fibrils with different growing height. F) 
Supra-molecular aggregate with height of approximately 115 nm. G) Analysis of fibrillar morphology: 
fibrils average convoluted (see first chapter, Fig. 1.14) width as a function of height. 
 The smaller oligomeric species have an average height of 3-6 nm at 0 days (Figure 
6.2A), of approximately 10 nm at 2 days (Figure 6.2B) and between 10-15 nm at 7 days (Figure 
6.2C). A statistical analysis of the height of the smaller oligomeric species in the AFM maps 
confirmed that this parameter is increasing as a function of the incubation time (Figure 6.2C-
E). Correspondingly, the smaller population of fibrils have an average height of ~10-15 nm 
(Figure 6.2G). In other words, at 7 days, the height of fibrillar structures corresponds to that of 
the oligomers, indicating that aggregation is following the usual process of oligomerization, in 
agreement with previous studies.153  
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Figure 6.2 Morphological analysis of the oligomerization process. 
A) AFM detail of the smaller oligomeric species at 0 days and relative cross-sectional dimensions. B) 
AFM detail of the smaller oligomeric species after 2 days of incubation and relative cross-sectional 
dimensions. C) Histogram distribution of the population of the smaller oligomers measured at 0 days, 
typical value of about 3-6 nm. D) Histogram of the height of the oligomers at 2 days, the typical value 
is about 10 nm. E) Histogram of the height of the oligomers at 7 days, the oligomeric population 
stabilized to approximately 10-15 nm height. 
6.3.2 Nanomechanical properties of Josephin aggregates 
To map the evolution of the nanomechanical properties of the Josephin aggregates, we used a 
fast force-volume system (Quantitative-Imaging - QI). We produced QI maps of the oligomeric 
(Figure 6.3A,B) and fibrillar (Figure 6.3C) structures. Before incubation, the spheroidal 
oligomers have a uniform Young’s modulus of 450 ± 200 MPa (Figure 6.3D). This value is 
appreciably smaller than what expected for an amyloid structure.10,12,163 After 2 days of 
incubation, the sample did not have uniform mechanical properties any longer and two different 
populations were observed. The first showed stiffness similar to the previous time point (550 ± 
170 MPa), while the latter showed a larger Young’s modulus of 1.1 ± 0.5 GPa (Figure 6.3E), 
a value consistent with formation of a -rich structure due to misfolding.46,288 The final fibrillar 
structures, after 7 days of incubation, had uniform stiffness of 1.9 ± 0.4 GPa (Figure 6.3F), in 
good agreement with the generally accepted value of stiffness of a mature and complete amyloid 
cross -sheet structure.10,12,163 
117 
 
 
Figure 6.3 Young’s modulus increases as a function of aggregation. 
AFM Quantitative imaging of: A) Oligomeric proteins at 0 days, B) Oligomers after 2 days, C) Fibrillar 
structure after 7 days of incubation at 37 °C. Stiffness cross sections of D) oligomers at 0 days, E) 
oligomers at 2 days, F) fibrillar structures. 
6.3.3 Infrared nanospectroscopy of Josephin amyloid species 
AFM can only provide a morphologic description of the species formed during the aggregation 
pathway but does not tell us if/at which time point misfolding occurs nor what is the structure 
of the individual species. We thus used nanoIR to characterize further the aggregation pathway. 
This technique is of particular value when studying non homogeneous samples, such as amyloid 
aggregates, offering an important advancement as compared to conventional IR techniques 
which, like most spectroscopies, averages the structural information over the highly 
heterogeneous aggregating solution. 
Native Oligomeric Species before incubation  
 We investigated the structural properties of Josephin, before incubation at 37 °C (Figure 
6.4 and 6.5). The images show the morphology (Figure 6.4 A) and the absorption of IR light 
in the amide I (1700 cm-1 and 1655 cm-1, Figure 6.4 B,C) and amide III (1300 cm-1, Figure 
6.4D) bands. From the comparison of the absorption maps and considering the components of 
118 
 
amide I band related to proteins secondary structure,184 we can infer that the oligomers adsorb 
mainly IR radiation in the spectral region of the amide I band, related to -helical and random 
coil conformations. These chemical absorption maps clearly indicated that the instrument could 
detect oligomeric structures with minimal average heights of approximately 50-100 nm.282  
 
Figure 6.4 AFM-IR chemical map of Josephin proteins before incubation at 37 °C (0 days). 
A) AFM height image. IR absorption map at: B) 1700 cm-1 (amide I). C) 1655 cm-1 (amide I). D) 1300 
cm-1 (amide III). 
 To confirm quantitatively the trend of absorption shown by IR, we acquired spectra of 
individual oligomeric aggregates present on the surface (Figure 6.5). The spectra range 
investigated was between 1800-1200 cm-1, where the amide band I, II and III of proteins are 
present. The nanoscale spectra acquisition was possible by positioning the AFM tip on each 
structure and collecting several spectra (minimum 10) inside their area, which is indicated in 
Figure 6.4 A by coloured circles.  System sensitivity to the photothermal expansion allowed to 
acquire spectra of objects with thickness (height in the AFM map) as small as approximately 
100 nm.210,211 
119 
 
 
Figure 6.5 AFM-IR spectra of the oligomeric species before incubation. 
Numbers in the caption correspond to the oligomers indicated in Figure 6.4. Spectrum number 6 derives 
from the measurement of an aggregate out of the presented image. 
 The comparison of these spectra shows that they have similar peak amplitudes and 
positions. The amide I band is approximately within 1655 cm-1 (-helix) and 1620 cm-1 (-
sheet) and centred at ~1630-1640 cm-1 (random coil) with a shoulder within 1720-1680 cm-1 
(antiparallel -sheets, -turns and side chains vibrations). The position of the amide II band is 
approximately within 1590-1560 cm-1. However, it is worth to note that sensitivity of the 
instrument in the spectra region within 1610-1550 cm-1 is limited by the extremely low power 
and higher instability of the laser in this region, which causes signal instability and low signal-
to-noise ratio (Figure 6.6). For this reason, in these region, the acquisition of chemical 
properties of objects with thickness close to the ultimate one (100 nm)210,211 is affected by noise 
and spectra deformation. The amide III band, centred at 1300 cm-1, appeared to be coupled with 
a second peak, which is visible at 1410-1400 cm-1. This was already observed in our studies on 
lysozyme, where we observed a change of the relative ratio of the amplitude of this peak and 
the amide III band during the process of aggregation.282 This peak can be attributed to a 
combination of COO-, C-N, C-C stretching vibration, C-H and N-H bending, in plane O-H 
bending. A weaker contribution derives from the vibration of the glutamine (1410 cm-1), 
glutamic acid (1404 cm-1) and aspartic acid (1402 cm-1) side chains.182,289 
120 
 
 
Figure 6.6 nanoIR laser’s power spectrum.  
Effective power of the laser at each wavenumber. The spectra are normalized in order to have constant 
laser power along all the investigated spectral region. 
 We estimated the secondary structure content of our Josephin uniform spheroidal 
intermediates before incubation at 37 ºC by de-convolution of the amide I band of the spectrum 
of the uniform protein aggregates before incubation (Figure 6.7). The analysis was performed 
by XPSPEAK and a -squared of at least 0.001 was reached for the statistical significance of 
the fit. The shoulder of the spectrum around 1715-1725 cm-1 was fitted by considering the IR 
absorption peaks of the side chain vibrations of aspartic and glutamic acids.290 The addition of 
this band in the fit is easily explicable considering that these amino acids are relatively abundant 
in the Josephin structure (~15% of total composition, ~30% more abundant than in the average 
protein composition). Moreover, these residues have stronger absorbance coefficients than the 
average side chains absorption and they are not superimposed to any other secondary structure 
component of amide I band. Although the shape of the band is affected by the high noise 
between 1610 cm-1 and 1550 cm-1, we could estimate a secondary structure content of 33% -
helix, 29% random coil, 23% -sheet and 15% -turn. These values are in excellent agreement 
with the monomeric structure of Josephin (35% -helix, 29% random coil, 19% -turn and 16% 
-sheet).283 Thus, before incubation, proteins retain a native structure. 
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Figure 6.7 Average oligomeric IR spectrum and secondary structure de-convolution of amide I 
band.  
 As mentioned above, the ultimate resolution for spectra acquisition was a sample 
thickness of approximately 100 nm. Even if we could not acquire the IR spectra of objects with 
smaller height than 100 nm, the division of IR maps by the corresponding AFM height map 
allowed enhancing the visualization of differential response of the structures to different IR 
light excitation.  In Figure 6.8 A,B, we focus our attention on several spheroidal oligomers 
with typical height of approximately 50-60 nm. Besides, we can observe the ratio maps resulting 
from the division of the IR absorption maps at 1655 cm-1 (Figure 6.8 C) and at 1300 cm-1 
(Figure 6.8 D) by the corresponding morphology map (Figure 6.8 A).  The comparison of the 
two ratio maps showed that it is possible to retrieve the spectroscopic behaviour of oligomeric 
species as small as 50-60 nm in height (for example oligomers 1 and 2 in Figure 6.8 A,B). 
Indeed, it is possible to observe that the spheroidal intermediates have higher absorption in the 
amide band I than in the amide band III, as already measured for the oligomeric species with 
bigger volume. This means that even if a full IR spectrum is not acquirable for such small 
objects, by functional imaging we can still retrieve the spectroscopic properties of objects as 
small as 50-60 nm in height.  
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Figure 6.8 Smallest detectable structures by infrared nanospectroscopy.  
AFM height. b) Height cross sections. IR absorption at c) 1655 cm-1 divided by height and at d) 1300 
cm-1 divided by height. 
Misfolded oligomeric species 
We repeated the measurements after incubation for two days (Figure 6.9). As for the 0-day 
case, we collected the AFM morphology (Figure 6.9 A) and the IR absorption maps (Figure 
6.9 B,C). At this time point, the IR absorption in the amide I spectral region, between 1700 cm-
1 and 1655 cm-1, remained approximately unchanged. Thus, we focused on the spheroidal 
structures present on the surface and acquired full IR spectrum (Figure 6.9 D,E). We could 
distinguish two different families of oligomeric structures. The amide I band of the first 
oligomeric species resonates at frequencies (1655-1620 cm-1) similar to the values observed for 
the spheroidal oligomers observed before incubation. However, the band shows an increased 
absorption around 1700 cm-1, which is consistent with an increased content of antiparallel -
sheet and -strand. The shift of the amide I band is more dramatic for the second species, which 
shows two bands with maxima at 1700 cm-1 and 1640 cm-1 respectively, indicating the 
disappearance of the -helical component and the increase of the antiparallel -sheet content, 
as also supported by an inversion of the amplitude ratio between amide III band and the one at 
1410 cm-1.  
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Figure 6.9 AFM and nanoIR analysis of oligomers at 2 days of incubation..  
A) AFM height image. IR absorption in amide I band at B) 1700 cm-1 C) 1655 cm-1. D) Spectra of 
misfolded oligomers, which are monomers-like with amide I similar to the monomeric structures. E) 
Spectra of misfolded oligomers, fibrils-like showing a conformational switch towards -sheet structure. 
Oligomeric and mature fibrillar species 
 After 7 days incubation, both oligomers and fibrils are present in the AFM images 
(Figure 6.10 A) with typical heights of 100-150 nm (Figure 6.10 B). Comparison of the 
absorption maps collected at the amide I band (Figure 6.11 A,B) and at the band around 1430 
cm-1 (Figure 6.11 C), shows a clear difference between oligomers and fibrils. The first species 
has higher absorption in the -helix component of the amide I band (1655 cm-1). The latter have 
higher absorption close to the -sheet and -turn components (1700-1680 cm-1) and at 1430 
cm-1. In other words, by performing absorption maps at different wavenumbers, we can clearly 
distinguish the structure of oligomers from that of fibrils through their different secondary 
structure content, which is causing differential response to IR light exposure. To prove the 
behaviour shown by the IR maps, we acquired spectra of individual oligomeric and fibrillar 
aggregates (Figure 6.11 E,F). Overall, the spectra of the fibrils are different from those of 
oligomers: they show a shift of the maximum of the amide I band at 1700 cm-1 and an inversion 
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of the amplitude ratio within the amide III band and the band around 1400 cm-1 , which has also 
a net shift towards higher wavenumbers (~1430 cm-1). This measurements showed that it is 
possible to distinguish structurally different amyloid species within the same AFM map.  
 
Figure 6.10 Morphological properties of aggregates after 7 days incubation.  
A) AFM height. B) Height cross sections. 
 
Figure 6.11 Spectra of oligomeric and fibrillar structures after 7 days incubation. 
IR absorption maps at: A) 1700 cm-1 (amide I), B) 1655 cm-1, (amide I) C) 1430 cm-1. Spectra of amyloid 
structures: D) Misfolded oligomers (corresponding structures to the spectra are indicated by numbers in 
Figure 6.10), E) Fibrils (corresponding structures to the spectra are indicated by letters in Figure 6.10).  
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6.3.4 Spectral signature of amyloid structure formation 
Finally, we performed Principal Components Analysis (PCA) to prove that the spectral 
differences measured between the different populations are statistically significant and to 
extract the spectral fingerprint of amyloid formation. PCA allowed noise reduction, resolution 
of subtle differences and detection of sub–groupings within the spectra. The most important 
results of PCA are the Scores Plots and the Loadings Plots. The Scores Plots represent the 
spectra in the multidimensional space of Principal Components, which represent the degree of 
variability within the ensemble of spectra. The Loadings Plots show which variables are 
responsible in the data set for the greatest degree of separation inside this spectra ensemble. 
The spectral differences are presented in the Loadings Plots. These determine clustering of 
spectra in the multidimensional Scores Plots. For the raw data, the maximum (minimum) of 
loading is related to the position of a particular vibrational motion, which is typical of the 
spectra clustered on the positive (negative) values of corresponding Principal Component (PC) 
on the Scores Plot. 
The collected spectra are placed in the new space of the Principal Components (PCs). Thus, we 
can distinguish three distinct clusters, corresponding to three groups of aggregates: native 
oligomers, misfolded oligomers and amyloid fibrils (Figure 6.12 A). PC-1, which explains 50% 
of total variance within the ensemble of spectra (black in Figure 6.12 B), is positively correlated 
with the wavenumbers attributed to the amide I in spectral range from 1710 cm -1 to 1680 cm-
1, to the COO- vibration around 1430 cm-1 and to the amide III at 1285 cm-1 (Figure 6.12 B). 
The Scores Plot shows that these three bands are positively correlated with the PC-1 scores for 
fibrils and, partially, for misfolded oligomers and negatively correlated with the PC-1 scores 
for native oligomers and partially for misfolded oligomers (Figure 6.12 B). This shows that the 
amide I band between 1655-1620 cm-1 and the amide III band at 1308 cm-1 are typical of these 
species. The PC-3, representing 10% of the total variance, clearly indicates a shift of the COO- 
band. The PC-3 is positively correlated with the COO- band at 1430 cm-1 (fibrils and partially 
misfolded oligomers) and negatively correlated with the band at 1412 cm-1 (native oligomers 
and partially misfolded oligomers).  
This analysis confirms statistically that the shift of the amide I band from 1655-1620 cm -1 to 
1710-1680 cm-1, the peak at 1430 cm-1 and the shift of amide III band from 1308 cm -1 to 1295 
cm-1 are markers (arrows in the Loadings Plot, Figure 6.12B) of the conformational transitions 
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from the random coil/-helical structure in native oligomers to -turn/antiparallel -sheet 
conformations in misfolded oligomers and final amyloids fibrils. 
 
Figure 6.12 PCA analysis.  
The results of PCA analysis in the spectral range 1800 cm-1 – 1270 cm-1 (excluding 1620 cm-1 – 1480 
cm-1) applied to three groups of spectra: native oligomers, misfolded oligomers and fibrils. a) 3-D Scores 
Plot. b) Loadings Plot. The arrows indicate the fingerprint of the conformational changes during amyloid 
formation. 
6.3.5 Correlation between nanomechanical and structural properties 
The aggregation pathway of Josephin comprises species of large heterogeneity, as we 
confirmed by using different AFM based techniques. Morphology measurements showed that 
fibrillization follows the usual nucleation process of oligomerization. QI force volume indicated 
that the intrinsic stiffness of amyloidogenic species increases as a function of fibrillation 
maturity (Figure 6.13 A). A more direct answer on the structural changes that individual 
amyloid species undergo during aggregation was provided by coupling these results with 
infrared nanospectroscopy. The initial uniformity of the sample before incubation and the 
presence of two structurally different oligomeric species at 2 days are well in agreement with 
intrinsic stiffness measurements performed by QI. For both techniques, we observed two 
families of misfolded oligomers (Figure 6.3 and 6.9). The first has nanomechanical and 
structural properties similar to those of native oligomers, and we have denominated it native-
like. The latter shows an increased stiffness and -sheet content, and we called it fibril-like. 
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Finally, the system evolves into a uniform group of fibrillar structures exhibiting the stiffness 
values and -sheet content typical of amyloids (Fig. 6.13 A,B). 
 
Figure 6.13 Model of the link between nanomechanical and structural properties. 
A) Young’s modulus increases as a function of fibrillization maturity. B) Spectra of native oligomers at 
0 days (blue), misfolded oligomers at 7 days (orange) and amyloid fibrils at 7 days (red). The red arrow 
indicates the increase of content of -sheets secondary structure. c) Model of the possible pathways of 
Josephin aggregation: the transparent model refers to the generally accepted model “first-misfolding-
then-aggregation”, the solid one depicts the model we suggest in this work, “first-aggregation-then-
misfolding”. In the lower part of the panel, to illustrate the steps of the fibrillization, we show 
representative AFM images collected at 0, 2 and 7 days. 
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6.4 Discussion 
Characterization of all the species formed along the aggregation pathway of a protein is 
essential in view of the role that protein aggregation has in human health and in material science. 
In this work, we have investigated, for the first time at the nanoscale, the aggregation pathway 
of the Josephin domain of ataxin-3, a protein known to be highly fibrillogenic. We could 
observe directly the conformational transition from native spheroidal oligomers, through 
misfolded oligomers, to the final amyloid fibrils. We probed the secondary structure of the 
aggregates down to 50 nm and demonstrated that, before incubation, the secondary structure of 
Josephin inside the spheroidal oligomers is clearly native, while misfolding occurs only later, 
when a conformational transition towards -enriched structure occurs. This indicates the 
intermediate nature of the oligomers, some sharing the structural properties of native monomers 
(monomer-like), the others being more similar to fibrils (fibril-like). The fibril-like oligomers 
form mature fibrils, which have a -rich structure and mechanical properties typical of 
amyloids. This means that we can identify the spectral fingerprint of the -to- transition that 
native proteins undergo during fibrillization at the nanoscale. 
 In this way, we correlated the secondary structure of amyloid intermediates and final 
aggregates to their nanomechanical properties. Indeed, it is central to measure and quantify the 
ultrastructural properties of amyloid fibrils in order to appreciate their full potential as 
biomaterials. It was already suggested that the content of -sheets in the aggregates during 
fibrillization process is an important parameter affecting the nanomechanical properties of these 
structures. AFM measurements and simulations suggested that the intermolecular interactions 
(e.g. hydrogen bonds) between -sheet layers are responsible for the notable mechanical 
properties of amyloid fibrils.238-241 Our results directly demonstrated, together with the 
nanomechanical measurements of amyloid structures showed in the fourth chapter,291 for the 
first time at the individual amyloid species scale, that the increase of -sheet content is a 
fundamental parameter determining the growth of amyloids intrinsic stiffness. Moreover, our 
evidence strongly suggests that Josephin aggregation precedes misfolding, indicating this 
protein as an example in which the assumption of ‘first-misfolding-and-then-aggregation’ may 
not be true.292 This possibility is often assumed implicitly or explicitly, mainly because of the 
observation that misfolding of many globular proteins occurs only upon destabilization of the 
native fold. Such misfolding allows exposure of fibrillogenic sequences otherwise protected in 
the hydrophobic core. On the other hand, a different pathway to amyloid formation (‘first- 
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aggregation-and-then-misfolding’) has been more recently identified, in which aggregation of 
normally globular proteins has been suggested to start from conformational states close to 
native ones, with no need of transitions across the major energy barrier for unfolding.293 Our 
conclusions agree with the evidence that Josephin aggregation is promoted by exposed 
hydrophobic patches, which have evolved to allow interaction with the non-pathologic cellular 
partner ubiquitin. 
Infrared nanospectroscopy proved to be ideal for this study and to characterize individually the 
species formed along the aggregation pathway, which comprises species of large heterogeneity. 
We were able to reconstruct the aggregation process and to link nanomechanical and structural 
properties of individual amyloidogenic species throughout their fibrillization pathway. 
Conventional methods could not have provided this information with the same clarity. This is 
promising for the development of biomaterials for a broad spectrum of applications in food, 
nanotechnology and in medicine. Under this perspective, the use of nanoIR can have terrific 
applications and provide a unique tool to study the aggregation pathway of proteins and help us 
to design molecules that could interfere with amyloid aggregation. 
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Chapter 7. Conclusions and future perspectives 
A key reason for the longstanding and widespread interest in the biophysical and biochemistry 
studies of amyloids fibrillation is the strict link with several human illnesses and 
neurodegenerative diseases. Despite its fundamental role in biological function and 
malfunction, the mechanism of protein aggregation and the fundamental origins of the 
connection between the aggregation process and cellular toxicity have remained challenging to 
elucidate in molecular detail. Strong evidence intimately correlated the physical and structural 
properties of intermediate and final forms of amyloids to the biochemistry of 
neurodegeneration. However, the molecular origins of the process of neurodegeneration and its 
connection with amyloid formation remain unclear and there is no cure to the related diseases. 
Therefore, the unraveling of the mechanisms of amyloid formation and polymorphism, as well 
as the mechanical and structural properties of the products of their aggregation is fundamental 
to understand their stability, toxicity and mechanism of clearance in the body. This is central in 
order to design new therapeutic strategies to the diseases problem. Furthermore, it has been 
recently found that it exists an always-bigger class of functional amyloids occurring naturally 
in several disease-unrelated biological processes and that many artificial peptides can form 
amyloid-like structures in-vitro. For this reason, in order to appreciate the full potential of 
amyloid fibrils also as biomaterials for future biomedical and nanotechnology applications, it 
is important to measure and quantify the structural and mechanical properties of amyloid fibrils 
and understand how they emerge from the fibrillization process. 
 In the frame of this PhD thesis, we have been able to bring new insight into the nanoscale 
investigation of several specific aspects of the amyloid fibrillation process and of the structural 
properties of the products of the aggregation. We challenged this problem by the use of single 
molecule AFM-based methodologies. Together with conventional AFM imaging, we reported 
the successful application of nanomechanical mapping (PF-QNM) to inquire the nature of the 
notable intrinsic stiffness of amyloids and we reported the first application of infrared 
nanospectroscopy to elucidate proteins misfolding and amyloid species ultrastructural 
properties at the single aggregate scale. These studies led to new insights into the problem of 
biophysical investigation of amyloid formation and structure, which enabled us formulating the 
following conclusions:  
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- Proteins mutations can enhance/inhibit the kinetics of oligomerization and 
fibrillization. 
  A statistical analysis of oligomeric, protofibrillar and fibrillar cross-sectional 
dimensions has been successfully applied to compare the kinetics of wild type and mutated 
forms of -synuclein and huntingtin proteins. In the first case, it was demonstrated the link 
between a sequence mutation (H50Q) in -synuclein, enhancing aggregation propensity, 
and Parkinson’s disease onset. In the latter, it was investigated the effects of post-
translational mutations, and in particular of the N-terminus phosphorylation, in the 
fibrillization kinetics of the huntingtin protein. We showed that phosphorylation of the 
protein conspicuously slowed down the oligomerization and fibrillization process. 
Elucidating the role of mutations is fundamental to investigate both physiological and 
disease related functions of proteins. 
- The early stages of -synuclein aggregation proceed directly through the assembly of 
monomers into single monomeric strands amyloid species.  
  Scanning probe analyses are routinely limited to the use of only one substrate 
and this procedure produces just a partial depiction of the extremely heterogeneous 
aggregating solution. In our work, the use of three different surfaces of deposition with 
different state of charge (positive, negative, hydrophobic) allowed to overcome the 
problem of surface selectivity, to inquire deeply amyloids polymorphism and to have a 
complete representation of the heterogeneity of the aggregating amyloid solution. Thus, we 
investigated the slow and fast aggregation process of -synuclein by means of the 
differential surface-protein absorption method. We showed that their early aggregation 
stages did not follow the classical oligomers-nucleated process. More specifically, we were 
able to highlight that the first stages of amyloid formation comes from direct assembling 
of unfolded monomers into prefibrillar species, which further hierarchically assembly into 
the mature fibrils. Remarkably, this behavior is independent on pH and the agitation of the 
sample during incubation. This new mechanism of fibril formation might bring new 
insights to the problem of neurodegeneration. Indeed the discovered new monomeric 
prefibrillar species could be the species ascribed to toxicity. 
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- The -sheet content determines the mechanical properties of amyloid species during 
aggregation. 
  We observed a monotonic evolution of the elastic modulus of amyloid species 
of a-synuclein and A42, as a function of sample fibrillization and incubation maturity, by 
means of the innovative PF-QNM method. Coupling this study with secondary structure 
bulk measurements, we could conclude that the increase of stiffness is strictly linked to the 
improving of -sheet structural ordering and of intermolecular hydrogen bonds into 
aggregates during the process of aggregation. Notably, the different elastic modulus 
between monomeric, protofibrillar and fibrillar structure could be strictly linked to their 
toxicity. Finally, the understanding of amyloid mechanical properties would be 
fundamental for the development of new amyloid bioengineered materials.  
- Infrared nanospectroscopy allows studying amyloid misfolding and structure at the 
nanoscale. 
  AFM-based infrared spectroscopy allowed studying amyloids ultrastructural 
properties at the nanoscale with astonishing resolution. The obtained results promise 
notable advances for the comprehension of the pathway of fibrils formation and for the 
studying of amyloid polymorphism. Initially, as proof of concept, the technique was 
applied to investigate structural differences in the IR spectra of monomeric and aggregated 
lysozyme from single -droplets with picolitre volume. In particular, the shift of the amide 
I band toward lower wavenumbers allowed identifying an -to- structure transition 
associated with amyloid formation. Successively, we applied nanoIR to measure the 
properties of the several species present in the heterogeneous aggregation solution at the 
nanoscale. We could reconstruct the conformational changes that the Josephin domain of 
ataxin-3 undergoes during aggregation. In particular, coupling these studies with parallel 
nanomechanical measurements, we could link mechanical and structural properties of 
oligomers and fibrils at the individual nanoscale aggregate scale. Furthermore, the recent 
improvements in the nanoIR technique could allow measuring directly at single molecule 
scale the misfolding of monomers and the conformational changes of proteins during their 
aggregation.  
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These specific studies and conclusions brought new insights into the problem of protein self-
assembling. Notwithstanding the usefulness of this information, several general scientific 
questions, whose answer is fundamental to address successfully the problem of misfolding 
diseases, are still open: 
a) Which is the main pathway of fibrillation process? Do amyloid fibrils generally form 
directly from naturally unfolded monomers association? Could oligomers be always off-
pathway with respect to the formation of mature fibrils? 
b) Would it be possible to have direct information at the single molecule level on the link 
between elastic and structural properties of amyloids at the single molecule scale? 
c) Which are the structural properties of the different amyloidogenic structures? 
 In order to answer these questions, we believe the idea that bridging together bulk and 
single molecule techniques has central importance. Consequently, we have already planned 
some future studies to inquire these questions. First, an extensive application, for different 
amyloid proteins, of differential surface-protein absorption effect in combination with bulk 
techniques, such as ThioflavinT and Circular Dichroism, and an advanced application of 
statistical theory of biopolymers could bring new information to understand the general 
pathway of amyloid formation. The possibility of successfully measuring at the single molecule 
scale the secondary structure of amyloid species has been achieved by exploiting quantum 
cascade lasers, which have allowed a 10-fold improvement in the sensitivity of infrared 
spectroscopy (nanoIR2, Anasys Instruments) , allowing measurements of IR spectra of single 
molecules. Preliminary measurements already enabled to inquire the secondary structure of 
single amyloid fibrils. Furthermore, the ability to study spectroscopically the contents of single 
microdroplets individually with a high-precision method opens up the possibility for a wide 
range of experiments benefiting from the unique advantages of microfluidics. We would like to 
pursue in the future two key experiments. In the first, we aim to combine nanoIR with 
microfluidic on-chip selection techniques and pre-screening for a predefined species within 
droplets for a high-throughput investigation of protein aggregation evolution. In the latter, we 
would apply nanoIR to investigate directly liquid phase separation in concentrated protein 
solutions and its effect on amyloid formation. Together with mechanical and structural analysis 
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of the micro-gel, this could bring direct information between mechanical and structural 
properties of amyloids.  
 We believe that the development of new biophysical methodologies, which are able to 
bridge together the investigation of morphological and ultrastructural properties of amyloid at 
the nanoscale, represents a fruitful avenue to address the challenge of solving the problem of 
protein self-assembly, to unravel monomer misfolding and to elucidate the molecular 
mechanisms of amyloid polymorphism and formation. Such a molecular level understanding of 
the key pathogenic processes is crucial in order to provide the basis to answer the proposed 
above scientific questions. Their elucidation would be fundamental for establishing rational 
approaches to the prevention and to the design of pharmacological approaches to combat 
amyloid-related diseases. 
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